GWAS:0001 1,5-anhydroglucitol levels GWAS:0002 3-hydroxy-1-methylpropylmercapturic acid levels in smokers GWAS:0003 3-hydroxypropylmercapturic acid levels in smokers GWAS:0004 3-month functional outcome in ischaemic stroke modified Rankin score GWAS:0005 3-month functional outcome in lacunar ischaemic stroke modified Rankin score GWAS:0006 3-month functional outcome in non-lacunar ischaemic stroke modified Rankin score GWAS:0007 5-HTT brain serotonin transporter levels GWAS:0008 6-month creatinine clearance change response to tenofovir treatment in HIV infection treatment arm interaction GWAS:0009 Abdominal aortic aneurysm GWAS:0010 Ability to confide in someone GWAS:0011 Abnormal white matter microstructure in first episode schizophrenia multivariate analysis GWAS:0012 Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease Alzhiemer's diagnosis trajectory interaction GWAS:0013 Accelerometer-based physical activity measurement average acceleration GWAS:0014 Accelerometer-based physical activity measurement fraction of time with accelerations >425 milli-gravities GWAS:0015 Acenocoumarol maintenance dosage GWAS:0016 Achilles tendinopathy GWAS:0017 Acne severe GWAS:0018 Acoustic startle blink response GWAS:0019 ACPA-positive rheumatoid arthritis smoking interaction GWAS:0020 Activated partial thromboplastin time GWAS:0021 Acute anterior uveitis in ankylosing spondylitis GWAS:0022 Acute anterior uveitis with or without ankylosing spondylitis GWAS:0023 Acute graft versus host disease in bone marrow transplantation donor effect GWAS:0024 Acute graft versus host disease in bone marrow transplantation recipient effect GWAS:0025 Acute insulin response GWAS:0026 Acute insulin response insulin secretion adjusted GWAS:0027 Acute kidney injury in coronary artery bypass surgery creatinine rise GWAS:0028 Acute kidney injury in critical illness GWAS:0029 Acute lymphoblastic leukemia adolescents and young adults GWAS:0030 Acute lymphoblastic leukemia B-cell precursor GWAS:0031 Acute lymphoblastic leukemia childhood GWAS:0032 Acute lymphoblastic leukemia in childhood B cell precursor GWAS:0033 Acute-on-chronic liver failure in hepatitis B GWAS:0034 Acute urticaria and angioedema non-steroidal anti-inflammatory drug-induced GWAS:0035 Acylcarnitine levels GWAS:0036 ADAMTS13 activity GWAS:0037 ADAMTS13 levels GWAS:0038 Addiction GWAS:0039 Adenocarcinoma GWAS:0040 Adiponectin levels GWAS:0041 Adiponectin levels BMI-adjusted GWAS:0042 Adiponectin levels in pregnancy GWAS:0043 Adiposity GWAS:0044 Adolescent idiopathic scoliosis GWAS:0045 Adolescent idiopathic scoliosis severe GWAS:0046 Adult asthma GWAS:0047 Advanced age-related macular degeneration GWAS:0048 Advanced glycation end-product levels GWAS:0049 Adventurousness GWAS:0050 Adverse response to antithyroid drugs in Graves disease GWAS:0051 Adverse response to aromatase inhibitors GWAS:0053 Adverse response to chemotherapy in breast cancer alopecia GWAS:0054 Adverse response to chemotherapy in breast cancer alopecia anti-microtubule GWAS:0055 Adverse response to chemotherapy in breast cancer alopecia cyclophosphamidedoxorubicin -5FU GWAS:0056 Adverse response to chemotherapy in breast cancer alopecia cyclophosphamideepirubicin -5FU GWAS:0057 Adverse response to chemotherapy in breast cancer alopecia docetaxel GWAS:0058 Adverse response to chemotherapy in breast cancer alopecia paclitaxel GWAS:0059 Adverse response to chemotherapy neutropenia leucopenia 5-fluorouracil GWAS:0060 Adverse response to chemotherapy neutropenia leucopenia all anthracycline-based drugs GWAS:0061 Adverse response to chemotherapy neutropenia leucopenia all antimetabolite drugs GWAS:0062 Adverse response to chemotherapy neutropenia leucopenia all antimicrotubule drugs GWAS:0063 Adverse response to chemotherapy neutropenia leucopenia all platinum-based drugs GWAS:0064 Adverse response to chemotherapy neutropenia leucopenia all topoisomerase inhibitors GWAS:0065 Adverse response to chemotherapy neutropenia leucopenia camptothecin GWAS:0066 Adverse response to chemotherapy neutropenia leucopenia carboplatin GWAS:0067 Adverse response to chemotherapy neutropenia leucopenia cisplatin GWAS:0068 Adverse response to chemotherapy neutropenia leucopenia cyclophosphamide GWAS:0069 Adverse response to chemotherapy neutropenia leucopenia docetaxel GWAS:0070 Adverse response to chemotherapy neutropenia leucopenia doxorubicin GWAS:0071 Adverse response to chemotherapy neutropenia leucopenia epirubicin GWAS:0072 Adverse response to chemotherapy neutropenia leucopenia etoposide GWAS:0073 Adverse response to chemotherapy neutropenia leucopenia gemcitabine GWAS:0074 Adverse response to chemotherapy neutropenia leucopenia paclitaxel GWAS:0075 Adverse response to chemotherapy neutropenia leucopenia paclitaxel carboplatin GWAS:0076 Adverse response to lamotrigine and phenytoin GWAS:0077 Adverse response to radiation therapy GWAS:0078 Affective disorder and suicide attempts GWAS:0079 Age at first birth GWAS:0080 Age at first sexual intercourse GWAS:0081 Age at loss of ambulation in Duchenne muscular dystrophy GWAS:0082 Age at menopause GWAS:0083 Age at smoking initiation in chronic obstructive pulmonary disease GWAS:0084 Age at voice drop GWAS:0085 Age of smoking initiation GWAS:0086 Age of smoking initiation MTAG GWAS:0087 Age-related cataracts GWAS:0088 Age-related cataracts age at onset GWAS:0089 Age-related disease endophenotypes GWAS:0090 Age-related diseases and mortality GWAS:0091 Age-related diseases, mortality and associated endophenotypes GWAS:0092 Age-related hearing impairment GWAS:0093 Age-related macular degeneration GWAS:0094 Age-related macular degeneration choroidal neovascularisation GWAS:0095 Age-related macular degeneration CNV vs GA GWAS:0096 Age-related macular degeneration extreme sampling GWAS:0097 Age-related macular degeneration geographic atrophy GWAS:0098 Age-related macular degeneration smoking status interaction GWAS:0099 Age-related macular degeneration wet GWAS:0100 Age-related nuclear cataracts GWAS:0101 Age spots GWAS:0102 Aggressiveness in attention deficit hyperactivity disorder GWAS:0103 Aggressive periodontitis GWAS:0104 Aggressive periodontitis sex interaction GWAS:0105 Aging GWAS:0106 Aging facial GWAS:0107 Aging time to death GWAS:0108 Aging time to event GWAS:0109 Aging traits GWAS:0110 AIDS GWAS:0111 AIDS progression GWAS:0112 Airflow obstruction GWAS:0113 Airway hyperresponsiveness GWAS:0114 Airway imaging phenotypes GWAS:0115 Airway responsiveness in chronic obstructive pulmonary disease GWAS:0116 Airway wall thickness GWAS:0117 Alanine aminotransferase ALT levels after remission induction therapy in actute lymphoblastic leukemia ALL GWAS:0118 Alanine aminotransferase levels GWAS:0119 Alanine aminotransferase levels in excessive alcohol consumption GWAS:0120 Alanine aminotransferase levels in low alcohol consumption GWAS:0121 Alanine transaminase levels GWAS:0122 Albumin-globulin ratio GWAS:0123 Alcohol and nicotine co-dependence GWAS:0124 Alcohol consumption GWAS:0125 Alcohol consumption drinkers vs non-drinkers GWAS:0126 Alcohol consumption drinks per week GWAS:0127 Alcohol consumption drinks per week MTAG GWAS:0128 Alcohol consumption heavy vs light non-drinkers GWAS:0129 Alcohol consumption in current drinkers GWAS:0130 Alcohol consumption max-drinks GWAS:0131 Alcohol consumption over the past year GWAS:0132 Alcohol consumption transferrin glycosylation GWAS:0133 Alcohol dependence GWAS:0134 Alcohol dependence age at onset GWAS:0135 Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis GWAS:0136 Alcohol dependence symptom count GWAS:0137 Alcoholic chronic pancreatitis GWAS:0138 Alcoholism 12-month weekly alcohol consumption GWAS:0139 Alcoholism alcohol dependence factor score GWAS:0140 Alcoholism alcohol use disorder factor score GWAS:0141 Alcoholism heaviness of drinking GWAS:0142 Alcohol misuse trauma interaction GWAS:0143 Alcohol use disorder consumption score GWAS:0144 Alcohol use disorder dependence and problematic use scores GWAS:0145 Alcohol use disorder total score GWAS:0146 Allergic dermatitis nickel GWAS:0147 Allergic disease asthma, hay fever or eczema GWAS:0148 Allergic rhinitis GWAS:0149 Allergic rhinitis in asthma GWAS:0150 Allergic rhinitis in non-asthmatics GWAS:0151 Allergic sensitization GWAS:0152 Allergy GWAS:0153 Alloimmunization response to pregnancy HLA class I GWAS:0154 Alloimmunization response to red blood cell transfusion in sickle cell anemia GWAS:0155 Alopecia areata GWAS:0156 Alzheimer disease and age of onset GWAS:0157 Alzheimer's disease GWAS:0158 Alzheimer's disease age of onset GWAS:0159 Alzheimer's disease APOE e4 interaction GWAS:0160 Alzheimer's disease biomarkers GWAS:0161 Alzheimer's disease cognitive decline GWAS:0162 Alzheimer's disease in APOE e4 carriers GWAS:0163 Alzheimer's disease in APOE e4- carriers GWAS:0164 Alzheimer's disease late onset GWAS:0165 Alzheimer's disease or family history of Alzheimer's disease GWAS:0166 Alzheimer's disease or small vessel stroke GWAS:0167 Alzheimer's disease progression score GWAS:0168 Alzheimer's disease survival time GWAS:0169 Alzheimer's disease with language domain impairment GWAS:0170 Alzheimer's disease with memory domain impairment GWAS:0171 Alzheimer's disease with multiple cognitive domain impairments GWAS:0172 Alzheimer's disease with no specific cognitive domain impairment GWAS:0173 Alzheimer's disease with visuospatial domain impairment GWAS:0174 Amino acid levels GWAS:0175 Amyloid A serum levels GWAS:0176 Amyotrophic lateral sclerosis GWAS:0177 Amyotrophic lateral sclerosis age of onset GWAS:0178 Amyotrophic lateral sclerosis C9orf72 mutation interaction GWAS:0179 Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals GWAS:0180 Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals GWAS:0181 Amyotrophic lateral sclerosis or frontotemporal dementia GWAS:0182 Amyotrophic lateral sclerosis sporadic GWAS:0183 Androgen levels GWAS:0184 Anger GWAS:0185 Angiotensin-converting enzyme activity GWAS:0186 Angiotensin-converting enzyme inhibitor intolerance GWAS:0187 Ankle-brachial index GWAS:0188 Ankle injury GWAS:0189 Ankylosing spondylitis GWAS:0190 Anorexia nervosa GWAS:0191 Anorexia nervosa excluding migration to or from binge-eating disorder or bulimia nervosa GWAS:0192 Anorexia nervosa or obsessive-compulsive disorder GWAS:0193 Anterior chamber depth GWAS:0194 Anterior cruciate ligament rupture GWAS:0195 Anthracycline-induced cardiotoxicity in childhood cancer GWAS:0196 Anthropometric traits GWAS:0197 Anthropometric traits in newborns GWAS:0198 Anthropometric traits multi-trait analysis GWAS:0199 Antibody level in response to infection GWAS:0200 Antibody status in Tripanosoma cruzi seropositivity GWAS:0201 Anticoagulant levels GWAS:0202 Anti-cyclic Citrullinated Peptide Antibody GWAS:0203 Antidepressant treatment resistance > 2 drugs prescribed GWAS:0204 Antidepressant treatment resistance number of drugs prescribed GWAS:0205 Anti-Epstein-Barr virus nuclear antigen EBNA IgG levels GWAS:0206 Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age GWAS:0207 Antineutrophil cytoplasmic antibody-associated vasculitis GWAS:0208 Antinuclear antibody levels GWAS:0209 antipsychotic drug dosage in schizophrenia or schizoaffective disorder GWAS:0210 Antipsychotic drug-induced QTc interval change in schizophrenia GWAS:0211 Antipsychotic drug-induced QTc interval prolongation GWAS:0212 Antipsychotic drug-induced weight gain GWAS:0213 Antipsychotic drug-induced weight gain time interaction GWAS:0214 Anti-saccade error rate in psychotic disorders GWAS:0215 Anti-saccade response GWAS:0216 Antithyroid drug-induced agranulocytosis GWAS:0217 Anti-thyroid drug induced agranulocytosis GWAS:0218 Antitragus size GWAS:0219 Anxiety and major depressive disorder GWAS:0220 Anxiety disorder GWAS:0221 Anxiety disorder factor score GWAS:0222 Anxiety in major depressive disorder GWAS:0223 Anxiety tension special factor of neuroticism GWAS:0224 Aortic root size GWAS:0225 Aortic stiffness GWAS:0226 Aortic-valve calcification GWAS:0227 Aortic valve stenosis GWAS:0228 Apolipoprotein A1 levels GWAS:0229 Apolipoprotein A-IV levels GWAS:0230 Apolipoprotein Levels GWAS:0231 Appendicitis GWAS:0232 Appendicular lean mass GWAS:0233 AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor GWAS:0234 Area under the curve of insulin levels GWAS:0235 Arsenic metabolism GWAS:0236 Arterial stiffness GWAS:0237 Arthritis juvenile idiopathic GWAS:0238 Asparaginase hypersensitivity in acute lymphoblastic leukemia GWAS:0239 Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia onset time GWAS:0240 Aspartate aminotransferase levels GWAS:0241 Aspartate aminotransferase levels in excessive alcohol consumption GWAS:0242 Aspartate aminotransferase levels in low alcohol consumption GWAS:0243 Asperger disorder GWAS:0244 Aspirin exacerbated respiratory disease in asthmatics GWAS:0245 Aspirin hydrolysis plasma GWAS:0246 Asthma GWAS:0247 Asthma and hay fever GWAS:0248 Asthma bronchodilator response GWAS:0249 Asthma childhood onset GWAS:0250 Asthma-chronic obstructive pulmonary disease overlap syndrome GWAS:0251 Asthma corticosteroid response GWAS:0252 Asthma exacerbations in inhaled corticosteroid treatment GWAS:0253 Asthma moderate or severe GWAS:0254 Asthma or allergic disease pleiotropy GWAS:0255 Asthma or chronic obstructive pulmonary disease GWAS:0256 Asthma sex interaction GWAS:0257 Asthma toluene diisocyanate-induced GWAS:0258 Asymmetrical dimethylarginine levels GWAS:0259 Atazanavir levels GWAS:0260 Atopic dermatitis GWAS:0261 Atopic march GWAS:0262 Atopy GWAS:0263 Atrial fibrillation GWAS:0264 Atrial fibrillation atrial flutter GWAS:0265 Atrioventricular conduction GWAS:0266 Atrioventricular septal defects in Down syndrome GWAS:0267 Attention deficit hyperactivity disorder GWAS:0268 Attention deficit hyperactivity disorder and conduct disorder GWAS:0269 Attention deficit hyperactivity disorder combined symptoms GWAS:0270 Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms GWAS:0271 Attention deficit hyperactivity disorder inattention symptoms GWAS:0272 Attention deficit hyperactivity disorder motor coordination GWAS:0273 Attention deficit hyperactivity disorder or amygdala volume pleiotropy GWAS:0274 Attention deficit hyperactivity disorder or cannabis use GWAS:0275 Attention deficit hyperactivity disorder or caudate nucleus volume pleiotropy GWAS:0276 Attention deficit hyperactivity disorder or intracranial volume pleiotropy GWAS:0277 Attention deficit hyperactivity disorder or putamen volume pleiotropy GWAS:0278 Attention deficit hyperactivity disorder symptom score GWAS:0279 Attention deficit hyperactivity disorder symptoms maternal expressed emotions interaction GWAS:0280 Attention deficit hyperactivity disorder time to onset GWAS:0281 Attention function GWAS:0282 Attention function in attention deficit hyperactive disorder GWAS:0283 Autism GWAS:0284 Autism and educational attainment MTAG GWAS:0285 Autism and major depressive disorder MTAG GWAS:0286 Autism and schizophrenia MTAG GWAS:0287 Autism spectrum disorder GWAS:0288 Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined GWAS:0289 Autism spectrum disorder or schizophrenia GWAS:0290 Autism spectrum disorder-related traits GWAS:0291 Autoimmune hepatitis in primary sclerosing cholangitis GWAS:0292 Autoimmune hepatitis type-1 GWAS:0293 Autoimmune thyroid diseases Graves disease or Hashimoto's thyroiditis GWAS:0294 Autoimmune traits GWAS:0295 Automobile speeding propensity GWAS:0296 Axial length GWAS:0297 Axial length or spherical error univariate decomposition analysis GWAS:0298 B6 vitamer levels multivariate analysis GWAS:0299 Bacteremia GWAS:0300 Bacterial meningitis GWAS:0301 Balding GWAS:0302 Balding type 1 GWAS:0303 Barrett's esophagus GWAS:0304 Barrett's esophagus or Esophageal adenocarcinoma GWAS:0305 Barrett's esophagus x BMI interaction GWAS:0306 Barrett's esophagus x pack-years of smoking exposure interaction GWAS:0307 Basal cell carcinoma GWAS:0308 Basal ganglia growth GWAS:0309 Basal metabolic rate GWAS:0310 Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma GWAS:0311 Basophil percentage of granulocytes GWAS:0312 Basophil percentage of white cells GWAS:0313 B cell acute lymphoblastic leukaemia abnormal cytogenetics GWAS:0314 B cell acute lymphoblastic leukaemia hyperdiploid negative GWAS:0315 B cell acute lymphoblastic leukaemia in adulthood GWAS:0316 B cell acute lymphoblastic leukaemia in young adulthood GWAS:0317 B cell acute lymphoblastic leukaemia normal cytogenetics GWAS:0318 B cell acute lymphoblastic leukaemia Philadelphia chromosome negative GWAS:0319 B-cell malignancies chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma pleiotropy GWAS:0320 B cell non-Hodgkin lymphoma GWAS:0321 Beard thickness GWAS:0322 Behavioral disturbance or psychiatric symptoms and prion disease GWAS:0323 Behavioral disturbance or psychiatric symptoms in prion disease GWAS:0324 Behavioural changes in frontotemporal lobe dementia GWAS:0325 Behavioural disinhibition generation interaction GWAS:0326 Behcet's disease GWAS:0327 Benign prostatic hyperplasia and lower urinary tract symptoms GWAS:0328 Benign prostatic hyperplasia and lower urinary tract symptoms prostate cancer excluded GWAS:0329 Benign prostatic hyperplasia and or lower urinary tract symptoms GWAS:0330 beta2-Glycoprotein I beta2-GPI plasma levels GWAS:0331 Beta-2 microglubulin plasma levels GWAS:0332 Betaine levels in individuals undergoing cardiac evaluation GWAS:0333 beta-nerve growth factor levels GWAS:0334 Beta thalassemia hemoglobin E disease GWAS:0335 Beta-trace protein levels GWAS:0336 Biliary atresia GWAS:0337 Bilirubin levels GWAS:0338 Bilirubin levels in extreme obesity GWAS:0339 Bilirubin levels in tenofovir-treated HIV infection GWAS:0340 Binge eating behaviour and bipolar disorder GWAS:0341 Binge eating behaviour in bipolar disorder GWAS:0342 Biochemical measures GWAS:0343 Biomedical quantitative traits GWAS:0344 Bipolar disorder GWAS:0345 Bipolar disorder age of onset <21 or attention deficit hyperactivity disorder GWAS:0346 Bipolar disorder age of onset and psychotic symptoms GWAS:0347 Bipolar disorder and eating disorder GWAS:0348 Bipolar disorder and schizophrenia GWAS:0349 Bipolar disorder body mass index interaction GWAS:0350 Bipolar disorder early onset GWAS:0351 Bipolar disorder inflammation and infection response interaction GWAS:0352 Bipolar disorder lithium response categorical or schizophrenia GWAS:0353 Bipolar disorder lithium response continuous or schizophrenia GWAS:0354 Bipolar disorder mania GWAS:0355 Bipolar disorder or attention deficit hyperactivity disorder GWAS:0356 Bipolar disorder or major depressive disorder GWAS:0357 Bipolar disorder with mood-incongruent psychosis GWAS:0358 Bipolar I disorder GWAS:0359 Birdshot chorioretinopathy GWAS:0360 Birth length GWAS:0361 Birth weight GWAS:0362 Bitter taste perception GWAS:0363 Bitter taste perception multivariate analysis GWAS:0364 Bitter taste response GWAS:0365 Black vs blond hair color GWAS:0366 Black vs non-black hair color GWAS:0367 Black vs red hair color GWAS:0368 Bladder cancer GWAS:0369 Bladder cancer smoking interaction GWAS:0370 Blond vs brown black hair color GWAS:0371 Blond vs brown hair color GWAS:0372 Blond vs non-blond hair color GWAS:0373 Blood and toenail selenium levels GWAS:0374 Blood glucose levels GWAS:0375 Blood metabolite levels GWAS:0376 Blood metabolite ratios GWAS:0377 Blood osmolality transformed sodium GWAS:0378 Blood pressure GWAS:0379 Blood pressure age interaction GWAS:0380 Blood pressure anthropometric measures interaction GWAS:0381 Blood pressure measurement cold pressor test GWAS:0382 Blood pressure measurement high sodium and potassium intervention GWAS:0383 Blood pressure measurement high sodium intervention GWAS:0384 Blood pressure measurement low sodium intervention GWAS:0385 Blood pressure smoking interaction GWAS:0386 Blood pressure traits multi-trait analysis GWAS:0387 Blood protein levels GWAS:0388 Blood sugar levels GWAS:0389 Blood trace element Cu levels GWAS:0390 Blood trace element Se levels GWAS:0391 Blood trace element Zn levels GWAS:0392 Blood urea nitrogen levels GWAS:0393 Blue vs brown eyes GWAS:0394 Blue vs green eyes GWAS:0395 BMI adjusted for smoking behaviour GWAS:0396 BMI in non-smokers GWAS:0397 BMI in smokers GWAS:0398 BMI smoking interaction GWAS:0399 Body fat distribution arm fat ratio GWAS:0400 Body fat distribution leg fat ratio GWAS:0401 Body fat distribution trunk fat ratio GWAS:0402 Body fat mass GWAS:0403 Body fat percentage GWAS:0404 Body mass in chronic obstructive pulmonary disease GWAS:0405 Body mass index GWAS:0406 Body mass index adult GWAS:0407 Body mass index age <50 GWAS:0408 Body mass index age>50 GWAS:0409 Body mass index age interaction GWAS:0410 Body mass index alcohol intake interaction GWAS:0411 Body mass index and cholesterol psychopharmacological treatment GWAS:0412 Body mass index and waist-hip ratio pleiotropy GWAS:0413 Body mass index change over time GWAS:0414 Body mass index change over time in cancer GWAS:0415 Body mass index change over time in cancer or chronic obstructive pulmonary disease GWAS:0416 Body mass index change over time in chronic obstructive pulmonary disease GWAS:0417 Body mass index change over time in gastrointestinal cancer GWAS:0418 Body mass index change over time in gastrointestinal cancer or chronic obstructive pulmonary disease GWAS:0419 Body mass index change over time in lung cancer GWAS:0420 Body mass index change over time in lung cancer or chronic obstructive pulmonary disease GWAS:0421 Body mass index dietary energy interaction GWAS:0422 Body mass index education interaction GWAS:0423 Body mass index ever vs never smoking interaction GWAS:0424 Body mass index in asthmatics GWAS:0425 Body mass index in non-asthmatics GWAS:0426 Body mass index in physically active individuals GWAS:0427 Body mass index in physically inactive individuals GWAS:0428 Body mass index joint analysis main effects and physical activity interaction GWAS:0429 Body mass index joint analysis main effects and smoking interaction GWAS:0430 Body mass index physical activity interaction GWAS:0431 Body mass index recreational physical activity interaction GWAS:0432 Body mass index smoking years interaction GWAS:0433 Body mass index SNP x SNP interaction GWAS:0434 Body mass index variance GWAS:0435 Body mass index x age interaction GWAS:0436 Body mass index x sex x age interaction 4df test GWAS:0437 Body mass lean GWAS:0438 Bone erosion in rheumatoid arthritis GWAS:0439 Bone fracture in osteoporosis GWAS:0440 Bone mineral accretion in asthma oral corticosteroid dose interaction GWAS:0441 Bone mineral density GWAS:0442 Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia GWAS:0443 Bone mineral density femoral neck GWAS:0444 Bone mineral density femoral neck in inflammatory bowel disease GWAS:0445 Bone mineral density hip GWAS:0446 Bone mineral density hip and age at menarche GWAS:0447 Bone mineral density lumbar spine in inflammatory bowel disease GWAS:0448 Bone mineral density paediatric, lower limb GWAS:0449 Bone mineral density paediatric, skull GWAS:0450 Bone mineral density paediatric, total body less head GWAS:0451 Bone mineral density paediatric, upper limb GWAS:0452 Bone mineral density spine GWAS:0453 Bone mineral density spine and age at menarche GWAS:0454 Bone mineral density total hip GWAS:0455 Bone mineral density Ward's triangle area GWAS:0456 Bone mineral density wrist GWAS:0457 Bone mineral density x blood lead interaction in current smokers 1df test GWAS:0458 Bone mineral density x blood lead interaction in current smokers 2df test GWAS:0459 Bone properties heel GWAS:0460 Bone ultrasound measurement broadband ultrasound attenuation GWAS:0461 Bone ultrasound measurement velocity of sound GWAS:0462 Borderline personality disorder GWAS:0463 Borderline personality disorder features GWAS:0464 Bortezomib-induced peripheral neuropathy in multiple myeloma GWAS:0465 Brachial circumference GWAS:0466 Brain connectivity GWAS:0467 Brain cytoarchitecture GWAS:0468 Brain glucose metabolism fluorodeoxyglucose uptake GWAS:0469 Brain imaging GWAS:0470 Brain imaging in schizophrenia dorsolateral prefrontal cortex interaction GWAS:0471 Brain imaging measurements GWAS:0472 Brain lesion load GWAS:0473 Brain structure GWAS:0474 Brain structure hippocampal volume GWAS:0475 Brain structure temporal lobe volume GWAS:0476 Brain volume in infants cerebrospinal fluid GWAS:0477 Brain volume in infants grey matter GWAS:0478 Brain volume in infants intracranial brain volume GWAS:0479 Brain volume in infants white matter GWAS:0480 Branched-chain amino acid levels Isoleucine GWAS:0481 Branched-chain amino acid levels Leucine GWAS:0482 Branched-chain amino acid levels Valine GWAS:0483 BRCA1 2-negative high-risk breast cancer GWAS:0484 Breast cancer GWAS:0485 Breast cancer and or colorectal cancer GWAS:0486 Breast cancer early onset GWAS:0487 Breast cancer estrogen-receptor negative GWAS:0488 Breast cancer estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative GWAS:0489 Breast cancer estrogen-receptor positive GWAS:0490 Breast cancer-free interval treatment with aromatase inhibitor GWAS:0491 Breast Cancer in BRCA1 mutation carriers GWAS:0492 Breast cancer in BRCA2 mutation carriers GWAS:0493 Breast cancer in childhood cancer survivors GWAS:0494 Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy GWAS:0495 Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy GWAS:0496 Breast cancer male GWAS:0497 Breast cancer menopausal hormone therapy interaction GWAS:0498 Breast cancer progesterone-receptor positive GWAS:0499 Breast cancer prognosis GWAS:0500 Breast cancer specific mortality in breast cancer GWAS:0501 Breast cancer specific mortality in estrogen receptor negative breast cancer GWAS:0502 Breast cancer specific mortality in estrogen receptor positive breast cancer GWAS:0503 Breast cancer survival GWAS:0504 Breastfeeding duration GWAS:0505 Breast milk fatty acid composition infant genotype effect GWAS:0506 Breast milk fatty acid composition maternal genotype effect GWAS:0507 Breast size GWAS:0508 Broad depression or bipolar disorder GWAS:0509 Broad depression or major depressive disorder recurrent GWAS:0510 Broad depression or major depressive disorder self-reported GWAS:0511 Broad depression or schizophrenia GWAS:0512 Bronchial hyperresponsiveness in asthma GWAS:0513 Bronchial neuroendocrine tumor GWAS:0514 Bronchodilator response in asthma GWAS:0515 Bronchodilator response in asthma inhaled corticosteroid treatment interaction GWAS:0516 Bronchopulmonary dysplasia GWAS:0517 Bronchopulmonary dysplasia in preterm infants GWAS:0518 Brooding response to stress GWAS:0519 Brown vs black hair color GWAS:0520 Brown vs non-brown hair color GWAS:0521 Brugada syndrome GWAS:0522 B-type natriuretic peptide levels GWAS:0523 B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio GWAS:0524 Bulimia nervosa GWAS:0525 Butyrylcholinesterase levels GWAS:0526 C4b binding protein levels GWAS:0527 Caffeine consumption GWAS:0528 Caffeine metabolism plasma 1,3,7-trimethylxanthine caffeine level GWAS:0529 Caffeine metabolism plasma 1,3-dimethylxanthine theophylline level GWAS:0530 Caffeine metabolism plasma 1,7-dimethylxanthine paraxanthine level GWAS:0531 Caffeine metabolism plasma 1,7-dimethylxanthine paraxanthine to 1,3,7-trimethylxanthine caffeine ratio GWAS:0532 Caffeine metabolism plasma 3,7-dimethylxanthine theobromine level GWAS:0533 Calcaneal bone ultrasound measurement speed of sound GWAS:0534 Calcaneus stiffness index GWAS:0535 Calcific aortic valve stenosis GWAS:0536 Calcium levels GWAS:0537 Callous-unemotional behaviour GWAS:0538 Cancer GWAS:0539 Cancer pleiotropy GWAS:0540 Cannabis dependence GWAS:0541 Cannabis dependence symptom count GWAS:0542 Cannabis use GWAS:0543 Cannabis use age at onset GWAS:0544 Cannabis use initiation GWAS:0545 Capecitabine sensitivity GWAS:0546 Carboplatin disposition in epthelial ovarian cancer GWAS:0547 Cardiac hypertrophy GWAS:0548 Cardiac muscle measurement GWAS:0550 Cardiac structure and function GWAS:0551 Cardiac Troponin-T levels GWAS:0552 Cardia gastric cancer GWAS:0553 Cardiometabolic and hematological traits GWAS:0554 Cardiovascular disease GWAS:0555 Cardiovascular disease in hypertension ACE inhibitor interaction GWAS:0556 Cardiovascular disease in hypertension calcium channel blocker interaction GWAS:0557 Cardiovascular disease risk factors GWAS:0558 Cardiovascular event in rheumatoid arthritis GWAS:0559 Cardiovascular heart disease in diabetics GWAS:0560 Cardiovascular risk factors GWAS:0561 Cardiovascular risk factors age interaction GWAS:0562 Carotenoid and tocopherol levels GWAS:0563 Carotenoid levels alpha-carotene GWAS:0564 Carotid artery intima media thickness sex interaction GWAS:0565 Carotid atherosclerosis in HIV infection GWAS:0566 Carotid intima media thickness GWAS:0567 Carotid intima media thickness in rheumatoid arthritis GWAS:0568 Carotid plaque burden GWAS:0569 Carotid plaque burden smoking interaction GWAS:0570 Carotid plaques in rheumatoid arthritis GWAS:0571 Carotid plaque GWAS:0572 Carpal tunnel syndrome GWAS:0573 Cataracts in type 2 diabetes GWAS:0574 Caudate activity during reward GWAS:0575 Caudate nucleus volume GWAS:0576 Caudate volume in trauma-exposed individuals GWAS:0577 CD4CD8 lymphocyte ratio GWAS:0578 Celiac disease GWAS:0579 Celiac disease or Rheumatoid arthritis GWAS:0580 Cellular adhesion molecule red blood cell fatty acid level interaction GWAS:0581 Cellular nuclear factor erythroid-derived 2-like 2 levels GWAS:0582 Central corneal thickness GWAS:0583 Cephalic index GWAS:0584 Cerebellum growth GWAS:0585 Cerebral amyloid angiopathy GWAS:0586 Cerebral amyloid deposition in APOEe4 non-carriers PET imaging GWAS:0587 Cerebral amyloid deposition PET imaging GWAS:0588 Cerebral amyloid deposition positivity PET imaging GWAS:0589 Cerebral blood flow GWAS:0590 Cerebral cortical growth GWAS:0591 Cerebrospinal AB1-42 levels in Alzheimer's disease dementia GWAS:0592 Cerebrospinal AB1-42 levels in mild cognitive impairment GWAS:0593 Cerebrospinal AB1-42 levels in normal cognition GWAS:0594 Cerebrospinal fluid AB1-42 levels GWAS:0595 Cerebrospinal fluid beta-site APP cleaving enzyme levels GWAS:0596 Cerebrospinal fluid biomarker levels GWAS:0597 Cerebrospinal fluid clusterin levels GWAS:0598 Cerebrospinal fluid clusterin levels in APOEe4- carriers GWAS:0599 Cerebrospinal fluid clusterin levels in APOEe4 carriers GWAS:0600 Cerebrospinal fluid levels of Alzheimer's disease-related proteins GWAS:0601 Cerebrospinal fluid p-Tau181pAB1-42 ratio GWAS:0602 Cerebrospinal fluid p-tau levels GWAS:0603 Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia GWAS:0604 Cerebrospinal fluid p-tau levels in mild cognitive impairment GWAS:0605 Cerebrospinal fluid p-tau levels in normal cognition GWAS:0606 Cerebrospinal fluid pyridoxal phosphate levels GWAS:0607 Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio GWAS:0608 Cerebrospinal fluid ?-synuclein levels GWAS:0609 Cerebrospinal fluid t-tauAB1-42 ratio GWAS:0610 Cerebrospinal fluid t-tau levels GWAS:0611 Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia GWAS:0612 Cerebrospinal fluid t-tau levels in mild cognitive impairment GWAS:0613 Cerebrospinal fluid t-tau levels in normal cognition GWAS:0614 Cerebrospinal P-tau181p levels GWAS:0615 Cerebrospinal T-tau levels GWAS:0616 Cerivastatin-induced rhabdomyolysis GWAS:0617 Cervical artery dissection GWAS:0618 Cervical cancer GWAS:0619 Chagas cardiomyopathy in Tripanosoma cruzi seropositivity GWAS:0620 Change in glucose in response to thiazide diuretic treatment in hypertension GWAS:0621 Change in HbA1c levels in response to metformin treatment in type 2 diabetes GWAS:0622 Change in intraocular pressure in response to steroid treatment triamcinolone acetonide GWAS:0623 Change in LVEF in response to paclitaxel and trastuzumab in HER2 breast cancer GWAS:0624 Cheek morphology partial least square model GWAS:0625 Chemerin levels GWAS:0626 Chickenpox GWAS:0627 Childhood absence epilepsy GWAS:0628 Childhood and early adolescence aggressive behavior GWAS:0629 Childhood body mass index GWAS:0630 Childhood dental caries in permanent teeth GWAS:0631 Childhood dental caries in primary teeth GWAS:0632 Childhood ear infection GWAS:0633 Childhood onset systemic lupus erythematosus GWAS:0634 Childhood onset ulcerative colitis GWAS:0635 Childhood steroid-sensitive nephrotic syndrome GWAS:0636 Chin dimples GWAS:0638 Chloride levels GWAS:0639 Cholangiocarcinoma in primary sclerosing cholangitis GWAS:0640 Cholangiocarcinoma in primary sclerosing cholangitis time to event GWAS:0641 Cholelithiasis-related traits in sickle cell anemia GWAS:0642 Cholesterol GWAS:0643 Cholesterol and Triglycerides GWAS:0644 Cholesterol efflux capacity GWAS:0645 Cholesterol efflux capacity ABCA-1 dependent assay GWAS:0646 Cholesterol efflux capacity BHK stimulated assay GWAS:0647 Cholesterol efflux capacity cAMP stimulated assay GWAS:0648 Cholesterol ester levels in large LDL GWAS:0649 Cholesterol ester levels in medium LDL GWAS:0650 Cholesterol ester levels in very large HDL GWAS:0651 Cholesterol, total GWAS:0652 Cholesteryl ester transfer protein levels GWAS:0653 Chronic back pain GWAS:0654 Chronic bronchitis and chronic obstructive pulmonary disease GWAS:0655 Chronic bronchitis in chronic obstructive pulmonary disease GWAS:0656 Chronic central serous retinopathy GWAS:0657 Chronic hepatitis B infection GWAS:0658 Chronic hepatitis C infection GWAS:0659 Chronic inflammatory diseases ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis pleiotropy GWAS:0660 Chronic kidney disease GWAS:0661 Chronic kidney disease and diabetic kidney disease in type 2 diabetes GWAS:0662 Chronic kidney disease and serum creatinine levels GWAS:0663 Chronic kidney disease chronic kidney disease vs normal or mildly reduced eGFR in type 1 diabetes GWAS:0664 Chronic kidney disease in diabetes GWAS:0665 Chronic kidney disease in type 2 diabetes GWAS:0666 Chronic kidney disease severe chronic kidney disease vs normal kidney function in type 1 diabetes GWAS:0667 Chronic lymphocytic leukemia GWAS:0668 Chronic mucus hypersecretion GWAS:0669 Chronic myeloid leukemia GWAS:0670 Chronic obstructive pulmonary disease GWAS:0671 Chronic obstructive pulmonary disease moderate to severe GWAS:0672 Chronic obstructive pulmonary disease or coronary artery disease pleiotropy GWAS:0673 Chronic obstructive pulmonary disease or high blood pressure pleiotropy GWAS:0674 Chronic obstructive pulmonary disease or resting heart rate pleiotropy GWAS:0675 Chronic obstructive pulmonary disease-related biomarkers GWAS:0676 Chronic obstructive pulmonary disease severe GWAS:0677 Chronic periodontitis GWAS:0678 Chronic periodontitis localised GWAS:0679 Chronic periodontitis mean interproximal clinical attachment level GWAS:0680 Chronic rhinosinusitis GWAS:0681 Chronic rhinosinusitis with nasal polyps GWAS:0682 Chronic sinus infection GWAS:0683 Chronic venous disease GWAS:0684 Chronotype GWAS:0685 Cigarettes smoked per day MTAG GWAS:0686 Cingulate cortical amyloid beta load GWAS:0687 Circulating cell-free DNA GWAS:0688 Circulating chemerin levels GWAS:0689 Circulating chromogranin peptide levels GWAS:0690 Circulating fibroblast growth factor 23 levels GWAS:0691 circulating leptin levels GWAS:0692 circulating leptin levels adjusted for BMI GWAS:0693 Circulating myeloperoxidase levels plasma GWAS:0694 Circulating myeloperoxidase levels serum GWAS:0695 Circulating odd-numbered chain saturated fatty acid levels C150 GWAS:0696 Circulating odd-numbered chain saturated fatty acid levels C150C170 GWAS:0697 Circulating odd-numbered chain saturated fatty acid levels C170 GWAS:0698 Circulating odd-numbered chain saturated fatty acid levels C190 GWAS:0699 Circulating odd-numbered chain saturated fatty acid levels C230 GWAS:0700 Circulating phylloquinone levels GWAS:0701 Circulating vasoactive peptide levels GWAS:0702 Cirrhosis alcohol related GWAS:0703 Cisplatin-induced ototoxicity GWAS:0704 Classic bladder exstrophy GWAS:0705 Cleft lip GWAS:0706 Cleft lip with or without cleft palate GWAS:0707 Cleft lip with or without cleft palate maternal periconceptional alcohol intake interaction GWAS:0708 Cleft lip with or without cleft palate maternal periconceptional cigarette smoking interaction GWAS:0709 Cleft lip with or without cleft palate maternal periconceptional vitamin use interaction GWAS:0710 Cleft palate GWAS:0711 Cleft plate environmental tobacco smoke interaction GWAS:0712 Clinical laboratory measurements GWAS:0713 Clinically amyopathic dermatomyositis GWAS:0714 Clopidogrel active metabolite levels GWAS:0715 Clostridium difficile infection in multiple myeloma GWAS:0716 Clozapine-induced agranulocytosis GWAS:0717 Clozapine-induced agranulocytosis granulocytopenia in treatment-resistant schizophrenia GWAS:0718 Clozapine-induced cytotoxicity GWAS:0719 Clubfoot GWAS:0720 Cluster headache GWAS:0721 Coagulation factor levels GWAS:0722 Cocaine dependence GWAS:0723 Coenzyme Q10 levels GWAS:0724 Coffee consumption GWAS:0725 Coffee consumption cups per day GWAS:0726 Cognitive ability GWAS:0727 Cognitive ability MTAG GWAS:0728 Cognitive decline GWAS:0729 Cognitive decline age-related GWAS:0730 Cognitive decline rate in late mild cognitive impairment GWAS:0731 Cognitive empathy GWAS:0732 Cognitive flexibility GWAS:0733 Cognitive function GWAS:0734 Cognitive impairment test score GWAS:0735 Cognitive performance GWAS:0736 Cognitive performance MTAG GWAS:0737 Cognitive test performance GWAS:0738 Cold medicine-related Stevens-Johnson syndrome toxic epidermal necrolysis SJS TEN with severe mucosal involvement GWAS:0739 Cold medicine-related Stevens-Johnson syndrome toxic epidermal necrolysis SJS TEN with severe ocular complications GWAS:0740 Cold sores GWAS:0741 Collagenous colitis GWAS:0742 Colon cancer GWAS:0743 Colonoscopy-negative controls vs population controls GWAS:0744 Colorectal adenoma advanced GWAS:0745 Colorectal cancer GWAS:0746 Colorectal cancer alcohol consumption interaction GWAS:0747 Colorectal cancer aspirin and or NSAID use interaction GWAS:0748 Colorectal cancer calcium intake interaction GWAS:0749 Colorectal cancer diet interaction GWAS:0750 Colorectal cancer oestrogen-progestogen hormone therapy interaction GWAS:0751 Colorectal carcinoma in primary sclerosing cholangitis GWAS:0752 Colorectal or endometrial cancer GWAS:0753 Common carotid intima-media thickness GWAS:0754 Common carotid intima-media thickness in HIV infection GWAS:0755 Common carotid intima-media thickness in HIV negative individuals GWAS:0756 Common traits Other GWAS:0757 Complement C3 and C4 levels GWAS:0758 Complete remission in asthma GWAS:0759 Comprehensive strength and appendicular lean mass GWAS:0760 Conduct disorder GWAS:0761 Conduct disorder maternal expressed emotions interaction GWAS:0762 Conduct disorder symptom count GWAS:0763 Congenital heart disease GWAS:0764 Congenital heart disease inherited effect GWAS:0765 Congenital heart disease maternal effect GWAS:0766 Congenital heart malformation GWAS:0767 Congenital left-sided heart lesions GWAS:0768 Congenital left-sided heart lesions maternal effect GWAS:0769 Conotruncal heart defects GWAS:0770 Conotruncal heart defects inherited effects GWAS:0771 Conotruncal heart defects maternal effects GWAS:0772 Conscientiousness GWAS:0773 Contrast sensitivity GWAS:0774 Corneal astigmatism GWAS:0775 Corneal curvature GWAS:0776 Corneal structure GWAS:0777 Coronary arterial lesions in patients with Kawasaki disease GWAS:0778 Coronary artery aneurysm in Kawasaki disease GWAS:0779 Coronary artery calcification GWAS:0780 Coronary artery calcified atherosclerotic plaque 130 HU threshold in type 2 diabetes GWAS:0781 Coronary artery calcified atherosclerotic plaque 90 or 130 HU threshold in type 2 diabetes GWAS:0782 Coronary artery calcified atherosclerotic plaque score in type 2 diabetes GWAS:0783 Coronary artery disease GWAS:0784 Coronary artery disease and HDL cholesterol levels multivariate analysis GWAS:0785 Coronary artery disease and LDL cholesterol levels multivariate analysis GWAS:0786 Coronary artery disease and total cholesterol levels multivariate analysis GWAS:0787 Coronary artery disease and triglyceride levels multivariate analysis GWAS:0788 Coronary artery disease in diabetes GWAS:0789 Coronary artery disease in type 1 diabetes GWAS:0790 Coronary artery disease myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease GWAS:0791 Coronary artery disease or ischemic stroke GWAS:0792 Coronary artery disease or large artery stroke GWAS:0793 Coronary atherosclerosis increased number of diseased vessels traffic exposure interaction GWAS:0794 Coronary heart disease GWAS:0795 Coronary heart disease event reduction statin therapy interaction GWAS:0796 Coronary restenosis GWAS:0797 Coronary spasm GWAS:0798 Corrected insulin response adjusted for insulin sensitivity index GWAS:0799 Corrected insulin response GWAS:0800 Cortical amyloid beta load GWAS:0801 Cortical brain region measurements area, volume and thickness GWAS:0802 Cortical thickness GWAS:0803 Corticobasal degeneration GWAS:0804 Corticosteroid-induced adrenal suppression peak cortisol < 350 nmol L GWAS:0805 Corticosteroid-induced adrenal suppression peak cortisol < 500 nmol L GWAS:0806 Cortisol levels saliva GWAS:0807 Cotinine glucuronidation GWAS:0808 Cotinine levels in smokers with chronic obstructive pulmonary disease GWAS:0809 Cough in response to angiotensin-converting enzyme inhibitor drugs GWAS:0810 C-peptide levels in type I diabetes GWAS:0811 Cranial base width GWAS:0812 Craniofacial microsomia GWAS:0813 C-reactive protein GWAS:0814 C-reactive protein and white blood cell count GWAS:0815 C-reactive protein levels GWAS:0816 C-reactive protein levels in ischemic stroke GWAS:0817 C-reactive protein levels or HDL-cholesterol levels pleiotropy GWAS:0818 C-reactive protein levels or LDL-cholesterol levels pleiotropy GWAS:0819 C-reactive protein levels or total cholesterol levels pleiotropy GWAS:0820 C-reactive protein levels or triglyceride levels pleiotropy GWAS:0821 C-reactive protein red blood cell fatty acid level interaction GWAS:0823 Creatine kinase levels GWAS:0824 Creatinine clearance GWAS:0825 Creatinine levels GWAS:0826 Creatinine levels in ischemic stroke GWAS:0827 Creutzfeldt-Jakob disease GWAS:0828 Creutzfeldt-Jakob disease sporadic GWAS:0829 Creutzfeldt-Jakob disease variant GWAS:0830 Crohn's disease GWAS:0831 Crohn's disease and celiac disease GWAS:0832 Crohn's disease and psoriasis GWAS:0833 Crohn's disease and sarcoidosis combined GWAS:0834 Crohn's disease indolent vs progressive GWAS:0835 Crohn's disease need for surgery GWAS:0836 Crohn's disease-related phenotypes GWAS:0837 Crohn's disease time to first abdominal surgery GWAS:0838 Crohn's disease time to progression GWAS:0839 Crohn's disease time to surgery GWAS:0840 CSF tryptophan concentration in tuberculous meningitis GWAS:0841 CTACK levels GWAS:0842 Current cigarettes per day in chronic obstructive pulmonary disease GWAS:0843 Curve progression in adolescent idiopathic scoliosis GWAS:0844 Cutaneous lupus erythematosus GWAS:0845 Cutaneous malignant melanoma GWAS:0846 Cutaneous nevi GWAS:0847 Cutaneous psoriasis GWAS:0848 Cutaneous squamous cell carcinoma GWAS:0849 Cystatin C GWAS:0850 Cystic fibrosis-related diabetes GWAS:0851 Cystic fibrosis severity GWAS:0852 Cytokine and corticosteroid-stimulated IL-6 production GWAS:0853 Cytokine-stimulated IL-6 production GWAS:0854 Cytomegalovirus antibody response GWAS:0855 Daytime nap GWAS:0856 Daytime sleepiness GWAS:0857 Daytime sleep phenotypes GWAS:0858 D-dimer levels GWAS:0859 DDT metabolite p,p'-DDE levels GWAS:0860 Decline in glucose metabolism in posterior cingulate cortex GWAS:0861 Deep ovarian and or rectovaginal disease with dense adhesions GWAS:0862 Dehydroepiandrosterone sulphate levels GWAS:0863 Delayed reward discounting GWAS:0864 Deliberate self-harm GWAS:0865 Delta-5 desaturase activity GWAS:0866 Delta-5 desaturase activity response to n3-polyunsaturated fat supplement GWAS:0867 Delta-6 desaturase activity GWAS:0868 Delta-6 desaturase activity response to n3-polyunsaturated fat supplement GWAS:0869 Dementia and core Alzheimer's disease neuropathologic changes GWAS:0870 Dementia with Lewy bodies GWAS:0871 Dengue shock syndrome GWAS:0872 Dental caries GWAS:0873 Dentate gyrus granule cell layer volume GWAS:0874 Dentate gyrus granule cell layer volume corrected for total hippocampal volume GWAS:0875 Dentate gyrus molecular layer volume GWAS:0876 Dentate gyrus molecular layer volume corrected for total hippocampal volume GWAS:0877 Depressed affect GWAS:0878 Depression GWAS:0879 Depression and alcohol dependence GWAS:0880 Depression broad GWAS:0881 Depression in response to interferon-based therapy in chronic hepatitis C GWAS:0882 Depression in smokers GWAS:0883 Depression quantitative trait GWAS:0884 Depressive and manic episodes in bipolar disorder GWAS:0885 Depressive episodes in bipolar disorder GWAS:0886 Depressive symptom improvement GWAS:0887 Depressive symptom measurement or major depressive disorder GWAS:0888 Depressive symptoms GWAS:0889 Depressive symptoms measurement somatic complaints domain GWAS:0890 Depressive symptoms MTAG GWAS:0891 Depressive symptoms SSRI exposure interaction GWAS:0892 Depressive symptoms stressful life events interaction GWAS:0893 Depressive symptoms x dependent stressful life events interaction 1df test GWAS:0894 Depressive symptoms x dependent stressful life events interaction 2df test GWAS:0895 Depressive symptoms x independent stressful life events interaction 1df test GWAS:0896 Depressive symptoms x independent stressful life events interaction 2df test GWAS:0897 Dermatomyositis GWAS:0898 Dermatomyositis or juvenile dermatomyositis GWAS:0899 Developmental dysplasia of the hip GWAS:0900 Developmental language disorder GWAS:0901 Developmental language disorder linguistic errors GWAS:0902 Developmental language disorder syntactic complexity GWAS:0903 Diabetes gestational GWAS:0904 Diabetes incident GWAS:0905 Diabetes in response to antihypertensive drug treatment treatment strategy interaction GWAS:0906 Diabetes mellitus GWAS:0907 Diabetes related insulin traits GWAS:0908 Diabetic kidney disease GWAS:0909 Diabetic kidney disease in diabetes ESRD vs no ESRD GWAS:0910 Diabetic kidney disease in type 2 diabetes GWAS:0911 Diabetic kidney disease in type 2 diabetes ESRD vs no ESRD GWAS:0912 Diabetic macular edema in type 2 diabetes GWAS:0913 Diabetic nephropathy in type 1 diabetes GWAS:0914 Diabetic retinopathy GWAS:0915 Diabetic retinopathy all NPDR and PDR GWAS:0916 Diabetic retinopathy in type 2 diabetes GWAS:0917 Diabetic retinopathy moderate NPDR and PDR GWAS:0918 Dialysis-related mortality GWAS:0919 Diarrhoea-associated Entamoeba histolytica infection GWAS:0920 Diarrhoea in darapladib-treated cardiovascular disease time to event GWAS:0921 diarrhoeal disease at age 1 GWAS:0922 diarrhoeal disease at age 1 with doctor diagnosis GWAS:0923 diarrhoeal disease at age 2 GWAS:0924 diarrhoeal disease at age 2 with doctor diagnosis GWAS:0925 Diastolic blood pressure GWAS:0926 Diastolic blood pressure alcohol consumption interaction GWAS:0927 Diastolic blood pressure cigarette smoking interaction GWAS:0928 Diastolic blood pressure in combination therapy beta blocker and thiazide diuretic GWAS:0929 Diastolic blood pressure long-term average GWAS:0930 Diastolic blood pressure night-to-day ratio in hypertension GWAS:0931 Diastolic blood pressure response to hydrochlorothiazide in hypertension GWAS:0932 Diastolic blood pressure x alcohol consumption interaction 1df test GWAS:0933 Diastolic blood pressure x alcohol consumption interaction 2df test GWAS:0934 Diastolic blood pressure x alcohol consumption light vs heavy interaction 2df test GWAS:0935 Diastolic blood pressure x smoking status current vs non-current interaction 1df test GWAS:0936 Diastolic blood pressure x smoking status current vs non-current interaction 2df test GWAS:0937 Diastolic blood pressure x smoking status ever vs never interaction 1df test GWAS:0938 Diastolic blood pressure x smoking status ever vs never interaction 2df test GWAS:0939 Diastolic blood pressure x sodium interaction 1df test GWAS:0940 Diastolic blood pressure x sodium interaction 2df test GWAS:0941 Dietary macronutrient intake GWAS:0942 Differentiated thyroid cancer GWAS:0943 Diffuse cutaneous systemic sclerosis GWAS:0944 Diffuse large B cell lymphoma GWAS:0945 Diffusing capacity of carbon monoxide GWAS:0946 Diffusing capacity of the lung for carbon monoxide traits GWAS:0947 Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined GWAS:0948 Digit length ratio GWAS:0949 Digit length ratio left hand GWAS:0950 Digit length ratio right hand GWAS:0951 Diisocyanate-induced asthma GWAS:0952 Disc degeneration lumbar GWAS:0953 Discordance in emotional problems in monozygotic twins GWAS:0954 Disease-free survival in breast cancer GWAS:0955 Disease progression in age-related macular degeneration GWAS:0956 Disease progression to choroidal neovascularization form in age-related macular degeneration GWAS:0957 Disorders of lipid metabolism GWAS:0958 Disrupted circadian rhythm low relative amplitude of rest-activity cycles GWAS:0959 Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia GWAS:0960 Diverticular disease GWAS:0961 DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia GWAS:0962 DNA methylation parent-of-origin GWAS:0963 DNA methylation variation GWAS:0964 DNA methylation variation age effect GWAS:0965 Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer GWAS:0966 Double-edged eyelids GWAS:0967 Drinking behavior GWAS:0968 Drug abuse GWAS:0969 Drug experimentation measurement GWAS:0970 Drug-induced cholestatic mixed liver injury GWAS:0971 Drug-induced hepatocellular liver injury GWAS:0972 Drug-induced liver injury GWAS:0973 Drug-induced liver injury amoxicillin-clavulanate GWAS:0974 Drug-induced liver injury anti-tuberculosis drugs GWAS:0975 Drug-induced liver injury diclofenac GWAS:0976 Drug-induced liver injury flucloxacillin GWAS:0977 Drug-induced liver injury fluoroquinolones GWAS:0978 Drug-induced liver injury in interferon-beta-treated multiple sclerosis GWAS:0979 Drug-induced liver injury nitrofurantoin GWAS:0980 Drug-induced liver injury nonsteroidal anti-inflammatory drugs GWAS:0981 Drug-induced liver injury statins GWAS:0982 Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis SJS TEN GWAS:0983 Drug-induced torsades de pointes GWAS:0984 Duloxetine response in major depressive disorder change in symptom score GWAS:0985 Duodenal ulcer GWAS:0986 Dupuytren's disease GWAS:0987 Dysmenorrheic pain GWAS:0988 Dysmenorrheic pain severity GWAS:0989 Dysphagia GWAS:0990 Early age at menarche GWAS:0991 Early childhood aggressive behavior GWAS:0992 Early diabetic kidney disease in diabetes GWAS:0993 Early diabetic kidney disease in type 2 diabetes GWAS:0994 Early onset atrial fibrillation GWAS:0995 Early response to risperidone in schizophrenia GWAS:0996 Ear morphology GWAS:0997 Ear protrusion GWAS:0998 Ease of getting up in the morning GWAS:0999 Eating disorder in bipolar disorder GWAS:1000 Eating disorders GWAS:1001 Eating disorders purging via substances GWAS:1002 Echocardiographic traits GWAS:1003 Economic and political preferences GWAS:1004 Economic and political preferences environmentalism GWAS:1005 Economic and political preferences fairness GWAS:1006 Economic and political preferences feminism equality GWAS:1007 Economic and political preferences immigration crime GWAS:1008 Economic and political preferences time GWAS:1009 Eczema GWAS:1010 Educational attainment GWAS:1011 Educational attainment college completion GWAS:1012 Educational attainment MTAG GWAS:1013 Educational attainment years of education GWAS:1014 EGFR mutation-positive lung adenocarcinoma GWAS:1015 Egg allergy GWAS:1016 Egg allergy maternal genetic effects GWAS:1017 Egg allergy parent-of-origin effect GWAS:1018 Ejection fraction GWAS:1019 Ejection fraction in Tripanosoma cruzi seropositivity GWAS:1020 Electrocardiographic conduction measures GWAS:1021 Electrocardiographic traits GWAS:1022 Electrodermal activity GWAS:1023 Electroencephalogram traits GWAS:1024 Electroencephalographic traits in alcoholism GWAS:1025 Elevated fasting plasma glucose GWAS:1026 Elevated serum carcinoembryonic antigen levels GWAS:1027 Elevated serum prostate-specific antigen levels in healthy men GWAS:1028 Emotional dysregulation GWAS:1029 Empathy quotient GWAS:1030 Emphysema distribution in smoking GWAS:1031 Emphysema imaging phenotypes GWAS:1032 Emphysema-related traits GWAS:1033 Endometrial cancer GWAS:1034 Endometrial cancer endometrioid histology GWAS:1035 Endometrial cancer Non-endometrioid histology GWAS:1036 Endometrial endometrioid carcinoma GWAS:1037 Endometrioid ovarian cancer GWAS:1038 Endometriosis GWAS:1039 Endometriosis or endometrial cancer pleiotropy GWAS:1040 Endothelial function traits GWAS:1041 Endothelial growth factor levels GWAS:1042 End-stage coagulation GWAS:1043 End-stage renal disease GWAS:1044 End stage renal disease in APOL1 risk genotype-negative individuals GWAS:1045 End-stage renal disease in Type 1 diabetics GWAS:1046 End-stage renal disease in type 2 diabetes GWAS:1047 End-stage renal disease non-diabetic GWAS:1048 End stage renal disease x APOL1 genotype interaction GWAS:1049 Energy expenditure 24h GWAS:1050 Energy expenditure GWAS:1051 Energy intake GWAS:1052 Enteric fever GWAS:1053 Entorhinal cortical thickness GWAS:1054 Entorhinal cortical thickness Alzheimer's disease interaction GWAS:1055 Entorhinal cortical volume GWAS:1056 Entorhinal cortical volume Alzheimer's disease interaction GWAS:1057 Eosinophil counts GWAS:1058 Eosinophilic esophagitis GWAS:1059 Eosinophilic esophagitis pediatric GWAS:1060 Eosinophil percentage of granulocytes GWAS:1061 Eosinophil percentage of white cells GWAS:1062 Eotaxin levels GWAS:1063 Epilepsy GWAS:1064 Epilepsy and lamotrigine-induced maculopapular eruptions GWAS:1065 Epilepsy remission after treatment GWAS:1066 Epirubicin-induced leukopenia GWAS:1067 Episodic memory GWAS:1068 Epithelial ovarian cancer GWAS:1069 Epstein-Barr virus copy number in lymphoblastoid cell lines GWAS:1070 Epstein-Barr virus immune response EBNA-1 GWAS:1071 Epstein-Barr virus immune response multivariate analysis GWAS:1072 Epstein Barr virus nuclear antigen 1 IgG levels GWAS:1073 Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis GWAS:1074 Epstein Barr virus nuclear antigen 1 IgG seropositivity GWAS:1075 Erectile dysfunction GWAS:1076 Erectile dysfunction and prostate cancer treatment GWAS:1077 Erectile dysfunction in type 1 diabetes GWAS:1078 Erosive tooth wear severe vs none or mild GWAS:1079 Erosive tooth wear severe vs non-severe GWAS:1080 Erythema nodosum in inflammatory bowel disease GWAS:1081 Erythrocyte cadmium concentration GWAS:1082 Erythrocyte cadmium concentration in never smokers GWAS:1083 Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia GWAS:1084 Erythrocyte sedimentation rate GWAS:1085 Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia GWAS:1086 E-selectin levels GWAS:1087 Esophageal adenocarcinoma GWAS:1088 Esophageal adenocarcinoma x gastroesophageal reflux disease interaction GWAS:1089 Esophageal adenocarcinoma x pack-years of smoking exposure interaction GWAS:1090 Esophageal adenocarcinoma x smoking interaction GWAS:1091 Esophageal cancer GWAS:1092 Esophageal cancer alcohol interaction GWAS:1093 Esophageal cancer and gastric cancer GWAS:1094 Esophageal cancer squamous cell GWAS:1095 Esophageal squamous cell cancer length of survival GWAS:1096 Esophageal squamous cell carcinoma GWAS:1097 Essential tremor GWAS:1098 Esterified cholesterol levels GWAS:1099 Estimated glomerular filtration rate GWAS:1100 Estimated glomerular filtration rate after 1 year in renal transplantation donor effect GWAS:1101 Estimated glomerular filtration rate after 1 year in renal transplantation recipient effect GWAS:1102 Estimated glomerular filtration rate after 5 years in renal transplantation donor effect GWAS:1103 Estimated glomerular filtration rate after 5 years in renal transplantation recipient effect GWAS:1104 Estimated glomerular filtration rate change in renal transplantation donor effect GWAS:1105 Estimated glomerular filtration rate change in renal transplantation recipient effect GWAS:1106 Estimated glomerular filtration rate in coronary artery disease and impaired kidney function GWAS:1107 Estradiol levels GWAS:1108 Estradiol plasma levels breast cancer GWAS:1109 Estrogen receptor status in breast cancer GWAS:1110 Estrogen receptor status in HER2 negative breast cancer GWAS:1111 Estrone androstenedione ratio in resected early stage-receptor positive breast cancer GWAS:1112 Estrone conjugates estrone ratio in resected early stage estrogen-receptor positive breast cancer GWAS:1113 Estrone levels GWAS:1114 Eudaimonic well-being GWAS:1115 Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy GWAS:1116 Event-related brain oscillations GWAS:1117 Ewing sarcoma GWAS:1118 Excessive daytime sleepiness GWAS:1119 Excessive hairiness GWAS:1120 Excessive sweating GWAS:1121 Executive function in ADHD GWAS:1123 Executive inhibition Stroop WIT and CIT in attention deficit hyperactivity disorder GWAS:1124 Exercise treadmill test traits GWAS:1125 Exfoliation glaucoma or exfoliation syndrome GWAS:1126 Exfoliation syndrome GWAS:1127 Exhaled carbon monoxide levels GWAS:1128 Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease GWAS:1129 Exhaled nitric oxide levels GWAS:1130 Exhaled nitric oxide output GWAS:1131 Experiencing mood swings GWAS:1132 Exploratory eye movement dysfunction in schizophrenia cognitive search score GWAS:1133 Exploratory eye movement dysfunction in schizophrenia mean eye scanning length GWAS:1134 Exploratory eye movement dysfunction in schizophrenia number of eye fixations GWAS:1135 Exploratory eye movement dysfunction in schizophrenia responsive search score GWAS:1136 Exploratory eye movement dysfunction in schizophrenia total eye scanning length GWAS:1137 Expressive vocabulary in infants GWAS:1138 Extraversion GWAS:1139 Extremely high intelligence GWAS:1140 Extrinsic epigenetic age acceleration GWAS:1141 Exudative age-related macular degeneration GWAS:1142 Eyebrow thickness GWAS:1143 Eye color GWAS:1144 Eye color brightness GWAS:1145 Eye color hue GWAS:1146 Eye color saturation GWAS:1147 Eye color traits GWAS:1148 Eye length GWAS:1149 Eye morphology GWAS:1150 Eye movement horizontal position gain GWAS:1151 Eye movement in schizophrenia horizontal position gain GWAS:1152 Facial depth GWAS:1153 Facial emotion recognition GWAS:1154 Facial emotion recognition angry faces GWAS:1155 Facial emotion recognition fearful faces GWAS:1156 Facial emotion recognition happy faces GWAS:1157 Facial emotion recognition sad faces GWAS:1158 Facial morphology GWAS:1159 Facial morphology factor 10, width of nasal floor GWAS:1160 Facial morphology factor 11, projection of the nose GWAS:1161 Facial morphology factor 12, vertical position of sublabial sulcus relative to central midface GWAS:1162 Facial morphology factor 13, vertical position of alar curvature relative to upper lip GWAS:1163 Facial morphology factor 14, intercanthal width GWAS:1164 Facial morphology factor 15, philtrum width GWAS:1165 Facial morphology factor 16 GWAS:1166 Facial morphology factor 17, height of vermillion upper lip GWAS:1167 Facial morphology factor 18 GWAS:1168 Facial morphology factor 19 GWAS:1169 Facial morphology factor 1, breadth of lateral portion of upper face GWAS:1170 Facial morphology factor 20 GWAS:1171 Facial morphology factor 21, depth of nasal alae GWAS:1172 Facial morphology factor 22 GWAS:1173 Facial morphology factor 23 GWAS:1174 Facial morphology factor 2, vertical position of orbits relative to midface GWAS:1175 Facial morphology factor 3, length of philtrum GWAS:1176 Facial morphology factor 4, facial height related to vertical position of gnathion GWAS:1177 Facial morphology factor 5, width of mouth relative to central midface GWAS:1178 Facial morphology factor 6, height of vermillion lower lip GWAS:1179 Facial morphology factor 7, width of cartilaginous portion of nose GWAS:1180 Facial morphology factor 8, orbital inclination due to vertical and horizontal position of exocanthion GWAS:1181 Facial morphology factor 9, facial height related to vertical position of nasion GWAS:1182 facial morphology traits multivariate analysis GWAS:1183 Facial pigmentation GWAS:1184 Facial wrinkles GWAS:1185 Factor VII GWAS:1186 Factor VII activity GWAS:1187 Factor VII activity or levels GWAS:1188 Factor VIII levels GWAS:1189 Factor VII levels GWAS:1190 Factor XI GWAS:1191 Familial hepatitis B virus-related hepatocellular carcinoma GWAS:1192 Familial lung adenocarcinoma GWAS:1193 Familial lung cancer GWAS:1194 Familial squamous cell lung carcinoma GWAS:1195 Family history of Alzheimer's disease GWAS:1196 Fast beta electroencephalogram GWAS:1197 Fasting blood glucose GWAS:1198 Fasting blood glucose adjusted for BMI GWAS:1199 Fasting blood glucose BMI interaction GWAS:1200 Fasting blood insulin GWAS:1201 Fasting blood insulin BMI interaction GWAS:1202 Fasting glucose in pregnancy gestational week 14-16 GWAS:1203 Fasting insulin dietary factor interaction GWAS:1204 Fasting plasma glucose GWAS:1205 Fasting plasma glucose childhood GWAS:1206 Fat body mass GWAS:1207 Fat distribution HIV GWAS:1208 Fat-free mass GWAS:1209 Fatty acid desaturase activity adipose tissue GWAS:1210 Fatty acid desaturase activity serum GWAS:1211 F-cell distribution GWAS:1212 F-cell distribution in sickle cell anaemia GWAS:1213 Fear of medical pain dental GWAS:1214 Fear of minor pain GWAS:1215 Fear of pain GWAS:1216 Fear of severe pain GWAS:1217 Febrile seizures GWAS:1218 Febrile seizures MMR vaccine-related GWAS:1219 Febrile seizures MMR vaccine-unrelated GWAS:1220 Feeling fed-up GWAS:1221 Feeling guilty GWAS:1222 Feeling hurt GWAS:1223 Feeling lonely GWAS:1224 Feeling miserable GWAS:1225 Feeling nervous GWAS:1226 Feeling tense GWAS:1227 Feeling worry GWAS:1228 Femoral neck bone geometry GWAS:1229 Femoral neck bone geometry and menarche age at onset GWAS:1230 Femoral neck bone mineral density GWAS:1231 Femoral neck length GWAS:1232 Femoral neck section modulus GWAS:1233 Fentanyl consumption in laparoscopic-assisted colectomy first 24 hours GWAS:1234 Ferritin levels GWAS:1235 Fetal hemoglobin levels GWAS:1236 Fetal hemoglobin levels in sickle cell anemia GWAS:1237 FEV1 GWAS:1238 Fibrinogen GWAS:1239 Fibrinogen levels GWAS:1240 Fibrinogen levels in ischemic stroke GWAS:1241 Fibrinogen levels smoking status, alcohol consumption or body mass index interaction GWAS:1242 Fibroblast growth factor basic levels GWAS:1243 Focal epilepsy GWAS:1244 Focal epilepsy with hippocampal sclerosis GWAS:1245 Folate pathway vitamin levels GWAS:1246 Folding of antihelix GWAS:1247 Follicular lymphoma GWAS:1250 Food addiction GWAS:1251 Food allergy GWAS:1252 Food allergy maternal genetic effects GWAS:1253 Food allergy parent-of-origin effect GWAS:1254 Food antigen IgG levels GWAS:1255 Foot ulcer and neuropathy in diabetes GWAS:1256 Foot ulcer in diabetes and neuropathy GWAS:1257 Forced expiratory volume in 1 second environmental tobacco smoke interaction GWAS:1258 Forced expiratory volume in 1 second occupational environmental exposures interaction GWAS:1259 Forearm bone mineral density GWAS:1260 Forehead morphology GWAS:1261 Formal thought disorder in schizophrenia GWAS:1262 Fractional excretion of metabolites in chronic kidney disease GWAS:1263 Fractional excretion of uric acid GWAS:1264 Fractional exhaled nitric oxide childhood GWAS:1265 Fractional exhaled nitric oxide levels GWAS:1266 Fractional shortening GWAS:1267 Fractures GWAS:1268 Fractures vertebral GWAS:1269 Fragile X syndrome GWAS:1270 Freckles GWAS:1271 Freckling GWAS:1272 Free cholesterol levels GWAS:1273 Free cholesterol levels in large HDL GWAS:1274 Free cholesterol levels in large LDL GWAS:1275 Free cholesterol levels in medium HDL GWAS:1276 Free cholesterol levels in medium VLDL GWAS:1277 Free thyroxine concentration GWAS:1278 Frontotemporal dementia GWAS:1279 Frontotemporal dementia age at onset GWAS:1280 Frontotemporal dementia with GRN mutation GWAS:1281 Frontotemporal dementia with GRN mutation age at onset GWAS:1282 Fructosamine levels GWAS:1283 Fuchs's corneal dystrophy GWAS:1284 Full scale intelligence quotient cesarean section interaction GWAS:1285 Fulminant type 1 diabetes GWAS:1286 Functional impairment in major depressive disorder, bipolar disorder and schizophrenia GWAS:1287 Functional MRI GWAS:1288 Gait rhythm GWAS:1289 Gait speed in old age GWAS:1290 Gait variability GWAS:1291 Gallbladder cancer GWAS:1292 Gallstone disease GWAS:1293 Gambling GWAS:1294 Gamma glutamyl transferase levels GWAS:1295 Gamma glutamyl transferase levels in excessive alcohol consumption GWAS:1296 Gamma glutamyl transferase levels in low alcohol consumption GWAS:1297 Gamma glutamyl transpeptidase GWAS:1298 Gastric adenocarcinoma histologically verified GWAS:1299 Gastric cancer GWAS:1300 Gastric parietal cell autoantibody levels in type 1 diabetes GWAS:1301 Gastritis GWAS:1302 Gastroesophageal reflux disease GWAS:1303 Gaucher disease severity GWAS:1304 Gemcitabine-induced early high-grade neutropenia in pancreatic cancer GWAS:1305 Gene methylation in lung tissue GWAS:1306 General cognitive ability GWAS:1307 General factor of neuroticism GWAS:1308 General glucose level in pregnancy gestational week 30-32 GWAS:1309 Generalized epilepsy GWAS:1310 General risk tolerance MTAG GWAS:1311 Gestational age at birth child effect GWAS:1312 Gestational age at birth in labor-initiated deliveries child effect GWAS:1313 Gestational age at birth in labor-initiated deliveries maternal effect GWAS:1314 Gestational age at birth in premature rupture of membrane-initiated deliveries child effect GWAS:1315 Gestational age at birth in premature rupture of membrane-initiated deliveries maternal effect GWAS:1316 Gestational age at birth maternal effect GWAS:1317 Giant cell arteritis GWAS:1318 GIP levels in response to oral glucose tolerance test 120 minutes GWAS:1319 GIP levels in response to oral glucose tolerance test fasting GWAS:1320 Glaucoma GWAS:1321 Glaucoma exfoliation GWAS:1322 Glaucoma high intraocular pressure GWAS:1323 Glaucoma low intraocular pressure GWAS:1324 Glaucoma primary angle closure GWAS:1325 Glaucoma primary open-angle GWAS:1326 Glioblastoma GWAS:1327 Glioblastoma age-stratified GWAS:1328 Glioma GWAS:1329 Glioma high-grade GWAS:1330 Global electrical heterogeneity phenotypes GWAS:1331 Glomerular filtration rate GWAS:1332 Glomerular filtration rate change in heart transplantation GWAS:1333 Glomerular filtration rate creatinine GWAS:1334 Glomerular filtration rate cystatin C GWAS:1335 Glomerular filtration rate in chronic kidney disease GWAS:1336 Glomerular filtration rate in diabetes GWAS:1337 Glomerular filtration rate in diabetics creatinine GWAS:1338 Glomerular filtration rate in non diabetics creatinine GWAS:1339 Glomerular filtration rate in type 2 diabetes GWAS:1340 Glomerular load of uric acid GWAS:1341 Glomerulosclerosis GWAS:1342 GLP-1 levels in response to oral glucose tolerance test 120 minutes GWAS:1343 GLP-1 levels in response to oral glucose tolerance test fasting GWAS:1344 Glucagon levels in response to oral glucose tolerance test 120 minutes GWAS:1345 Glucagon levels in response to oral glucose tolerance test fasting GWAS:1346 Glucocorticoid-induced osteonecrosis GWAS:1347 Glucocorticoid-induced osteonecrosis age 10 years and older GWAS:1348 Glucocorticoid-induced osteonecrosis time dependent analysis GWAS:1349 Glucose homeostasis traits GWAS:1350 Glycated hemoglobin levels GWAS:1351 Glycated hemoglobin levels in type 1 diabetes GWAS:1352 Glycemic traits GWAS:1353 Glycemic traits multi-trait analysis GWAS:1354 Glycemic traits pregnancy GWAS:1355 Glycerophospholipid levels GWAS:1356 Glycine levels GWAS:1357 Gondoic acid 201n-9 levels GWAS:1358 Gout GWAS:1359 Gout in chronic kidney disease GWAS:1360 Gout vs Hyperuricemia GWAS:1361 Granulocyte-colony stimulating factor levels GWAS:1362 Granulocyte count GWAS:1363 Granulocyte percentage of myeloid white cells GWAS:1364 Graves' disease GWAS:1365 Gray matter volume schizophrenia interaction GWAS:1366 Growth differentiation factor-15 levels GWAS:1367 Growth differentiation factor-15 levels conditioned on rs888663 GWAS:1368 Growth-regulated protein alpha levels GWAS:1369 Gut microbiome composition summer GWAS:1370 Gut microbiome composition summer and winter GWAS:1371 Gut microbiome composition winter GWAS:1372 Gut microbiota bacterial taxa GWAS:1373 Gut microbiota beta diversity GWAS:1374 Gut microbiota functional units GWAS:1375 Hair color GWAS:1376 Hair greying GWAS:1377 Hair morphology GWAS:1378 Hair morphology traits GWAS:1379 Hair shape GWAS:1380 Handedness GWAS:1381 Handedness in dyslexia GWAS:1382 Handedness Left-handed vs non-left-handed GWAS:1383 Handedness Right-handed vs non-right-handed GWAS:1384 Hand grip strength GWAS:1385 Haptoglobin levels GWAS:1386 Hashimoto thyroiditis GWAS:1387 Hashimoto thyroiditis versus Graves' disease GWAS:1388 HATA volume GWAS:1389 HbA2 levels GWAS:1390 HDL cholesterol GWAS:1391 HDL cholesterol and triglyceride levels GWAS:1392 HDL cholesterol and triglyceride levels pleiotropy GWAS:1393 HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes GWAS:1394 HDL Cholesterol in HIV-infection GWAS:1395 HDL cholesterol levels GWAS:1396 HDL Cholesterol - Triglycerides HDLC-TG GWAS:1397 HDL cholesterol x physical activity interaction 1df test GWAS:1398 HDL cholesterol x physical activity interaction 2df test GWAS:1399 Headache GWAS:1400 Head circumference infant GWAS:1401 Healthspan GWAS:1402 Hearing function GWAS:1403 Hearing impairment GWAS:1404 Heart failure GWAS:1405 Heart rate GWAS:1406 Heart rate increase in response to exercise GWAS:1407 Heart rate response to beta blockers GWAS:1408 Heart rate response to beta blockers atenolol add-on therapy GWAS:1409 Heart rate response to beta blockers atenolol monotherapy GWAS:1410 Heart rate response to exercise GWAS:1411 Heart rate response to recovery post exercise 10 sec GWAS:1412 Heart rate response to recovery post exercise 20 sec GWAS:1413 Heart rate response to recovery post exercise 30 sec GWAS:1414 Heart rate response to recovery post exercise 40 sec GWAS:1415 Heart rate response to recovery post exercise 50 sec GWAS:1416 Heart rate response to recovery post exercise GWAS:1417 Heart rate variability traits GWAS:1418 Heart rate variability traits pvRSA HF GWAS:1419 Heart rate variability traits RMSSD GWAS:1420 Heart rate variability traits SDNN GWAS:1421 Heavy vaginal discharge GWAS:1422 Hedonic well-being GWAS:1423 Heel bone mineral density GWAS:1424 Height GWAS:1425 Height adjusted BMI GWAS:1426 Helicobacter pylori serologic status GWAS:1427 Helix rolling GWAS:1428 Helping behaviour self reported GWAS:1429 Hematocrit GWAS:1430 Hematological and biochemical traits GWAS:1431 Hematological parameters GWAS:1432 Hematology traits GWAS:1433 Hematoma volume in lobar spontaneous intracerebral hemorrhage GWAS:1434 Hematoma volume in non-lobar spontaneous intracerebral hemorrhage GWAS:1435 Hemoglobin GWAS:1436 Hemoglobin A1c levels GWAS:1437 Hemoglobin A2 levels in sickle cell anemia GWAS:1438 Hemoglobin concentration GWAS:1439 Hemoglobin levels GWAS:1440 Hemostatic factors and hematological phenotypes GWAS:1441 Hen's egg allergy GWAS:1442 Heparin-induced thrombocytopenia GWAS:1443 Hepatic lipid content in extreme obesity GWAS:1444 Hepatitis GWAS:1445 Hepatitis A GWAS:1446 Hepatitis B GWAS:1447 Hepatitis B surface antigen seroclearance in chronic hepatitis B infection GWAS:1448 Hepatitis B vaccine response GWAS:1449 Hepatitis B viral clearance GWAS:1450 Hepatitis B virus-related hepatocellular carcinoma GWAS:1451 Hepatitis C induced liver cirrhosis GWAS:1452 Hepatitis C induced liver fibrosis GWAS:1453 Hepatitis C spontaneous viral clearance GWAS:1454 Hepatocellular carcinoma GWAS:1455 Hepatocellular carcinoma in hepatitis B infection GWAS:1456 Hepatocellular carcinoma in hepatitis C infection GWAS:1457 Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy GWAS:1458 Hepatocyte growth factor levels GWAS:1459 Hepcidin ferritin ratio GWAS:1460 Hepcidin levels GWAS:1461 Hepcidin transferrin saturation ratio GWAS:1462 HER2 status in breast cancer GWAS:1463 Hereditary hemochromatosis-related traits HFE mutation homozygotes GWAS:1464 Heroin dependence GWAS:1465 Heschl's gyrus morphology GWAS:1466 High altitude adaptation GWAS:1467 High density lipoprotein cholesterol levels GWAS:1468 Highest math class taken GWAS:1469 Highest math class taken MTAG GWAS:1470 High fetal hemoglobin in sickle cell disease GWAS:1471 High-grade serous ovarian cancer GWAS:1472 High IL-1beta levels in gingival crevicular fluid GWAS:1473 High light scatter reticulocyte count GWAS:1474 High light scatter reticulocyte percentage of red cells GWAS:1475 High serum lipase activity GWAS:1476 Hip bone size GWAS:1477 Hip circumference GWAS:1478 Hip circumference adjusted for BMI GWAS:1479 Hip circumference psychosocial stress interaction GWAS:1480 Hip geometry GWAS:1481 Hip minimal joint space width GWAS:1482 Hippocampal atrophy GWAS:1483 Hippocampal fissure volume GWAS:1484 Hippocampal sclerosis GWAS:1485 Hippocampal sclerosis of aging GWAS:1486 Hippocampal subfield CA1 volume GWAS:1487 Hippocampal subfield CA1 volume corrected for total hippocampal volume GWAS:1488 Hippocampal subfield CA3 volume GWAS:1489 Hippocampal subfield CA4 volume GWAS:1490 Hippocampal tail volume GWAS:1491 Hippocampal tail volume corrected for total hippocampal volume GWAS:1492 Hippocampal volume GWAS:1493 Hippocampal volume in Alzheimer's disease dementia GWAS:1494 Hippocampal volume in mild cognitive impairment GWAS:1495 Hippocampal volume in normal cognition GWAS:1496 Hip shape DXA scan GWAS:1497 Hirschsprung disease GWAS:1498 HIV-1 control GWAS:1499 HIV-1 progression GWAS:1500 HIV-1 replication GWAS:1501 HIV-1 susceptibility GWAS:1502 HIV-1 viral setpoint GWAS:1503 HIV-associated dementia GWAS:1504 HIV-associated neurocognitive disorder GWAS:1505 HIV-associated neurocognitive disorder asymptomatic neurocogntive impairment GWAS:1506 HIV-associated neurocognitive disorder mild neurocognitive disorder GWAS:1507 HIV-associated neurocognitive disorder mild neurocognitive disorder or asymptomatic neurocognitive impairment GWAS:1508 Hoarding GWAS:1509 Hodgkin's lymphoma GWAS:1510 Homeostasis model assessment of beta-cell function GWAS:1511 Homeostasis model assessment of beta-cell function dietary factor interaction GWAS:1512 Homeostasis model assessment of insulin resistance GWAS:1513 Homeostasis model assessment of insulin resistance dietary factor interaction GWAS:1514 Homoarginine levels GWAS:1515 Homocysteine levels GWAS:1516 Hormone measurements GWAS:1517 Household income GWAS:1518 HPV seropositivity GWAS:1519 Huntington's disease age at onset GWAS:1520 Huntington's disease progression GWAS:1521 Hyperactive-impulsive symptoms GWAS:1522 Hyperemesis gravidarum GWAS:1523 Hyperopia GWAS:1524 Hypersomnia during a major depressive episode in bipolar disorder GWAS:1525 Hypersomnia HLA-DQB10602 negative GWAS:1526 Hypertension GWAS:1527 Hypertension risk in short sleep duration GWAS:1528 Hyperthyroidism GWAS:1529 Hypertriglyceridemia GWAS:1530 Hyperuricemia GWAS:1531 Hypospadias GWAS:1532 Hypothyroidism GWAS:1533 Ideal cardiovascular health clinical GWAS:1534 Ideal cardiovascular health clinical and behavioural GWAS:1535 Idiopathic dilated cardiomyopathy GWAS:1536 Idiopathic inflammatory myopathy GWAS:1537 Idiopathic intracranial hypertension GWAS:1538 Idiopathic membranous nephropathy GWAS:1539 Idiopathic osteonecrosis of the femoral head GWAS:1540 Idiopathic pulmonary fibrosis GWAS:1541 IFN-related cytopenia GWAS:1542 IgA levels GWAS:1543 IgA nephropathy GWAS:1544 IgE grass sensitization GWAS:1545 IgE levels GWAS:1546 IgE levels in asthmatics GWAS:1547 IgE levels in asthmatics Df specific GWAS:1548 IgE levels in asthmatics Dp specific GWAS:1549 IgG1 response to Plasmodium falciparum antigen GLURP GWAS:1550 IgG bisecting N-acetyl glucosamine phenotypes multivariate analysis GWAS:1551 IgG digalactosylation phenotypes multivariate analysis GWAS:1552 IgG disialylation phenotypes multivariate analysis GWAS:1553 IgG fucosylation phenotypes multivariate analysis GWAS:1554 IgG galactosylation phenotypes multivariate analysis GWAS:1555 IgG glycosylation GWAS:1556 IgG glycosylation patterns GWAS:1557 IgG levels GWAS:1558 IgG monogalactosylation phenotypes multivariate analysis GWAS:1559 IgG monosialylation phenotypes multivariate analysis GWAS:1560 IgG N-glycosylation phenotypes multivariate analysis GWAS:1561 IgG response to Plasmodium falciparum antigens GLURP, MSP2 FC27, MSP2 3D7 GWAS:1562 IgG sialylation phenotypes multivariate analysis GWAS:1563 IgM levels GWAS:1564 Ileal carcinoids GWAS:1565 Illicit drug use GWAS:1566 Immature fraction of reticulocytes GWAS:1567 Immune reponse to smallpox secreted IFN-alpha GWAS:1568 Immune reponse to smallpox secreted IL-10 GWAS:1569 Immune reponse to smallpox secreted IL-12p40 GWAS:1570 Immune reponse to smallpox secreted IL-1beta GWAS:1571 Immune reponse to smallpox secreted IL-2 GWAS:1572 Immune reponse to smallpox secreted TNF-alpha GWAS:1573 Immune response to anthrax vaccine GWAS:1574 Immune response to measles-mumps-rubella vaccine GWAS:1575 Immune response to measles vaccine measles-induced IFN gamma GWAS:1576 Immune response to measles vaccine measles-specific neutralising antibody titre GWAS:1577 Immune response to smallpox vaccine IL-6 GWAS:1578 Immunoglobulin A GWAS:1579 Immunoglobulin A vasculitis GWAS:1580 Immunoglobulin G index levels in multiple sclerosis GWAS:1581 Immunoglobulin light chain AL amyloidosis GWAS:1582 Immunoglobulin light chain AL amyloidosis heart and kidney involvement GWAS:1583 Immunoglobulin light chain AL amyloidosis heart involvement GWAS:1584 Immunoglobulin light chain AL amyloidosis kidney involvement GWAS:1585 Immunoglobulin light chain AL amyloidosis liver involvement GWAS:1586 Immunoglobulin light chain AL amyloidosis serum IgG profile GWAS:1587 Immunoglobulin light chain AL amyloidosis serum Ig lambda profile GWAS:1588 Immunoglobulin light chain AL amyloidosis serum Ig light chain only lambda based profile GWAS:1589 Immunoglobulin light chain AL amyloidosis serum Ig light chain only lambda kappa based profile GWAS:1590 Immunoglobulin M against phosphorylcholine IgM anti-PC levels GWAS:1591 Immunoglobulin measurement zinc sulfate turbidity test GWAS:1592 Impulsivity GWAS:1593 Impulsivity attentional GWAS:1594 Impulsivity motor GWAS:1595 Impulsivity non-planning GWAS:1596 Inattentive symptoms GWAS:1597 Incident atrial fibrillation GWAS:1598 Incident coronary heart disease GWAS:1599 Incident myocardial infarction GWAS:1600 Incremental insulin GWAS:1601 Infant, child and juvenile death in continuous marriage proportion of children died <15 years GWAS:1602 Infant, child and juvenile death proportion of children died <15 years GWAS:1603 Infantile hypertrophic pyloric stenosis GWAS:1604 Infant length GWAS:1605 Inflammatory biomarkers GWAS:1606 Inflammatory biomarkers in Kawasaki disease GWAS:1607 Inflammatory bowel disease GWAS:1608 Inflammatory bowel disease early onset GWAS:1609 Inflammatory skin disease GWAS:1610 Influenza A H1N1 infection GWAS:1611 Influenza A H1N1 severity GWAS:1612 Information processing speed GWAS:1613 Inguinal hernia GWAS:1614 Inhibitory control GWAS:1615 Initial alcohol sensitivity GWAS:1616 Initial pursuit acceleration GWAS:1617 Initial pursuit acceleration in psychotic disorders GWAS:1618 Insomnia GWAS:1619 Insomnia caffeine-induced GWAS:1620 Insomnia complaints GWAS:1621 Insomnia complaints continuous GWAS:1622 Insomnia complaints dichotomous GWAS:1623 Insomnia symptoms never rarely vs sometimes usually GWAS:1624 Insomnia symptoms never rarely vs usually GWAS:1625 Insulin disposition index GWAS:1626 Insulin levels adjusted for BMI GWAS:1627 Insulin levels in response to oral glucose tolerance test 120 minutes GWAS:1628 Insulin levels in response to oral glucose tolerance test 30 minutes GWAS:1629 Insulin levels in response to oral glucose tolerance test fasting GWAS:1630 Insulin levels GWAS:1631 Insulin-like growth factors GWAS:1632 Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes GWAS:1633 Insulin-related traits GWAS:1634 Insulin resistance response GWAS:1635 Insulin secretion rate GWAS:1636 Insulin sensitivity index GWAS:1637 Intelligence GWAS:1638 Intelligence childhood GWAS:1639 Intelligence MTAG GWAS:1640 Intercellular adhesion molecule 1 red blood cell fatty acid level interaction GWAS:1641 Interferon alpha levels in systemic lupus erythematosus GWAS:1642 Interferon gamma-induced protein 10 levels GWAS:1643 Interferon gamma levels GWAS:1644 Interleukin-10 levels GWAS:1645 Interleukin-12p70 levels GWAS:1646 Interleukin-13 levels GWAS:1647 Interleukin-16 levels GWAS:1648 Interleukin-17 levels GWAS:1649 Interleukin-18 levels GWAS:1650 Interleukin-1-beta levels GWAS:1651 Interleukin-1-receptor antagonist levels GWAS:1652 Interleukin-2 levels GWAS:1653 Interleukin-2 receptor antagonist levels GWAS:1654 Interleukin-4 levels GWAS:1655 Interleukin-5 levels GWAS:1656 Interleukin-6 levels GWAS:1657 Interleukin-6 red blood cell fatty acid level interaction GWAS:1658 Interleukin-7 levels GWAS:1659 Interleukin-8 levels GWAS:1660 Interleukin-9 levels GWAS:1661 Interstitial lung disease GWAS:1662 Intracerebral hemorrhage GWAS:1663 Intracranial, abdominal aortic or thoracic aortic aneurysm pleiotropy GWAS:1664 Intracranial aneurysm GWAS:1665 Intracranial volume GWAS:1666 Intra-individual response time variability selective attention GWAS:1667 Intraocular pressure GWAS:1668 Intrinsic epigenetic age acceleration GWAS:1669 Invasive epithelial ovarian cancer GWAS:1670 Iris characteristics GWAS:1671 Iris color GWAS:1672 Iris color a coordinate GWAS:1673 Iris color b coordinate GWAS:1674 Iris color L coordinate GWAS:1675 Iris heterochromicity GWAS:1676 Iron deficiency GWAS:1677 Iron levels GWAS:1678 Iron status biomarkers GWAS:1679 Iron status biomarkers ferritin levels GWAS:1680 Iron status biomarkers iron levels GWAS:1681 Iron status biomarkers total iron binding capacity GWAS:1682 Iron status biomarkers transferrin levels GWAS:1683 Iron status biomarkers transferrin saturation GWAS:1684 Irritable bowel syndrome GWAS:1685 Irritable mood GWAS:1686 Ischemic heart disease in rheumatoid arthritis GWAS:1687 Ischemic stroke GWAS:1688 Ischemic stroke cardioembolic GWAS:1689 Ischemic stroke large artery atherosclerosis GWAS:1690 Ischemic stroke small artery occlusion GWAS:1691 Ischemic stroke small-vessel GWAS:1692 Ischemic stroke undetermined subtype GWAS:1693 Isovolumetric relaxation time GWAS:1694 Itch intensity from mosquito bite GWAS:1695 Itch intensity from mosquito bite adjusted by bite size GWAS:1696 Job-related exhaustion GWAS:1697 Job-related exhaustion in shift workers GWAS:1698 Joint damage progression in ACPA-negative rheumatoid arthritis GWAS:1699 Joint mobility Beighton score GWAS:1700 JT interval sulfonylurea treatment interaction GWAS:1701 Juvenile idiopathic arthritis oligoarticular or rheumatoid factor-negative polyarticular GWAS:1702 Juvenile myoclonic epilepsy GWAS:1703 Juvenile osteochondritis dissecans GWAS:1704 Kashin-Beck disease GWAS:1705 Kawasaki disease GWAS:1706 Keloid GWAS:1707 Kidney disease early and late stages in type 1 diabetes GWAS:1708 Kidney disease early stage in type 1 diabetes GWAS:1709 Kidney disease end stage renal disease vs non-end stage renal disease in type 1 diabetes GWAS:1710 Kidney disease end stage renal disease vs normoalbuminuria in type 1 diabetes GWAS:1711 Kidney disease late stage in type 1 diabetes GWAS:1712 Kidney function decline traits GWAS:1713 Kidney stones GWAS:1714 Knee osteoarthritis GWAS:1715 Lachrymal Salivary gland lesion in type 1 autoimmune pancreatitis GWAS:1716 Lack of perseverance GWAS:1717 Lack of premeditation GWAS:1718 Lactate dehydrogenase levels GWAS:1719 Language impairment in frontotemporal lobe dementia GWAS:1720 Language performance in older adults adjusted for episodic memory GWAS:1721 Lapatinib-induced hepatotoxicity GWAS:1722 Large artery stroke GWAS:1723 Large B-cell lymphoma GWAS:1724 Large HDL particle concentration GWAS:1725 Large LDL particle concentration GWAS:1726 L-arginine levels GWAS:1727 Laryngeal squamous cell carcinoma GWAS:1728 Late diabetic kidney disease in type 2 diabetes GWAS:1729 Latent autoimmune diabetes GWAS:1730 Latent autoimmune diabetes vs type 1 diabetes GWAS:1731 Latent autoimmune diabetes vs type 2 diabetes GWAS:1732 Late-onset Alzheimer's disease GWAS:1733 Late-onset myasthenia gravis GWAS:1734 Laterality in neovascular age-related macular degeneration GWAS:1735 Lateral ventricle volume in trauma-exposed individuals GWAS:1736 Lateral ventricular volume in normal aging GWAS:1737 LDL cholesterol GWAS:1738 LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes GWAS:1739 LDL cholesterol levels GWAS:1740 LDL cholesterol to HDL cholesterol ratio GWAS:1741 LDL cholesterol x physical activity interaction 1df test GWAS:1742 LDL cholesterol x physical activity interaction 2df test GWAS:1743 LDL oxidized GWAS:1744 LDL peak particle diameter total fat intake interaction GWAS:1745 Lead levels in blood GWAS:1746 Lean body mass GWAS:1747 Lean body mass and age at menarche combined GWAS:1748 Left atrial antero-posterior diameter GWAS:1749 Left inferior lateral ventricle volume Cerebrospinal fluid biomarker status interaction GWAS:1750 Left superior temporal gyrus thickness schizophrenia interaction GWAS:1751 Left ventricle diastolic internal dimension GWAS:1752 Left ventricle systolic dysfunction GWAS:1753 Left ventricle wall thickness GWAS:1754 Left ventricular fractional shortening GWAS:1755 Left ventricular function change in anthracycline treatment GWAS:1756 Left ventricular internal dimension in diastole GWAS:1757 Left ventricular internal dimension in systole GWAS:1758 Left ventricular mass GWAS:1759 Left ventricular obstructive tract defect inherited effect GWAS:1760 Left ventricular obstructive tract defect maternal effect GWAS:1761 Left ventricular QRS voltage GWAS:1762 Leishmaniasis visceral GWAS:1763 Leisure-time exercise behaviour GWAS:1764 Leisure-time exercise behaviour age-stratified GWAS:1765 Length of menstrual cycle GWAS:1766 Lentiform nucleus volume GWAS:1767 Leprosy GWAS:1768 Lewy body disease GWAS:1769 Life satisfaction GWAS:1770 Lifespan GWAS:1771 Life threatening arrhythmia GWAS:1772 Lifetime average cigarettes per day in chronic obstructive pulmonary disease GWAS:1773 Light vs dark hair color GWAS:1774 Limited cutaneous systemic scleroderma GWAS:1775 Lipid levels in hepatitis C treatment GWAS:1776 Lipid metabolism phenotypes GWAS:1777 Lipid traits GWAS:1778 Lipid traits pleiotropy HIPO component 1 GWAS:1779 Lipid traits pleiotropy HIPO component 2 GWAS:1780 Lip morphology GWAS:1781 Lipoprotein a - cholesterol levels GWAS:1782 Lipoprotein a levels GWAS:1783 Lipoproteina levels adjusted for apolipoproteina isoforms GWAS:1784 Lipoprotein-associated phospholipase A2 activity and mass GWAS:1785 Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease GWAS:1786 Lipoprotein-associated phospholipase A2 activity change in response to statin therapy GWAS:1787 Lipoprotein phospholipase A2 activity in cardiovascular disease GWAS:1788 Liver disease severity in Alagille syndrome GWAS:1789 Liver enzyme levels GWAS:1790 Liver enzyme levels alanine transaminase GWAS:1791 Liver enzyme levels alkaline phosphatase GWAS:1792 Liver enzyme levels aspartate transaminase GWAS:1793 Liver enzyme levels gamma-glutamyl transferase GWAS:1794 Liver fibrosis in pediatric non-alcoholic fatty acid liver disease GWAS:1795 Liver fibrosis severity in HIV hepatitis C co-infection GWAS:1796 Liver injury in anti-retroviral drug treated HIV GWAS:1797 Liver injury in anti-tuberculosis drug treatment GWAS:1798 Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis GWAS:1799 Liver transplant-free survival in primary sclerosing cholangitis time to event GWAS:1800 Lobe attachment GWAS:1801 Lobe attachment rater scored GWAS:1802 Lobe attachment rater-scored or self-reported GWAS:1803 Lobe size GWAS:1804 Lobular breast cancer menopausal hormone therapy interaction GWAS:1805 Local histogram emphysema pattern GWAS:1806 Logical memory delayed recall GWAS:1807 Logical memory delayed recall in Alzheimer's disease dementia GWAS:1808 Logical memory delayed recall in mild cognitive impairment GWAS:1809 Logical memory delayed recall in normal cognition GWAS:1810 Logical memory immediate recall GWAS:1811 Logical memory immediate recall in Alzheimer's disease dementia GWAS:1812 Logical memory immediate recall in mild cognitive impairment GWAS:1813 Logical memory immediate recall in normal cognition GWAS:1814 Loneliness GWAS:1815 Loneliness linear analysis GWAS:1816 Loneliness MTAG GWAS:1817 Loneliness multivariate analysis GWAS:1818 Longevity GWAS:1819 Longevity 85 years and older GWAS:1820 Longevity 90 years and older GWAS:1821 Longitudinal alcohol consumption GWAS:1822 Longitudinal change in brain amyloid plaque burden GWAS:1823 Long-term memory delayed word recall task GWAS:1824 Low density lipoprotein cholesterol levels GWAS:1825 Lower body strength GWAS:1826 Lower facial height GWAS:1827 lower facial morphology traits quantitative measurement GWAS:1828 Low-grade serous and serous borderline ovarian cancer GWAS:1829 Low-grade serous ovarian cancer GWAS:1830 Low high density lipoprotein cholesterol levels GWAS:1831 Low tan response GWAS:1832 Low vWF levels GWAS:1833 Low white blood cell count GWAS:1834 Low white blood cell count conditioned on rs2814778 GWAS:1835 Lp a levels GWAS:1836 Lumbar spine bone mineral density GWAS:1837 Lumbar spine bone mineral density integral GWAS:1838 Lumbar spine bone mineral density trabecular GWAS:1839 Lumiracoxib-related liver injury GWAS:1840 Lung adenocarcinoma GWAS:1841 Lung cancer GWAS:1842 Lung cancer asbestos exposure interaction GWAS:1843 Lung Cancer DNA repair capacity GWAS:1844 Lung cancer in ever smokers GWAS:1845 Lung cancer in never smokers GWAS:1846 Lung cancer smoking interaction GWAS:1847 Lung cancer x radon exposure interaction 1df GWAS:1848 Lung disease severity in cystic fibrosis GWAS:1849 Lung function FEV1 GWAS:1850 Lung function FEV1 FVC GWAS:1851 Lung function FEV1 FVC in asthma dust mite allergen exposure interaction GWAS:1852 Lung function FEV1 in asthma dust mite allergen exposure interaction GWAS:1853 Lung function forced expiratory flow during mid-portion 25 and 75 of forced vital capacity GWAS:1854 Lung function forced expiratory volume in 1 second GWAS:1855 Lung function forced vital capacity GWAS:1856 Lung function FVC GWAS:1857 Lung function maximal voluntary ventilation GWAS:1858 Lupus nephritis in systemic lupus erythematosus GWAS:1859 Luteinizing hormone levels in polycystic ovary syndrome GWAS:1860 Lymphocyte counts GWAS:1861 Lymphocyte percentage of white cells GWAS:1862 Lymphoma GWAS:1863 Macrophage colony stimulating factor levels GWAS:1864 Macrophage inflammatory protein 1a levels GWAS:1865 Macrophage inflammatory protein 1b levels GWAS:1866 Macrophage Migration Inhibitory Factor levels GWAS:1867 Macular telangiectasia type 2 GWAS:1868 Macular thickness GWAS:1869 Magnesium levels GWAS:1870 Major coronary event in cardiovascular disease time to event darapladib treatment interaction GWAS:1871 Major coronary event in darapladib-treated cardiovascular disease time to event GWAS:1872 Major coronary event in placebo-treated cardiovascular disease time to event GWAS:1873 Major CVD GWAS:1874 Major depression and alcohol dependence GWAS:1875 Major depressive disorder GWAS:1876 Major depressive disorder broad GWAS:1877 Major depressive disorder ICD-10 coded GWAS:1878 Major depressive disorder probable GWAS:1879 Major depressive disorder stressful life events interaction GWAS:1880 Major depressive disorder unexposed to adversity GWAS:1881 Major mood disorders GWAS:1882 Malaria GWAS:1883 Male fertility GWAS:1884 Male infertility GWAS:1885 Male-pattern baldness GWAS:1886 Male sexual orientation GWAS:1887 Mammographic density GWAS:1888 Mammographic density dense area GWAS:1889 Mammographic density non-dense area GWAS:1890 Manic episodes in bipolar disorder GWAS:1891 Marginal zone lymphoma GWAS:1892 Maternal history of Alzheimer's disease GWAS:1893 Mathematical ability GWAS:1894 Mathematical ability in children with dyslexia GWAS:1895 Matrix metalloproteinase-8 levels GWAS:1896 Matrix metalloproteinase levels GWAS:1897 Maximal oxygen uptake response GWAS:1898 Maximum cranial length GWAS:1899 Maximum cranial width GWAS:1900 Mean arterial pressure GWAS:1901 Mean arterial pressure alcohol consumption interaction GWAS:1902 Mean arterial pressure long-term average GWAS:1903 Mean arterial pressure x alcohol consumption interaction 2df test GWAS:1904 Mean arterial pressure x alcohol consumption light vs heavy interaction 2df test GWAS:1905 Mean arterial pressure x sodium interaction 2df test GWAS:1906 Mean corpuscular hemoglobin GWAS:1907 Mean corpuscular hemoglobin concentration GWAS:1908 Mean corpuscular volume GWAS:1909 Mean diameter of HDL particles GWAS:1910 Mean forced vital capacity from 2 exams GWAS:1911 Mean platelet volume GWAS:1912 Measles GWAS:1913 Meconium ileus in cystic fibrosis GWAS:1914 Medication adherence in chronic diseases GWAS:1915 Medium HDL particle concentration GWAS:1916 Medium LDL particle concentration GWAS:1917 Medium VLDL particle concentration GWAS:1918 Melanoma GWAS:1919 Membranous nephropathy GWAS:1920 Memory dysfunction in frontotemporal lobe dementia GWAS:1921 Memory performance GWAS:1922 Menarche age at onset GWAS:1923 Menarche and menopause age at onset GWAS:1924 Meningioma GWAS:1925 Meningococcal disease GWAS:1926 Menopause age at onset GWAS:1927 Menstruation quality of life impact acne GWAS:1928 Menstruation quality of life impact aggressiveness GWAS:1929 Menstruation quality of life impact bowel movement GWAS:1930 Menstruation quality of life impact depression GWAS:1931 Menstruation quality of life impact dysmenorrhea GWAS:1932 Menstruation quality of life impact edema GWAS:1933 Menstruation quality of life impact fever GWAS:1934 Menstruation quality of life impact headache GWAS:1935 Menstruation quality of life impact increased appetite GWAS:1936 Menstruation quality of life impact joint pain GWAS:1937 Menstruation quality of life impact loss of concentration GWAS:1938 Menstruation quality of life impact nervousness GWAS:1939 Menstruation quality of life impact pressure in breast GWAS:1940 Menstruation quality of life impact sleepiness GWAS:1941 Menstruation quality of life impact stiff neck GWAS:1942 Mental composite score GWAS:1943 Mental development prenatal lead exposure interaction GWAS:1944 Mesial temporal lobe epilepsy with hippocampal sclerosis GWAS:1945 Metabolic coherence transcriptomic GWAS:1946 Metabolic syndrome GWAS:1947 Metabolic syndrome bivariate traits GWAS:1948 Metabolic syndrome multivariate analysis GWAS:1949 Metabolic traits GWAS:1950 Metabolite levels GWAS:1951 Metabolite levels 5-HIAA MHPG Ratio GWAS:1952 Metabolite levels 5-HIAA GWAS:1953 Metabolite levels Dihydroxy docosatrienoic acid GWAS:1954 Metabolite levels HVA-5-HIAA Factor score GWAS:1955 Metabolite levels HVA 5-HIAA ratio GWAS:1956 Metabolite levels HVA MHPG ratio GWAS:1957 Metabolite levels HVA GWAS:1958 Metabolite levels lipid measures GWAS:1959 Metabolite levels lipoprotein measures GWAS:1960 Metabolite levels MHPG GWAS:1961 Metabolite levels Pyroglutamine GWAS:1962 Metabolite levels small molecules and protein measures GWAS:1963 Metabolite levels X-11787 GWAS:1964 Metastasis at diagnosis in osteosarcoma GWAS:1965 Metastasis in stage I-III microsatellite instability low stable colorectal cancer time to event GWAS:1966 Methadone dose in opioid dependence GWAS:1967 Methamphetamine dependence GWAS:1968 Methotrexate clearance acute lymphoblastic leukemia GWAS:1969 Methotrexate-induced interstitial lung disease in rheumatoid arthritis GWAS:1970 Methotrexate phramacokinetics acute lymphoblastic leukemia GWAS:1971 MGMT methylation in smokers GWAS:1972 Microalbuminuria GWAS:1973 Middle childhood and early adolescence aggressive behavior GWAS:1974 middle facial morphology traits quantitative measurement GWAS:1975 Midgestational circulating levels of organochlorine pesticides GWAS:1976 Midgestational circulating levels of PBDEs GWAS:1977 Midgestational circulating levels of PBDEs fetal genetic effect GWAS:1978 Midgestational circulating levels of PCBs GWAS:1979 Midgestational circulating levels of PCBs fetal genetic effect GWAS:1980 Midgestational cytokine chemokine levels fetal genetic effect GWAS:1981 Midgestational cytokine chemokine levels maternal genetic effect GWAS:1982 Midregional pro atrial natriuretic peptide levels GWAS:1983 Migraine GWAS:1984 Migraine - clinic-based GWAS:1985 Migraine with aura GWAS:1986 Migraine without aura GWAS:1987 Mild influenza H1N1 infection GWAS:1988 Milk allergy GWAS:1989 Milk allergy maternal genetic effects GWAS:1990 Milk allergy parent-of-origin effect GWAS:1991 Mitochondrial DNA copy number GWAS:1992 Mitochondrial DNA copy number white blood cells GWAS:1993 Mitochondrial DNA levels GWAS:1994 Mitral valve prolapse GWAS:1995 Mixed cellularity Hodgkin lymphoma GWAS:1996 Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection GWAS:1997 Moderate or severe diarrhoea in darapladib-treated cardiovascular disease time to event GWAS:1998 Moderate to vigorous physical activity levels GWAS:1999 Modic changes GWAS:2000 Modified Stumvoll Insulin Sensitivity Index GWAS:2001 Modified Stumvoll Insulin Sensitivity Index BMI interaction GWAS:2002 Modified Stumvoll Insulin Sensitivity Index model adjusted for BMI GWAS:2003 Molar-incisor hypomineralization GWAS:2004 Monobrow GWAS:2005 Monobrow thickness GWAS:2006 Monocyte chemoattractant protein-1 levels GWAS:2007 Monocyte chemoattractant protein-1 red blood cell fatty acid level interaction GWAS:2008 Monocyte chemoattractant protein-3 levels GWAS:2009 Monocyte count GWAS:2010 Monocyte early outgrowth colony forming units GWAS:2011 Monocyte-lymphocyte ratio GWAS:2012 Monocyte percentage of white cells GWAS:2013 Monokine induced by gamma interferon levels GWAS:2014 Mononucleosis GWAS:2015 Mood disorder and prion disease GWAS:2016 Mood disorder in prion disease GWAS:2017 Mood instability GWAS:2018 Morbidity-free survival GWAS:2019 Morning person GWAS:2020 Morning vs evening chronotype GWAS:2021 Morphine dose requirement in tonsillectomy and adenoidectomy surgery GWAS:2022 Mortality GWAS:2023 Mortality in heart failure GWAS:2024 Mortality in sepsis GWAS:2025 Mosaic loss of chromosome Y GWAS:2026 Mosquito bite size GWAS:2027 Motion sickness GWAS:2028 Motor composite score GWAS:2029 Motor development prenatal lead exposure interaction GWAS:2030 Mouth morphology principal component model GWAS:2031 Moyamoya disease GWAS:2032 Mucinous adenocarcinoma in colorectal cancer GWAS:2033 Mucinous ovarian carcinoma GWAS:2034 Multiple cancers lung cancer, gastric cancer, and squamous cell carcinoma GWAS:2035 Multiple keratinocyte cancers GWAS:2036 Multiple myeloma GWAS:2037 Multiple myeloma and monoclonal gammopathy GWAS:2038 Multiple myeloma hyperdiploidy GWAS:2039 Multiple myeloma IgH translocation GWAS:2040 Multiple myeloma survival GWAS:2041 Multiple sclerosis GWAS:2042 Multiple sclerosis age of onset GWAS:2043 Multiple sclerosis and body mass index pleiotropy GWAS:2044 Multiple sclerosis and C-reactive protein levels pleiotropy GWAS:2045 Multiple sclerosis and HDL levels pleiotropy GWAS:2046 Multiple sclerosis and LDL levels pleiotropy GWAS:2047 Multiple sclerosis and systolic blood pressure pleiotropy GWAS:2048 Multiple sclerosis and triglyceride levels pleiotropy GWAS:2049 Multiple sclerosis and type 2 diabetes pleiotropy GWAS:2050 Multiple sclerosis and waist-to-hip-ratio pleiotropy GWAS:2051 Multiple sclerosis--Brain Glutamate Levels GWAS:2052 Multiple sclerosis OCB status GWAS:2053 Multiple sclerosis or amyotrophic lateral sclerosis GWAS:2054 Multiple sclerosis severity GWAS:2055 Multiple system atrophy GWAS:2056 Multiple system atrophy pathologically confirmed GWAS:2057 Mumps GWAS:2058 Musician's dystonia GWAS:2059 Myasthenia gravis GWAS:2060 Myeloid white cell count GWAS:2061 Myeloproliferative neoplasms GWAS:2062 Myocardial infarction GWAS:2063 Myocardial infarction early onset GWAS:2064 Myocardial infarction in cardiovascular disease time to event darapladib treatment interaction GWAS:2065 Myocardial infarction in coronary artery disease GWAS:2066 Myocardial infarction in darapladib-treated cardiovascular disease time to event GWAS:2067 Myocardial infarction in hypertension calcium channel blocker interaction GWAS:2068 Myopia GWAS:2069 Myopia age of diagnosis GWAS:2070 Myopia pathological GWAS:2071 Myopia severe GWAS:2072 Myopic maculopathy GWAS:2073 Myositis GWAS:2074 Myringotomy GWAS:2075 Narcolepsy GWAS:2076 Narcolepsy age of onset GWAS:2077 Narcolepsy onset before 2009 H1N1 influenza pandemic GWAS:2078 Narcolepsy with cataplexy GWAS:2079 Narrowest width of the femoral neck GWAS:2080 Nasal polyps GWAS:2081 Nasopharyngeal carcinoma GWAS:2082 Natriuretic peptide levels GWAS:2083 Negative urgency GWAS:2084 Neonatal cytokine chemokine levels fetal genetic effect GWAS:2085 Neonatal cytokine chemokine levels maternal genetic effect GWAS:2086 Neonatal lupus GWAS:2087 Neovascular age-related macular degeneration GWAS:2088 Nephrolithiasis GWAS:2089 Nephropathy GWAS:2090 Nephrotic syndrome acquired GWAS:2091 Neuranatomic and neurocognitive phenotypes GWAS:2092 Neuritic plaques or cerebral amyloid angiopathy pleiotropy GWAS:2093 Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy pleiotropy GWAS:2094 Neuritic plaques or neurofibrillary tangles pleiotropy GWAS:2095 Neuritic plaque GWAS:2096 Neuroblastoma GWAS:2097 Neuroblastoma 11q deletion GWAS:2098 Neuroblastoma 1p deletion GWAS:2099 Neuroblastoma high-risk GWAS:2100 Neuroblastoma MYCN amplification GWAS:2101 Neurociticism GWAS:2102 Neurocognitive impairment in HIV-1 infection continuous GWAS:2103 Neurocognitive impairment in HIV-1 infection dichotomous GWAS:2104 Neurofibrillary tangles or cerebral amyloid angiopathy pleiotropy GWAS:2105 Neurofibrillary tangles GWAS:2106 Neuromyelitis optica GWAS:2107 Neuromyelitis optica AQP4-IgG-positive GWAS:2108 Neuropathic pain in head and neck cancer GWAS:2109 Neuropathic pain in type 2 diabetes GWAS:2110 Neuroticism GWAS:2111 Neuroticism age interaction GWAS:2112 Neuroticism MTAG GWAS:2113 Neutralising antibody response to interferon beta therapy in multiple sclerosis area under the curve for the first two years GWAS:2114 Neutralising antibody response to interferon beta therapy in multiple sclerosis maximum antibody levels GWAS:2115 Neutralising antibody response to interferon beta therapy in multiple sclerosis mean antibody levels GWAS:2116 Neutralising antibody response to interferon beta therapy in multiple sclerosis presence of antibodies GWAS:2117 Neutrophil count GWAS:2118 Neutrophil count in HIV-infection GWAS:2119 Neutrophil level response to clozapine in treatment-resistant schizophrenia GWAS:2120 Neutrophil percentage of granulocytes GWAS:2121 Neutrophil percentage of white cells GWAS:2122 Nevirapine-induced hypersensitivity in HIV GWAS:2123 Nevirapine-induced hypersensitivity in HIV drug-induced liver injury GWAS:2124 Nevirapine-induced hypersensitivity in HIV Stevens-Johnson syndrome or toxic epidermal necrosis GWAS:2125 Nevirapine-induced rash GWAS:2126 Nevus count GWAS:2127 Nevus count or cutaneous melanoma GWAS:2128 N-glycan levels GWAS:2129 NHDL cholesterol to HDL cholesterol ratio GWAS:2130 Nicotine dependence GWAS:2131 Nicotine dependence and major depression severity of comorbidity GWAS:2132 Nicotine dependence symptom count GWAS:2133 Nicotine glucouronidation GWAS:2135 Nicotine use GWAS:2136 Nicotine withdrawal GWAS:2137 Nicotine withdrawal symptom count GWAS:2138 Night sleep phenotypes GWAS:2139 Nodular sclerosis Hodgkin lymphoma GWAS:2140 Noise-induced hearing loss GWAS:2141 Non-albumin protein levels GWAS:2142 Nonalcoholic fatty liver disease GWAS:2143 Non-alcoholic fatty liver disease histology AST GWAS:2144 Non-alcoholic fatty liver disease histology lobular GWAS:2145 Non-alcoholic fatty liver disease histology other GWAS:2146 Nonalcoholic steatohepatitis-derived hepatocellular carcinoma GWAS:2147 Non-cardia gastric cancer GWAS:2148 Non-chemotherapy drug induced agranulocytosis GWAS:2149 Non-glioblastoma glioma GWAS:2150 Non-melanoma skin cancer GWAS:2151 Non-obstructive azoospermia GWAS:2152 Non-response to antidepressants and depression GWAS:2153 Non-response to bupropion and depression GWAS:2154 Non-response to citalopram or escitalopram and depression GWAS:2155 Non-response to selective serotonin reuptake inhibitors and depression GWAS:2156 Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy GWAS:2157 Non-small cell lung cancer GWAS:2158 Non-small cell lung cancer recurrence rate GWAS:2159 Non-small cell lung cancer survival GWAS:2160 Non-steroidal anti-inflammatory drug-induced enteropathy GWAS:2161 Non-substance related behavioral disinhibition GWAS:2162 Nonsyndromic cleft lip with cleft palate GWAS:2163 Nonsyndromic cleft lip with or without cleft palate GWAS:2164 Nonsyndromic cleft lip with or without cleft palate x sex interaction 2df test GWAS:2165 Nontyphoidal Salmonella bacteraemia GWAS:2166 Non-word reading GWAS:2167 Non-word repetition GWAS:2168 Normal body mass index vs thin GWAS:2169 Normal facial asymmetry angle of deformation score GWAS:2170 Normal facial asymmetry angle of surface orientation score GWAS:2171 Normal facial asymmetry deformation magnitude GWAS:2172 Normalized brain volume GWAS:2173 Nose length GWAS:2174 Nose morphology GWAS:2175 Nose morphology partial least square model GWAS:2176 Nose size GWAS:2177 N-terminal pro B-type natriuretic peptide levels GWAS:2178 NT-proBNP levels in acute coronary syndrome GWAS:2179 Nucleus accumbens volume in trauma-exposed individuals GWAS:2180 Number of children GWAS:2181 Number of children 6 vs 0 or 1 GWAS:2182 Number of children ever born GWAS:2183 Number of common colds GWAS:2184 Number of live births GWAS:2185 Number of pregnancies GWAS:2186 Number of sexual partners GWAS:2187 Number of stillbirths in continuous marriage GWAS:2188 Number of twin births GWAS:2189 Obese vs thin GWAS:2190 Obesity GWAS:2191 Obesity and osteoporosis GWAS:2192 Obesity early onset extreme GWAS:2193 Obesity extreme GWAS:2194 Obesity in adult survivors of childhood cancer exposed to cranial radiation GWAS:2195 Obesity in adult survivors of childhood cancer not exposed to cranial radiation GWAS:2196 Obesity-related traits GWAS:2197 Obesity without metabolic disease GWAS:2198 Objective response to lithium treatment GWAS:2199 Objective response to lithium treatment in bipolar disorder GWAS:2200 Obsessive-compulsive disorder GWAS:2201 Obsessive-compulsive disorder or autism spectrum disorder GWAS:2202 Obsessive-compulsive disorder x sex interaction GWAS:2203 Obsessive-compulsive symptoms GWAS:2204 Obstetric antiphospholipid syndrome GWAS:2205 Obstructive sleep apnea GWAS:2206 Obstructive sleep apnea average oxygen saturation during sleep GWAS:2207 Obstructive sleep apnea during REM sleep apnea hypopnea index GWAS:2208 Obstructive sleep apnea trait apnea hypopnea index GWAS:2209 Obstructive sleep apnea trait average respiratory event duration GWAS:2210 Occipital cortical area total cortical area interaction GWAS:2211 Odorant perception beta-damascenone GWAS:2212 Odorant perception beta-ionone GWAS:2213 Odorant perception isobutyraldehyde GWAS:2214 Offspring birth weight GWAS:2215 Oleic acid 181n-9 levels GWAS:2216 Oligoclonal band status in multiple sclerosis GWAS:2217 Open-angle glaucoma and optic cup area GWAS:2218 Open-angle glaucoma and vertical cup-disc ratio GWAS:2219 Openness GWAS:2220 Opioid dependence GWAS:2221 Opioid requirements during laparoscopic-assisted colectomy GWAS:2222 Opioid sensitivity GWAS:2223 Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder GWAS:2224 Optic cup area GWAS:2225 Optic disc area GWAS:2226 Optic disc parameters GWAS:2227 Optic nerve measurement cup area GWAS:2228 Optic nerve measurement cup-to-disc ratio GWAS:2229 Optic nerve measurement disc area GWAS:2230 Optic nerve measurement rim area GWAS:2231 Oral cavity and pharyngeal cancer GWAS:2232 Oral cavity cancer GWAS:2233 Orofacial clefts GWAS:2234 Orofacial clefts maternal alcohol consumption interaction GWAS:2235 Oropharynx cancer GWAS:2236 Orthostatic hypotension GWAS:2237 Ossification of the posterior longitudinal ligament of the spine GWAS:2238 Osteoarthritis GWAS:2239 Osteoarthritis biomarkers GWAS:2240 Osteoarthritis hand, severe GWAS:2241 Osteoarthritis hip GWAS:2242 Osteoarthritis hospital diagnosed GWAS:2243 Osteoarthritis of the hip hospital diagnosed GWAS:2244 Osteoarthritis of the hip or knee GWAS:2245 Osteoarthritis of the hip or knee hospital diagnosed GWAS:2246 Osteoarthritis of the hip or knee with total joint replacement GWAS:2247 Osteoarthritis of the hip with total joint replacement GWAS:2248 Osteoarthritis of the knee hospital diagnosed GWAS:2249 Osteoarthritis of the knee with total joint replacement GWAS:2250 Osteoarthritis self-reported GWAS:2251 Osteoarthritis with total hip replacement GWAS:2252 Osteolysis in total hip arthroplasty GWAS:2253 Osteolysis in total hip arthroplasty time to prosthesis revision GWAS:2254 Osteonecrosis of the jaw GWAS:2255 Osteoporosis GWAS:2256 Osteoporosis-related phenotypes GWAS:2257 Osteoprotegerin levels GWAS:2258 Osteosarcoma GWAS:2259 Other erythrocyte phenotypes GWAS:2260 Otitis media GWAS:2261 Otitis media chronic GWAS:2262 Otitis media chronic recurrent GWAS:2263 Otitis media recurrent GWAS:2264 Otosclerosis GWAS:2265 Ovarian cancer GWAS:2266 Ovarian cancer in BRCA1 mutation carriers GWAS:2267 Ovarian cancer in BRCA2 mutation carriers GWAS:2268 Ovarian clear cell cancer GWAS:2269 Ovarian disease with few adhesions GWAS:2270 Ovarian reserve GWAS:2271 Overall survival in osteosarcoma GWAS:2272 Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin GWAS:2273 Overweight status GWAS:2274 Oxygenated hemoglobin levels GWAS:2275 Paclitaxel disposition in epithelial ovarian cancer GWAS:2276 Paclitaxel-induced cytotoxicity GWAS:2277 Paclitaxel-induced neuropathy GWAS:2278 Paediatric migraine GWAS:2279 Paget's disease GWAS:2280 Pain GWAS:2281 Pain medicine use during menstruation GWAS:2282 Pallidum volume in trauma-exposed individuals GWAS:2283 Palmitic acid 160 levels GWAS:2284 Palmitoleic acid 161n-7 levels GWAS:2285 Pancreatic cancer GWAS:2286 Pancreatic ductal adenocarcinoma GWAS:2287 Pancreatitis GWAS:2288 Paneth cell defects in Crohn's disease GWAS:2289 Panic disorder GWAS:2290 Papillary thyroid cancer GWAS:2291 Paraoxonase activity GWAS:2292 Parasitemia in Tripanosoma cruzi seropositivity GWAS:2293 Parental extreme longevity 95 years and older GWAS:2294 Parental lifespan GWAS:2295 Parental longevity at least one long-lived parent GWAS:2296 Parental longevity both parents in top 10 GWAS:2297 Parental longevity combined parental age at death GWAS:2298 Parental longevity combined parental attained age, Martingale residuals GWAS:2299 Parental longevity father's age at death GWAS:2300 Parental longevity father's attained age GWAS:2301 Parental longevity mother's age at death GWAS:2302 Parental longevity mother's attained age GWAS:2303 Parent of origin effect on language impairment paternal GWAS:2304 Parkinson disease and lewy body pathology GWAS:2305 Parkinsonism in frontotemporal lobe dementia GWAS:2306 Parkinson's disease GWAS:2307 Parkinson's disease age at diagnosis GWAS:2308 Parkinson's disease age of onset GWAS:2309 Parkinson's disease familial GWAS:2310 Parkinson's disease familial, age at onset GWAS:2311 Parkinson's disease motor and cognition GWAS:2312 Parkinson's disease pesticide exposure interaction GWAS:2313 Partial epilepsies GWAS:2314 Paternal history of Alzheimer's disease GWAS:2315 Pathological gambling GWAS:2316 PCA3 expression level GWAS:2317 Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma GWAS:2318 Peak creatinine levels in vancomycin therapy GWAS:2319 Peak expiratory flow GWAS:2320 Peak insulin response GWAS:2321 Peak insulin response insulin secretion adjusted GWAS:2322 Peak velocity of the mitral A-wave GWAS:2323 Peanut allergy GWAS:2324 Peanut allergy maternal genetic effects GWAS:2325 Peanut allergy parent-of-origin effect GWAS:2326 Pediatric areal bone mineral density concordant skeletal phenotype GWAS:2327 Pediatric areal bone mineral density radius GWAS:2328 Pediatric areal bone mineral density radius vs spine hip discordant skeletal phenotype GWAS:2329 Pediatric areal bone mineral density spine vs radius hip discordant skeletal phenotype GWAS:2330 Pediatric autoimmune diseases GWAS:2331 Pediatric bone mineral content femoral neck GWAS:2332 Pediatric bone mineral content hip GWAS:2333 Pediatric bone mineral content radius GWAS:2334 Pediatric bone mineral content spine GWAS:2335 Pediatric bone mineral density femoral neck GWAS:2336 Pediatric bone mineral density hip GWAS:2337 Pediatric bone mineral density spine GWAS:2338 Pediatric non-alcoholic fatty liver disease activity score GWAS:2339 Pediatric nonalcoholic steatohepatitis GWAS:2340 PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia GWAS:2341 Pelvic organ prolapse GWAS:2342 Pelvic organ prolapse moderate severe GWAS:2343 Pemphigus foliaceus GWAS:2344 Pemphigus vulgaris GWAS:2345 Perceived skin darkness GWAS:2346 Perceived unattractiveness to mosquitoes GWAS:2347 Percentage gas trapping GWAS:2348 Percent glycated albumin GWAS:2349 Percent mammographic density GWAS:2350 perceptual and visual search speed trail making test A GWAS:2351 perceptual and visual search speed trail making test A age interaction GWAS:2352 Perceptual rivalry voluntary modulation strength GWAS:2353 Performance intelligence quotient cesarean section interaction GWAS:2354 Pericardial adipose tissue adjusted for height and weight GWAS:2355 Pericardial fat GWAS:2357 Periodontal microbiota GWAS:2358 Periodontitis GWAS:2359 Periodontitis CDC AAP GWAS:2360 Periodontitis DPAL GWAS:2361 Periodontitis Mean PAL GWAS:2362 Periodontitis PAL4Q3 GWAS:2363 Perioperative myocardial infarction in coronary artery bypass surgery GWAS:2364 Peripheral arterial disease traffic-related air pollution interaction GWAS:2365 Peripheral artery disease GWAS:2366 Permanent tooth development GWAS:2367 Personality dimensions GWAS:2368 Personality traits in bipolar disorder GWAS:2369 Pharmacokinetics of antidepressant drugs in severe mental disorder concentration dose ratio GWAS:2370 Pharmacokinetics of antiepileptic drugs in severe mental disorder concentration drug ratio GWAS:2371 Pharmacokinetics of antipsychotic drugs in severe mental disorder concentration drug ratio GWAS:2372 Pharmacokinetics of olanzapine in severe mental disorder concentration dose ratio GWAS:2373 Phenytoin-induced maculopapular exanthema GWAS:2374 Philtrum width GWAS:2375 Phoneme awareness GWAS:2376 Phospholipid levels in large HDL GWAS:2377 Phospholipid levels in large VLDL GWAS:2378 Phospholipid levels in medium HDL GWAS:2379 Phospholipid levels in medium VLDL GWAS:2380 Phospholipid levels in small VLDL GWAS:2381 Phospholipid levels plasma GWAS:2382 Phosphorus levels GWAS:2383 Photic sneeze reflex GWAS:2384 Physical activity moderate intensity activity duration GWAS:2385 Physical activity overall physical activity time GWAS:2386 Physical activity walking duration GWAS:2387 Phytosterol levels GWAS:2388 Pit-and-Fissure caries GWAS:2389 Placebo response in major depressive disorder change in symptom score GWAS:2390 Placental abruption GWAS:2391 Plantar fascial disorders GWAS:2392 Plantar warts GWAS:2393 Plasma amyloid beta peptide concentrations ABx-40 GWAS:2394 Plasma amyloid beta peptide concentrations ABx-42 GWAS:2395 Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer GWAS:2396 Plasma androstenedione levels in resected early stage-receptor positive breast cancer GWAS:2397 Plasma clozapine levels in treatment-resistant schizophrenia GWAS:2398 Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia GWAS:2399 Plasma clusterin levels GWAS:2400 Plasma cystastin c levels in acute coronary syndrome GWAS:2401 Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer GWAS:2402 Plasma estrone levels in resected estrogen-receptor positive breast cancer GWAS:2403 Plasma factor VII activating protease levels GWAS:2404 Plasma free amino acid levels GWAS:2405 Plasma free amino acid levels adjusted for one other PFAA GWAS:2406 Plasma free amino acid levels adjusted for twenty other PFAAs GWAS:2407 Plasma free asparagine levels GWAS:2408 Plasma free proline levels GWAS:2409 Plasma haptoglobin levels in type 2 diabetes GWAS:2410 Plasma homocysteine levels GWAS:2411 Plasma homocysteine levels post-methionine load test GWAS:2412 Plasma kynurenine levels in major depressive disorder GWAS:2413 Plasma kynurenine to tryptophan ratio in major depressive disorder GWAS:2414 Plasma lactate levels GWAS:2415 Plasma neurofilament light levels GWAS:2416 Plasma norclozapine levels in treatment-resistant schizophrenia GWAS:2417 Plasma omega-3 polyunsaturated fatty acid level eicosapentaenoic acid GWAS:2418 Plasma omega-3 polyunsaturated fatty acid levels alphalinolenic acid GWAS:2419 Plasma omega-3 polyunsaturated fatty acid levels docosahexaenoic acid GWAS:2420 Plasma omega-3 polyunsaturated fatty acid levels docosapentaenoic acid GWAS:2421 Plasma omega-6 polyunsaturated fatty acid levels adrenic acid GWAS:2422 Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid GWAS:2423 Plasma omega-6 polyunsaturated fatty acid levels dihomo-gamma-linolenic acid GWAS:2424 Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid GWAS:2425 Plasma omega-6 polyunsaturated fatty acid levels linoleic acid GWAS:2426 Plasma parathyroid hormone levels GWAS:2427 Plasma plasminogen activator levels GWAS:2428 Plasma plasminogen levels GWAS:2429 Plasma proprotein convertase subtilisin kexin type 9 levels in stable coronary artery disease GWAS:2430 Plasma pyridoxal phosphate levels GWAS:2431 Plasma pyridoxal phosphate to pyridoxal ratio GWAS:2432 Plasma pyridoxic acid to pyridoxal phosphate ratio GWAS:2433 Plasma renin activity levels GWAS:2434 Plasma thyroid-stimulating hormone levels GWAS:2435 Plasma trimethylamine N-oxide levels GWAS:2436 Plasma trimethyllysine levels GWAS:2437 Plasma t-tau levels GWAS:2438 Plasminogen activator inhibitor type 1 levels PAI-1 GWAS:2439 Platelet aggregation GWAS:2440 Platelet count GWAS:2441 Plateletcrit GWAS:2442 Platelet-derived growth factor BB levels GWAS:2443 Platelet distribution width GWAS:2444 Platelet function and related traits GWAS:2445 Platelet thrombus formation GWAS:2446 Platinum-induced myelosuppression in non-small cell lung cancer GWAS:2447 Pneumococcal bacteremia GWAS:2448 Pneumoconiosis in silica exposure GWAS:2449 Pneumonia GWAS:2450 Political ideology GWAS:2451 Polychlorinated biphenyl levels GWAS:2452 Polycystic ovary syndrome GWAS:2453 Polymyositis GWAS:2454 Poor prognosis in Crohn's disease GWAS:2455 Positive affect GWAS:2456 Positive urgency GWAS:2457 Possible neuropathic pain in post total joint replacement surgery for osteoarthritis GWAS:2458 Post bronchodilator FEV1 GWAS:2459 Post bronchodilator FEV1 FVC ratio GWAS:2460 Post bronchodilator FEV1 FVC ratio in COPD GWAS:2461 Post bronchodilator FEV1 FVC ratio in smoking GWAS:2462 Post bronchodilator FEV1 in COPD GWAS:2463 Post bronchodilator percent predicted FEV1 in smoking GWAS:2464 Postburn hypertrophic scarring severity GWAS:2465 Postburn scar height GWAS:2466 Postburn scar pliability GWAS:2467 Posterior cortical atrophy and Alzheimer's disease GWAS:2468 Postoperative atrial fibrillation in coronary artery bypass grafting surgery GWAS:2469 Postoperative survival time in hepatocellular carcinoma GWAS:2470 Postprandial triglyceride response to high fat diet meal GWAS:2471 Post-traumatic stress disorder GWAS:2472 Post-traumatic stress disorder asjusted for relatedness GWAS:2473 Post traumatic stress disorder symptom count in trauma-exposed individuals GWAS:2474 Potassium levels GWAS:2475 Pre bronchodilator FEV1 GWAS:2476 Pre bronchodilator FEV1 FVC ratio GWAS:2477 Pre bronchodilator FEV1 FVC ratio in never-smokers GWAS:2478 Predicted suicide risk GWAS:2479 Preeclampsia GWAS:2480 Premature menopause in childhood cancer survivors GWAS:2481 Premature ovarian failure GWAS:2482 Preschool internalizing problems GWAS:2483 Presence of antiphospholipid antibodies GWAS:2484 Presubiculum volume GWAS:2485 Presubiculum volume corrected for total hippocampal volume GWAS:2486 Preterm birth maternal effect GWAS:2487 Preterm birth maternal effect maternal pre-pregnancy BMI interaction GWAS:2488 Pre-treatment pain in head and neck squamous cell carcinoma GWAS:2489 Prevalent atrial fibrillation GWAS:2490 Prevalent type 2 diabetes GWAS:2491 Primary biliary cholangitis GWAS:2492 Primary biliary cirrhosis GWAS:2493 Primary sclerosing cholangitis GWAS:2494 Primary tooth development number of teeth GWAS:2495 Primary tooth development time to first tooth eruption GWAS:2496 Primary vesicoureteric reflux GWAS:2497 PR interval GWAS:2498 PR interval in Tripanosoma cruzi seropositivity GWAS:2499 Prion diseases GWAS:2500 Problematic alcohol use in trauma-exposed individuals GWAS:2501 Progranulin levels GWAS:2502 Progression free survival in metastatic colorectal cancer CAPOX-B vs CAPOX-B plus cetuximab GWAS:2503 Progression free survival in metastatic colorectal cancer chemotherapy interaction GWAS:2504 Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel GWAS:2505 Progressive supranuclear palsy GWAS:2506 Proinsulin levels GWAS:2507 Proliferative diabetic retinopathy in type 2 diabetes GWAS:2508 Proliferative diabetic retinopathy vs no DR GWAS:2509 Proliferative diabetic retinopathy vs NPDR and no DR GWAS:2510 Prostate cancer GWAS:2511 Prostate cancer advanced GWAS:2512 Prostate cancer aggressiveness GWAS:2513 Prostate cancer early onset GWAS:2514 Prostate cancer survival GWAS:2515 Prostate-specific antigen levels GWAS:2516 Prostate-specific antigen levels conditioned on lead SNPs GWAS:2517 Protein biomarker GWAS:2518 Protein C levels GWAS:2519 Protein quantitative trait loci GWAS:2520 Proteinuria and chronic kidney disease GWAS:2521 Proteinuria in chronic kidney disease GWAS:2522 Prothrombin fragments F12 levels in ischemic stroke GWAS:2523 Prothrombin time GWAS:2524 PR segment GWAS:2525 Prudent dietary pattern GWAS:2526 Pseudoexfoliation syndrome GWAS:2527 Psoriasis GWAS:2528 Psoriasis vulgaris GWAS:2529 Psoriatic arthritis GWAS:2530 Psychiatric diseases pleiotropy HIPO component 1 GWAS:2531 Psychological distress GWAS:2532 Psychosis and Alzheimer's disease GWAS:2533 Psychosis atypical GWAS:2534 Psychosis in Alzheimer's disease GWAS:2535 Psychosis methamphetamine induced GWAS:2536 Psychosis proneness hypomanic personality scale GWAS:2537 Psychosis proneness hypomanic personality scale and perceptual aberration scale GWAS:2538 Psychosis proneness hypomanic personality scale and revised physical anhedonia scale GWAS:2539 Psychosis proneness hypomanic personality scale and revised social anhedonia scale GWAS:2540 Psychosis proneness perceptual aberration scale GWAS:2541 Psychosis proneness perceptual aberration scale and revised physical anhedonia scale GWAS:2542 Psychosis proneness perceptual aberration scale and revised social anhedonia scale GWAS:2543 Psychosis proneness revised physical anhedonia scale GWAS:2544 Psychosis proneness revised physical anhedonia scale and revised social anhedonia scale GWAS:2545 Psychosis proneness revised social anhedonia scale GWAS:2546 Psychotic symptoms and prion disease GWAS:2547 Psychotic symptoms in prion disease GWAS:2548 Pubertal anthropometrics GWAS:2549 Puberty onset GWAS:2550 Puberty onset breast development GWAS:2551 Puberty onset genital enlargement GWAS:2552 Pulmonary arterial hypertension GWAS:2553 Pulmonary arterial hypertension without BMPR2 mutations GWAS:2554 Pulmonary artery enlargement and chronic obstructive pulmonary disease GWAS:2555 Pulmonary artery enlargement in chronic obstructive pulmonary disease GWAS:2556 Pulmonary emphysema GWAS:2557 Pulmonary function GWAS:2558 Pulmonary function decline GWAS:2559 Pulmonary function in asthmatics GWAS:2560 Pulmonary function smoking interaction GWAS:2561 Pulse pressure GWAS:2562 Pulse pressure alcohol consumption interaction GWAS:2563 Pulse pressure in young-onset hypertension GWAS:2564 Pulse pressure x alcohol consumption interaction 2df test GWAS:2565 Pulse pressure x alcohol consumption light vs heavy interaction 2df test GWAS:2566 Pursuit maintenance gain GWAS:2567 Pursuit maintenance gain in psychotic disorders GWAS:2568 Putamen volume GWAS:2569 P wave duration GWAS:2570 P wave terminal force GWAS:2571 Pyoderma gangrenosum in inflammatory bowel disease GWAS:2572 Pyridoxal 5'-phosphate levels GWAS:2573 QRS complex 12-leadsum GWAS:2574 QRS complex Cornell GWAS:2575 QRS complex Sokolow-Lyon GWAS:2576 QRS duration GWAS:2577 QRS duration in Tripanosoma cruzi seropositivity GWAS:2578 QRS interval sulfonylurea treatment interaction GWAS:2579 QT interval GWAS:2580 QT interval ambient particulate matter interaction GWAS:2581 QT interval drug interaction GWAS:2582 QT interval in Tripanosoma cruzi seropositivity GWAS:2583 QT interval sulfonylurea treatment interaction GWAS:2584 QT interval tricyclic tetracyclic antidepressant use interaction GWAS:2585 Quantitative traits GWAS:2586 Radiation-induced brain injury in nasopharyngeal carcinoma GWAS:2587 Radiation response GWAS:2588 Random C-peptide levels in type I diabetes GWAS:2589 RANTES levels GWAS:2590 Rapid automised naming of digits GWAS:2591 Rapid automised naming of letters GWAS:2592 Rapid automised naming of pictures GWAS:2593 Rate of cognitive decline in mild cognitive impairment time interaction GWAS:2594 Ratio of apolipoprotein A1 to apolipoprotein B GWAS:2595 Ratio of the area under the curve for insulin and the area under the curve for glucose GWAS:2596 Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave GWAS:2597 Reaction time GWAS:2598 Reading ability multivariate GWAS:2599 Reading and spelling GWAS:2600 Reading disability or specific language impairment adjusted for intelligence quotient pleiotropy GWAS:2601 Reading disability or specific language impairment pleiotropy GWAS:2602 Reading or mathematical ability GWAS:2603 Reasoning GWAS:2604 Recalcitrant atopic dermatitis GWAS:2605 Recombination measurement GWAS:2606 Recombination measurement females GWAS:2607 Recombination measurement males GWAS:2608 Recombination rate females GWAS:2609 Recombination rate males GWAS:2610 Recurrent major depressive disorder GWAS:2611 Red blood cell count GWAS:2612 Red blood cell density in sickle cell anemia GWAS:2613 Red blood cell fatty acid levels GWAS:2614 Red blood cell folate levels GWAS:2615 Red blood cell traits GWAS:2616 Red cell distribution width GWAS:2617 Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A GWAS:2618 Red vs brown black hair color GWAS:2619 Red vs non-red hair color GWAS:2620 Red wine liking GWAS:2621 Reflection response to stress GWAS:2622 Refractive astigmatism GWAS:2623 Refractive error GWAS:2624 Refractory celiac disease type II GWAS:2625 Regular attendance at a gym or sports club GWAS:2626 Regular attendance at a pub or social club GWAS:2627 Regular attendance at a religious group GWAS:2628 Relapse in multiple sclerosis GWAS:2629 Relative amplitude of rest-activity cycles GWAS:2630 Relative hand skill GWAS:2631 Relative hand skill in reading disability GWAS:2632 Relative wall thickness GWAS:2633 Remission after SSRI treatment in major depression GWAS:2634 Remission after SSRI treatment in MDD or neuroticism GWAS:2635 Remission after SSRI treatment in MDD or openness GWAS:2636 Renal cell carcinoma GWAS:2637 Renal function and chronic kidney disease GWAS:2638 Renal function-related traits BUN GWAS:2639 Renal function-related traits eGRFcrea GWAS:2640 Renal function-related traits sCR GWAS:2641 Renal function-related traits urea GWAS:2642 Renal overload gout GWAS:2643 Renal sinus fat GWAS:2644 Renal transplant outcome GWAS:2645 Renal underexcretion gout GWAS:2646 Residual cognition GWAS:2647 Resistance to antihypertensive treatment in hypertension GWAS:2648 Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test continuous GWAS:2649 Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test dichotomous GWAS:2650 Resistant hypertension GWAS:2651 Resistin levels GWAS:2652 Respiratory diseases GWAS:2653 Response to abacavir-containing treatment in HIV-1 infection virologic failure GWAS:2654 Response to acetaminophen hepatotoxicity GWAS:2655 Response to alcohol consumption flushing response GWAS:2656 Response to amphetamines GWAS:2657 Response to angiotensin II receptor blocker therapy GWAS:2658 Response to angiotensin II receptor blocker therapy opposite direction w diuretic therapy GWAS:2659 Response to antidepressants GWAS:2660 Response to antidepressants and depression GWAS:2661 Response to antidepressants in depression GWAS:2662 Response to antidepressants symptom improvement GWAS:2663 Response to antidepressants symptom remission GWAS:2664 Response to antidepressant treatment citalopram GWAS:2665 Response to anti-depressant treatment in major depressive disorder GWAS:2666 Response to antineoplastic agents GWAS:2667 Response to antipsychotic therapy extrapyramidal side effects GWAS:2668 Response to antipsychotic treatment GWAS:2669 Response to antipsychotic treatment in schizophrenia GWAS:2670 Response to antipsychotic treatment in schizophrenia reasoning GWAS:2671 Response to antipsychotic treatment in schizophrenia working memory GWAS:2672 Response to anti-retroviral therapy ddI d4T in HIV-1 infection Grade 1 peripheral neuropathy GWAS:2673 Response to anti-retroviral therapy ddI d4T in HIV-1 infection Grade 2 peripheral neuropathy GWAS:2674 Response to anti-retroviral therapy ddI d4T in HIV-1 infection Grade 3 peripheral neuropathy GWAS:2675 Response to anti-TNF alpha therapy in inflammatory bowel disease GWAS:2676 Response to anti-TNF therapy in rheumatoid arthritis GWAS:2677 Response to aripiprazole in schizophrenia GWAS:2678 Response to bleomycin chromatid breaks GWAS:2679 Response to bronchodilator in chronic obstructive pulmonary disease change in FEV1 GWAS:2680 Response to bupropion and depression GWAS:2681 Response to bupropion in depression GWAS:2682 Response to carboplatin and paclitaxel in ovarian cancer Caspase 3 7 EC50 GWAS:2683 Response to carboplatin and paclitaxel in ovarian cancer MTT IC50 GWAS:2684 Response to carboplatin in ovarian cancer MTT IC50 GWAS:2685 Response to chemotherapy in breast cancer hypertension bevacizumab GWAS:2686 Response to chemotherapy in breast cancer hypertensive cases cumulative dose bevacizumab GWAS:2687 Response to cholinesterase inhibitors in Alzheimer's disease GWAS:2688 Response to citalopram or escitalopram and depression GWAS:2689 Response to citalopram or escitalopram in depression GWAS:2690 Response to citalopram treatment GWAS:2691 Response to clopidogrel therapy GWAS:2692 Response to cognitive-behavioural therapy in anxiety disorder GWAS:2693 Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis GWAS:2694 Response to cytadine analogues cytosine arabinoside GWAS:2695 Response to cytidine analogues gemcitabine GWAS:2696 Response to dabigatran etexilate treatment GWAS:2697 Response to Dalcetrapib treatment in acute coronary syndrome GWAS:2698 Response to diuretic therapy in hypertension GWAS:2699 Response to efavirenz-containing treatment in HIV 1 infection virologic failure GWAS:2700 Response to exercise triglyceride level interaction GWAS:2701 Response to fenofibrate GWAS:2702 Response to fenofibrate adiponectin levels GWAS:2703 Response to fenofibrate HDL cholesterol levels GWAS:2704 Response to fenofibrate LDL cholesterol levels GWAS:2705 Response to fenofibrate total cholesterol levels GWAS:2706 Response to fenofibrate triglyceride levels GWAS:2707 Response to gemcitabine in pancreatic cancer GWAS:2708 Response to haloperidol in psychosis GWAS:2709 Response to haloperidol in schizophrenia GWAS:2710 Response to hepatitis B vaccine GWAS:2711 Response to hepatitis C treatment GWAS:2712 Response to Homoharringtonine cytotoxicity GWAS:2713 Response to iloperidone treatment QT prolongation GWAS:2714 Response to inhaled corticosteroid treatment in asthma change in FEV1 GWAS:2715 Response to inhaled glucocorticoid treatment in asthma change in FEV1 GWAS:2716 Response to interferon beta in multiple sclerosis GWAS:2717 Response to interferon beta therapy GWAS:2718 Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer GWAS:2719 Response to irinotecan in non-small-cell lung cancer GWAS:2720 Response to ketamine in bipolar disorder or major depression antidepressant effects GWAS:2721 Response to ketamine in bipolar disorder or major depression dissociation effects GWAS:2722 Response to ketogenic dietary therapies in epilepsy GWAS:2723 Response to lithium treatment in bipolar disorder GWAS:2724 Response to long-chain n-3 polyunsaturated fatty acid supplementation change in triglyceride levels GWAS:2725 Response to long-term oxygen therapy in chronic obstructive pulmonary disease GWAS:2726 Response to lurasidone in schizophrenia GWAS:2727 Response to mepolizumab in severe asthma GWAS:2728 Response to metformin IC50 GWAS:2729 Response to metformin in type 2 diabetes glycemic GWAS:2730 Response to metformin in type 2 diabetes HbA1c reduction GWAS:2731 Response to methotrexate in juvenile idiopathic arthritis GWAS:2732 Response to methotrexate in rheumatoid arthritis GWAS:2733 Response to methylphenidate treatment in attention-deficit hyperactivity disorder blood pressure GWAS:2734 Response to montelukast in asthma change in FEV1 GWAS:2735 Response to mTOR inhibitor everolimus GWAS:2736 Response to mTOR inhibitor rapamycin GWAS:2737 Response to olanzapine in schizophrenia GWAS:2738 Response to opioid analgesics in cancer pain decrease GWAS:2739 Response to paclitaxel in ovarian cancer Caspase 3 7 EC50 GWAS:2740 Response to paclitaxel in ovarian cancer MTT IC50 GWAS:2741 Response to paliperidone in schizophrenia CGI-S score GWAS:2742 Response to paliperidone in schizophrenia Multivariate GWAS:2743 Response to paliperidone in schizophrenia negative Marder score GWAS:2744 Response to paliperidone in schizophrenia PANSS score GWAS:2745 Response to paliperidone in schizophrenia positive Marder score GWAS:2746 Response to Pazopanib in cancer hepatotoxicity GWAS:2747 Response to perphenazine in schizophrenia GWAS:2748 Response to platinum-based agents GWAS:2749 Response to platinum-based chemotherapy carboplatin GWAS:2750 Response to platinum-based chemotherapy cisplatin GWAS:2751 Response to platinum-based chemotherapy in non-small-cell lung cancer GWAS:2752 Response to platinum-based neoadjuvant chemotherapy in cervical cancer GWAS:2753 Response to protease inhibitor treatment in hepatitis c bilirubin toxicity GWAS:2754 Response to protease inhibitor treatment in hepatitis c peak serum total bilirubin levels GWAS:2755 Response to quetiapine in schizophrenia GWAS:2756 Response to radiotherapy in cancer late toxicity GWAS:2757 Response to radiotherapy in prostate cancer overall toxicity GWAS:2759 Response to radiotherapy in prostate cancer toxicity, rectal bleeding GWAS:2760 Response to radiotherapy in prostate cancer toxicity GWAS:2761 Response to radiotherapy in prostate cancer toxicity, urinary frequency GWAS:2762 Response to ranibizumab in age-related macular degeneration exudative GWAS:2763 Response to risperidone in schizophrenia GWAS:2764 Response to selective serotonin reuptake inhibitors and depression GWAS:2765 Response to selective serotonin reuptake inhibitors in depression GWAS:2766 Response to serotonin reuptake inhibitors in major depressive disorder GWAS:2767 Response to serotonin reuptake inhibitors in major depressive disorder plasma drug and metabolite levels GWAS:2768 Response to serotonin reuptake inhibitors in non-psychotic unipolar depression GWAS:2769 Response to simvastatin treatment PCSK9 protein level change GWAS:2770 Response to SSRI in MDD or conscientiouness GWAS:2771 Response to SSRI in MDD or openness GWAS:2772 Response to SSRI symptom remission GWAS:2773 Response to statins HDL cholesterol change GWAS:2774 Response to statins LDL cholesterol change GWAS:2775 Response to statin therapy GWAS:2776 Response to tamoxifen in breast cancer GWAS:2777 Response to tamoxifen in oestrogen receptor positive HER2 negative breast cancer GWAS:2778 Response to taxane treatment docetaxel GWAS:2779 Response to taxane treatment placlitaxel GWAS:2780 Response to temozolomide GWAS:2781 Response to thiopurine immunosuppressants in inflammatory bowel disease pancreatitis azathioprine and mercaptopurine GWAS:2782 Response to TNF-alpha inhibitors in rheumatoid arthritis GWAS:2783 Response to TNF antagonist treatment GWAS:2784 Response to TNF inhibitor in rheumatoid arthritis change in disease activity score GWAS:2785 Response to TNF inhibitor in rheumatoid arthritis change in patient global heath assessment score GWAS:2786 Response to TNF inhibitor in rheumatoid arthritis change in swollen 28-joint count GWAS:2787 Response to TNF inhibitor in rheumatoid arthritis change in tender 28-joint count GWAS:2788 Response to TNF inhibitor in rheumatoid arthritis erythrocyte sedimentation rate GWAS:2789 Response to tocilizumab in rheumatoid arthritis GWAS:2790 Response to treatment for acute lymphoblastic leukemia GWAS:2791 Response to Vitamin E supplementation GWAS:2792 Response to zileuton treatment in asthma FEV1 change interaction GWAS:2793 Response to ziprazidone in schizophrenia GWAS:2794 Resting heart rate GWAS:2795 Resting metabolic rate GWAS:2796 Resting oxygen saturation in chronic osbtructive pulmonary disease pulse oxymetry GWAS:2797 Resting-state electroencephalogram vigilance GWAS:2798 Restless legs syndrome GWAS:2799 Restricted and repetitive behaviours in autism spectrum disorder GWAS:2800 Reticulocyte count GWAS:2801 Reticulocyte fraction of red cells GWAS:2802 Retinal arteriolar caliber GWAS:2803 Retinal vascular caliber GWAS:2804 Retinol levels GWAS:2805 Retinopathy in non-diabetics GWAS:2806 Rhegmatogenous retinal detachment GWAS:2807 Rheumatic fever GWAS:2808 Rheumatic heart disease GWAS:2809 Rheumatoid arthritis GWAS:2810 Rheumatoid arthritis ACPA-negative GWAS:2811 Rheumatoid arthritis ACPA-positive GWAS:2812 Rheumatoid arthritis rheumatoid factor and or anti-cyclic citrullinated peptide seropositive GWAS:2813 Rheumatoid factor seropositivity in rheumatoid arthritis GWAS:2814 Ribavirin-induced anemia GWAS:2815 Right lateral prefrontal cortical growth GWAS:2816 Risk-taking tendency 4-domain principal component model GWAS:2817 Risky sexual behaviors alcohol dependence interaction GWAS:2818 Risky sexual behaviors in alcohol dependence GWAS:2819 Rosacea symptom severity GWAS:2820 Rotator cuff tears GWAS:2821 RR interval heart rate GWAS:2822 RR interval tricyclic tetracyclic antidepressant use interaction GWAS:2823 Rubella GWAS:2824 Rubella-specific interleukin-6 secretion GWAS:2825 Rumination response to stress GWAS:2826 Sagittal craniosynostosis GWAS:2827 Sarcoidosis GWAS:2828 Sarcoidosis Lofgren's syndrome GWAS:2829 Sarcoidosis Lofgren's syndrome vs non-Lofgren's syndrome GWAS:2830 Sarcoidosis non-Lofgren's syndrome GWAS:2831 Sarcoidosis non-Lofgren's syndrome without extrapulmonary manifestations GWAS:2832 Sasang constitutional medicine type So-Eum GWAS:2833 Scalp hair shape GWAS:2834 Scarlet fever GWAS:2835 Schizophrenia GWAS:2836 Schizophrenia age at onset GWAS:2837 Schizophrenia and type 2 diabetes GWAS:2838 Schizophrenia, bipolar disorder and depression combined GWAS:2839 Schizophrenia cytomegalovirus infection interaction GWAS:2840 Schizophrenia inflammation and infection response interaction GWAS:2841 Schizophrenia negative symptoms GWAS:2842 Schizophrenia or bipolar disorder GWAS:2843 Schizophrenia, schizoaffective disorder or bipolar disorder GWAS:2844 Schizophrenia treatment resistant GWAS:2845 Schizophrenia vs type 2 diabetes GWAS:2846 Sciatica caused by lumbar disc herniation treated with microdiscectomy GWAS:2847 Sclerosing cholangitis and ulcerative colitis combined GWAS:2848 Scoliosis GWAS:2849 Seasonality GWAS:2850 Seasonality and depression GWAS:2851 Seborrheic dermatitis GWAS:2852 Sedentary behaviour duration GWAS:2853 Select biomarker traits GWAS:2854 Selective IgA deficiency GWAS:2855 Self-employment GWAS:2856 Self-rated health GWAS:2857 Self-reported allergy GWAS:2858 Self-reported childhood asthma in adult smokers GWAS:2859 Self-reported math ability GWAS:2860 Self-reported math ability MTAG GWAS:2861 Self-reported risk-taking behaviour GWAS:2862 Self-reported tiredness GWAS:2863 Sensation seeking GWAS:2864 Sense of smell GWAS:2865 Sensory disturbances after bilateral sagittal split ramus osteotomy GWAS:2866 Sepsis from pneumonia survival GWAS:2867 Sepsis in extremely premature infants GWAS:2868 Sero-negative rheumatoid arthritis GWAS:2869 Serous borderline ovarian cancer GWAS:2870 Serous invasive ovarian cancer GWAS:2871 Serum 25-Hydroxyvitamin D levels GWAS:2872 Serum albumin level GWAS:2873 Serum alkaline phosphatase levels GWAS:2874 Serum alpha1-antitrypsin levels GWAS:2875 Serum bilirubin levels in metabolic syndrome GWAS:2876 Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome GWAS:2877 Serum bilirubin levels x sex interaction in metabolic syndrome GWAS:2878 Serum C3dC3 ratio systemic complement activation GWAS:2879 Serum ceruloplasmin levels GWAS:2880 Serum creatinine levels GWAS:2881 Serum dimethylarginine levels asymmetric symetric ratio GWAS:2882 Serum erythropoietin levels GWAS:2883 Serum folate levels GWAS:2884 Serum galactose-deficient IgA1 levels GWAS:2885 Serum IgA levels GWAS:2886 Serum IgE levels GWAS:2887 Serum lipase activity GWAS:2888 Serum lycopene concentrations GWAS:2889 Serum magnesium levels GWAS:2890 Serum metabolite concentrations in chronic kidney disease GWAS:2891 Serum metabolite levels GWAS:2892 Serum metabolite ratios in chronic kidney disease GWAS:2893 Serum parathyroid hormone levels GWAS:2894 Serum prostate-specific antigen levels GWAS:2895 Serum protein levels sST2 GWAS:2896 Serum selenium levels GWAS:2897 Serum sulfate level GWAS:2898 Serum tamsulosin hydrochloride concentration GWAS:2899 Serum thyroid-stimulating hormone levels GWAS:2900 Serum total cholesterol levels GWAS:2901 Serum total protein level GWAS:2902 Serum urate levels in chronic kidney disease GWAS:2903 Serum urea levels GWAS:2904 Serum uric acid levels GWAS:2905 Serum uric acid levels in response to allopurinol in gout GWAS:2906 Serum VEGFR2 concentration GWAS:2907 Serum vitamin D-binding protein levels GWAS:2908 Setpoint viral load in HIV-1 infection GWAS:2909 Severe aortic features in Marfan syndrome GWAS:2910 Severe depressive disorders in coronary artery disease GWAS:2911 Severe diabetic retinopathy in type 2 diabetes GWAS:2912 Severe gingival inflammation GWAS:2913 Severe influenza A H1N1 infection GWAS:2914 Severe malaria GWAS:2915 Severe malaria adjusted for sickle cell variant rs334 GWAS:2916 Severe progression in rheumatoid arthritis GWAS:2917 Severe skin toxicity response to cetuximab in colorectal cancer GWAS:2918 Severity of facial solar lentigines GWAS:2919 Severity of nausea and vomiting of pregnancy GWAS:2920 Sex hormone-binding globulin levels GWAS:2921 Sex hormone levels GWAS:2922 Sex ratio GWAS:2923 Sexual dimorphism in anthropometric traits GWAS:2924 Sexual dysfunction female GWAS:2925 Sexual dysfunction SSRI SNRI-related GWAS:2926 Shingles GWAS:2927 Short-term memory digit-span task GWAS:2928 Short-term memory visuospatial task GWAS:2929 Sickle cell anemia haemolysis GWAS:2930 Side of face morphology partial least square model GWAS:2931 Sight-threatening diabetic retinopathy in type 2 diabetes GWAS:2932 Sitting height ratio GWAS:2933 Sjogren's syndrome GWAS:2934 Skin aging microtopography measurement GWAS:2935 Skin and soft tissue Staphylococcus aureus infection GWAS:2936 Skin colour saturation GWAS:2937 Skin fluorescence in type 1 diabetes GWAS:2938 Skin, hair and eye pigmentation multivariate analysis GWAS:2939 Skin pigmentation GWAS:2940 Skin pigmentation traits GWAS:2941 Skin sensitivity to sun GWAS:2942 Sleep depth GWAS:2943 Sleep duration GWAS:2944 Sleep duration long sleep GWAS:2945 Sleep duration oversleepers vs undersleepers GWAS:2946 Sleep duration short sleep GWAS:2947 Sleep latency GWAS:2948 Sleep quality GWAS:2949 Sleep-related phenotypes GWAS:2950 Sleep time GWAS:2951 Sleep traits multi-trait analysis GWAS:2952 Small-cell lung cancer survival GWAS:2953 Small cell lung carcinoma GWAS:2954 Small intestine neuroendocrine tumor GWAS:2955 Small LDL particle concentration GWAS:2956 Small vessel stroke GWAS:2957 Small VLDL particle concentration GWAS:2958 Smoking behavior GWAS:2959 Smoking behaviour cigarettes smoked per day GWAS:2960 Smoking behaviour maximum cigarettes in a 24 hour period GWAS:2961 Smoking cessation GWAS:2962 Smoking cessation in chronic obstructive pulmonary disease GWAS:2963 Smoking cessation MTAG GWAS:2964 Smoking initiation GWAS:2965 Smoking initiation ever regular vs never regular MTAG GWAS:2966 Smoking initiation ever regular vs never regular GWAS:2967 Smoking quantity GWAS:2968 Smoking status GWAS:2969 Smoking status current vs former GWAS:2970 Smoking status ever vs never smokers GWAS:2971 Smoking status heavy vs light GWAS:2972 Smooth-surface caries GWAS:2973 Snoring GWAS:2974 Social autistic-like traits GWAS:2975 Social communication problems GWAS:2976 Social science traits pleiotropy HIPO component 1 GWAS:2977 Sodium levels GWAS:2978 Soluble E-selectin levels GWAS:2979 Soluble ICAM-1 GWAS:2980 Soluble interleukin-2 receptor subunit alpha GWAS:2981 Soluble leptin receptor levels GWAS:2982 Soluble levels of adhesion molecules GWAS:2983 Speech perception in dyslexia GWAS:2984 Sperm motility GWAS:2985 S-phenylmercapturic acid levels in smokers GWAS:2986 Spherical equivalent GWAS:2987 Spherical equivalent joint analysis main effects and education interaction GWAS:2988 Spherical equivalent or myopia age of diagnosis GWAS:2989 Sphingolipid levels GWAS:2990 Spine bone mineral density and alcohol drinking GWAS:2991 Spine bone size GWAS:2992 Spontaneous dizygotic twinning GWAS:2993 Spontaneous preterm birth maternal effect GWAS:2994 Spontaneous preterm birth preterm birth GWAS:2995 Spontaneous preterm birth preterm delivery GWAS:2996 Sporadic neuroblastoma GWAS:2997 Sporadic pituitary adenoma GWAS:2998 Squamous cell carcinoma GWAS:2999 Squamous cell lung carcinoma GWAS:3000 Staphylococcus aureus infection GWAS:3001 Staphylococcus aureus nasal carriage intermittent GWAS:3002 Staphylococcus aureus nasal carriage persistent GWAS:3003 Stearic acid 180 levels GWAS:3004 Stem cell factor levels GWAS:3005 Stem cell growth factor beta levels GWAS:3006 Stevens-Johnson syndrome and toxic epidermal necrolysis SJS-TEN GWAS:3007 Stimulated C-peptide levels in type I diabetes GWAS:3008 Straight vs curly hair GWAS:3009 Strenuous sports or other exercises GWAS:3010 Strep throat GWAS:3011 Stroke GWAS:3012 Stroke ischemic GWAS:3013 Stroke pediatric GWAS:3014 Stromal-cell-derived factor 1 alpha levels GWAS:3015 Subclinical atherosclerosis traits other GWAS:3016 Subclinical trait of interstitial lung disease basilar peel-core ratio of high attentuation areas on CT scan GWAS:3017 Subclinical trait of interstitial lung disease basilar percentage of high attenuation areas on CT scan GWAS:3018 Subclinical trait of interstitial lung disease percentage of high attenuation areas on CT scan GWAS:3019 Subcortical brain region volumes GWAS:3020 Subcutaneous adipose tissue GWAS:3021 Subcutaneous adipose tissue attenuation Hounsfield unit scale GWAS:3022 Subcutaneous adipose tissue sex interaction GWAS:3023 Sub-foveal choroidal thickness GWAS:3024 Subiculum volume GWAS:3025 Subiculum volume corrected for total hippocampal volume GWAS:3026 Subjective response to lithium treatment GWAS:3027 Subjective response to lithium treatment in bipolar disorder GWAS:3028 Subjective well-being GWAS:3029 Subjective well-being MTAG GWAS:3030 Substance dependence GWAS:3031 Substance use disorder GWAS:3032 Sudden cardiac arrest GWAS:3033 Suffering from nerves GWAS:3034 Suicidal ideation GWAS:3035 Suicidal ideation in depression or bipolar disorder GWAS:3036 Suicidality GWAS:3037 Suicidality suicidal ideation attempts GWAS:3038 Suicide GWAS:3039 Suicide attempts GWAS:3040 Suicide attempt severity GWAS:3041 Suicide attempts in bipolar disorder GWAS:3042 Suicide attempts in depression or bipolar disorder GWAS:3043 Suicide attempts in major depressive disorder GWAS:3044 Suicide behavior GWAS:3045 Suicide ideation score in major depressive disorder GWAS:3046 Suicide in bipolar disorder GWAS:3047 Suicide risk GWAS:3048 Sulfasalazine-induced agranulocytosis GWAS:3049 Sum basophil neutrophil counts GWAS:3050 Sum eosinophil basophil counts GWAS:3051 Sum neutrophil eosinophil counts GWAS:3052 Sunburns GWAS:3053 Superior crus of antihelix expression GWAS:3054 Superior frontal gyrus grey matter volume GWAS:3055 Supraventricular ectopy GWAS:3056 Surgical necrotising enterocolitis in extremely premature birth GWAS:3057 Survival in breast cancer estrogen-receptor positive GWAS:3058 Survival in colon cancer GWAS:3059 Survival in colorectal cancer distant metastatic GWAS:3060 Survival in colorectal cancer non-distant metastatic GWAS:3061 Survival in colorectal cancer GWAS:3062 Survival in endocrine treated breast cancer estrogen-receptor positive GWAS:3063 Survival in head and neck cancer GWAS:3064 Survival in microsatellite instability low stable colorectal cancer GWAS:3065 Survival in pancreatic cancer GWAS:3066 Survival in rectal cancer GWAS:3067 Survival in sporadic amyotrophic lateral sclerosis GWAS:3068 Susceptibility to persistent hepatitis B virus infection GWAS:3069 Symmetrical dimethylarginine levels GWAS:3070 Systemic juvenile idiopathic arthritis GWAS:3071 Systemic lupus erythematosus GWAS:3072 Systemic lupus erythematosus and Systemic sclerosis GWAS:3073 Systemic lupus erythematosus or rheumatoid arthritis GWAS:3074 Systemic sclerosis GWAS:3075 Systemic sclerosis anti-centromere-positive GWAS:3076 Systemic sclerosis anti-topoisomerase-positive GWAS:3077 Systemic seropositive rheumatic diseases Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies GWAS:3078 Systolic blood pressure GWAS:3079 Systolic blood pressure alcohol consumption interaction GWAS:3080 Systolic blood pressure change trajectories GWAS:3081 Systolic blood pressure cigarette smoking interaction GWAS:3082 Systolic blood pressure dietary potassium intake interaction GWAS:3083 Systolic blood pressure in combination therapy beta blocker and thiazide diuretic GWAS:3084 Systolic blood pressure in sickle cell anemia GWAS:3085 Systolic blood pressure long-term average GWAS:3086 Systolic blood pressure night-to-day ratio in hypertension GWAS:3087 Systolic blood pressure response to hydrochlorothiazide in hypertension GWAS:3088 Systolic blood pressure x alcohol consumption interaction 2df test GWAS:3089 Systolic blood pressure x alcohol consumption light vs heavy interaction 2df test GWAS:3090 Systolic blood pressure x smoking status current vs non-current interaction 1df test GWAS:3091 Systolic blood pressure x smoking status current vs non-current interaction 2df test GWAS:3092 Systolic blood pressure x smoking status ever vs never interaction 2df test GWAS:3093 Systolic blood pressure x sodium interaction 1df test GWAS:3094 Systolic blood pressure x sodium interaction 2df test GWAS:3095 Tacrolimus trough concentration in kidney transplant patients GWAS:3096 Takayasu arteritis GWAS:3097 Takotsubo syndrome GWAS:3098 Tandem gait GWAS:3099 Tanning GWAS:3100 Tardive dyskinesia GWAS:3101 Taxane-induced peripheral neuropathy in breast cancer GWAS:3102 TB-LM or TBLH-BMD pleiotropy GWAS:3103 Telomere length GWAS:3104 Temperament bipolar disorder GWAS:3105 Temperament GWAS:3106 Temporomandibular joint disorder GWAS:3107 Tenofovir clearance in HIV infection GWAS:3108 Testicular cancer GWAS:3109 Testicular germ cell cancer GWAS:3110 Testicular germ cell tumor GWAS:3111 Testosterone levels GWAS:3112 Testosterone levels in polycystic ovary syndrome GWAS:3113 Tetralogy of Fallot GWAS:3114 Theory of mind score in adolescence Emotional Triangles Task GWAS:3115 Thiazide-induced adverse metabolic effects in hypertensive patients GWAS:3116 Thick vs thin eyebrows GWAS:3117 Thionamide-induced agranulocytosis in Graves' disease GWAS:3118 Thiopurine-induced acute severe leukopenia in inflammatory bowel disease GWAS:3119 Thiopurine-induced acute severe leukopenia in inflammatory bowel disease conditioned on rs116855232 GWAS:3120 Thiopurine-induced alopecia in inflammatory bowel disease GWAS:3121 Thiopurine-induced digestive symptoms in inflammatory bowel disease GWAS:3122 Thiopurine-induced early leukopenia in Crohn's disease GWAS:3123 Thiopurine-induced leukopenia in inflammatory bowel disease GWAS:3124 Thiopurine-induced leukopenia in inflammatory bowel disease conditioned on rs116855232 GWAS:3125 Thiopurine-induced pancreatitis in inflammatory bowel disease GWAS:3126 Thiopurine-induced severe alopecia in inflammatory bowel disease GWAS:3127 Thiopurine-induced severe leukopenia in inflammatory bowel disease GWAS:3128 Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines GWAS:3129 Thiopurine S-methyltransferase activity GWAS:3130 Thoracic aortic aneurysms and dissections GWAS:3131 Thoracic-to-hip circumference ratio GWAS:3132 Thrombin-activatable fibrinolysis inhibitor activation peptide GWAS:3133 Thrombin-activatable fibrinolysis inhibitor levels GWAS:3134 Thrombin-antithrombin complex levels in ischemic stroke GWAS:3135 Thrombin generation potential phenotypes GWAS:3136 Thrombocytopenia in coronary artery bypass surgery GWAS:3137 Thrombomodulin levels in ischemic stroke GWAS:3138 Thrombosis GWAS:3139 Thyroid-associated orbitopathy in graves' disease GWAS:3140 Thyroid cancer GWAS:3141 Thyroid cancer Papillary, radiation-related GWAS:3142 Thyroid function GWAS:3143 Thyroid hormone levels GWAS:3144 Thyroid nodules GWAS:3145 Thyroid peroxidase antibody levels GWAS:3146 Thyroid peroxidase antibody positivity GWAS:3147 Thyroid peroxidase autoantibody levels in type 1 diabetes GWAS:3148 Thyroid stimulating hormone levels GWAS:3149 Thyroid volume GWAS:3150 Thyrotoxic hypokalemic periodic paralysis GWAS:3151 Thyroxine levels GWAS:3152 Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor GWAS:3153 Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection time and treatment arm interaction GWAS:3154 Toenail selenium levels GWAS:3155 Tonometry GWAS:3156 Tonsillectomy GWAS:3157 Tooth agenesis GWAS:3158 Tooth agenesis mandibular second premolars GWAS:3159 Tooth agenesis mandibular third molar GWAS:3160 Tooth agenesis maxillary lateral incisors GWAS:3161 Tooth agenesis maxillary second premolars GWAS:3162 Tooth agenesis third molar GWAS:3163 Total bilirubin levels GWAS:3164 Total bilirubin levels in HIV-1 infection GWAS:3165 Total body bone mineral density GWAS:3166 Total body bone mineral density age 0-15 GWAS:3167 Total body bone mineral density age 30-45 GWAS:3168 Total body bone mineral density age 45-60 GWAS:3169 Total body bone mineral density age over 60 GWAS:3170 Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes GWAS:3171 Total cholesterol levels GWAS:3172 Total cholesterol levels in HDL GWAS:3173 Total cholesterol levels in large HDL GWAS:3174 Total cholesterol levels in large LDL GWAS:3175 Total cholesterol levels in LDL GWAS:3176 Total cholesterol levels in medium LDL GWAS:3177 Total cholesterol levels in medium VLDL GWAS:3178 Total cholesterol levels in small LDL GWAS:3179 Total glycated albumin levels GWAS:3180 Total hippocampal volume GWAS:3181 Total mean fractional anisotropy measurement in first episode schizophrenia GWAS:3182 Total triglycerides levels GWAS:3183 Total ventricular volume GWAS:3184 Total ventricular volume Alzheimer's disease interaction GWAS:3185 Tourette's syndrome or obsessive-compulsive disorder GWAS:3186 Tourette syndrome GWAS:3187 Tragus size GWAS:3188 TRAIL levels GWAS:3189 Trans-epidermal water loss GWAS:3190 Trans fatty acid levels GWAS:3191 Treatment resistant depression GWAS:3192 Treatment response for severe sepsis GWAS:3193 Trichloroethylene-induced hypersensitivity syndrome GWAS:3194 Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes GWAS:3195 Triglyceride levels GWAS:3196 Triglyceride levels in large VLDL GWAS:3197 Triglyceride levels in medium VLDL GWAS:3198 Triglyceride levels in response to fenofibrate treatment parental genotype effect GWAS:3199 Triglyceride levels in small VLDL GWAS:3200 Triglyceride levels parental genotype effect GWAS:3201 Triglycerides GWAS:3202 Triglycerides-Blood Pressure TG-BP GWAS:3203 Triglycerides x physical activity interaction 2df test GWAS:3204 Triglyceride to HDL cholesterol ratio GWAS:3205 Triiodothyronine levels GWAS:3206 Triiodothyronine levels and thyroxine levels GWAS:3207 Triiodothyronine thyroxine ratio GWAS:3208 Triptolide cytotoxicity GWAS:3209 Tuberculosis GWAS:3210 Tumor biomarkers GWAS:3211 Tumor necrosis factor alpha levels GWAS:3212 Tumor necrosis factor beta levels GWAS:3213 Tumor necrosis factor receptor II red blood cell fatty acid level interaction GWAS:3214 Two-hour glucose GWAS:3215 Two-hour glucose challenge GWAS:3216 Two-hour glucose in pregnancy gestational week 30-32 GWAS:3217 Type 1 diabetes GWAS:3218 Type 1 diabetes and autoimmune thyroid diseases GWAS:3219 Type 1 diabetes autoantibodies in high risk HLA genotype individuals time to event GWAS:3220 Type 1 diabetes in high risk HLA genotype individuals time to event GWAS:3221 Type 1 diabetes nephropathy GWAS:3222 Type 2 diabetes GWAS:3223 Type 2 diabetes adjusted for BMI GWAS:3224 Type 2 diabetes age of onset GWAS:3225 Type 2 diabetes dietary heme iron intake interaction GWAS:3226 Type 2 diabetes nephropathy GWAS:3227 Type 2 diabetes nephropathy including microalbuminuria GWAS:3228 Type 2 diabetes young onset and obesity GWAS:3229 Ulcerative colitis GWAS:3230 Ulcerative colitis or Crohn's disease GWAS:3231 Ulna and radius bone mineral density GWAS:3232 Uncontrolled blood pressure in combination therapy beta blocker and thiazide diuretic GWAS:3233 Underweight status GWAS:3234 Upper eyelid morphology GWAS:3235 Upper eyelid sagging severity GWAS:3236 Urate levels GWAS:3237 Urate levels BMI interaction GWAS:3238 Urate levels in lean individuals GWAS:3239 Urate levels in obese individuals GWAS:3240 Urate levels in overweight individuals GWAS:3241 Urea levels GWAS:3242 Urgency urinary incontinence GWAS:3243 Uric acid clearance GWAS:3244 Uric acid levels GWAS:3245 Urinary 1,3-butadiene metabolite levels in smokers GWAS:3246 Urinary albumin excretion GWAS:3247 Urinary albumin excretion no hypertensive medication GWAS:3248 Urinary albumin excretion rate in type 1 diabetes GWAS:3249 Urinary albumin-to-creatinine ratio GWAS:3250 Urinary albumin-to-creatinine ratio in diabetes GWAS:3251 Urinary albumin-to-creatinine ratio in non-diabetics GWAS:3252 Urinary bladder cancer GWAS:3253 Urinary electrolytes magnesium calcium ratio GWAS:3254 Urinary haptoglobin levels in type 2 diabetes GWAS:3255 Urinary magnesium-to-creatinine ratio GWAS:3257 Urinary metabolite ratios in chronic kidney disease GWAS:3258 Urinary metabolites GWAS:3259 Urinary metabolites H-NMR features GWAS:3260 Urinary symptoms in response to radiotherapy in prostate cancer GWAS:3261 Urinary tract infection frequency GWAS:3262 Urinary uric acid to urinary creatinine ratio GWAS:3263 Urinary uromodulin levels GWAS:3264 Uterine fibroid number single vs multiple GWAS:3265 Uterine fibroids GWAS:3266 Uterine fibroid size maximum dimension GWAS:3267 Uterine fibroid size maximum volume GWAS:3268 Uveal melanoma GWAS:3269 Vaccenic acid 181n-7 levels GWAS:3270 Vaccine-related adverse events GWAS:3271 Vaginal discharge itching GWAS:3272 Vaginal discharge metrorrhagia GWAS:3273 Vaginal discharge smell GWAS:3274 Varicose veins GWAS:3275 Vascular brain injury GWAS:3276 Vascular dementia GWAS:3277 Vascular endothelial growth factor levels GWAS:3278 Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase GWAS:3279 Vaso-occlusive pain in sickle-cell anemia GWAS:3280 Vaspin levels GWAS:3281 Vein graft stenosis in coronary artery bypass grafting GWAS:3282 Velopharyngeal dysfunction GWAS:3283 Venlafaxine response in generalised anxiety disorder HAMA-A score reduction after 24 weeks GWAS:3284 Venlafaxine response in generalised anxiety disorder remitters vs non-remitters after 12 weeks GWAS:3285 Venlafaxine response in generalised anxiety disorder remitters vs non-remitters after 24 weeks GWAS:3286 Venlafaxine response in generalised anxiety disorder responders vs non-responders after 12 weeks GWAS:3287 Venlafaxine response in generalised anxiety disorder responders vs non-responders after 24 weeks GWAS:3288 Venous thromboembolism GWAS:3289 Venous thromboembolism adjusted for sickle cell variant rs77121243-T GWAS:3290 Ventricular ectopy GWAS:3291 Ventricular ectopy or supraventricular ectopy pleiotropy GWAS:3292 Verbal declarative memory GWAS:3293 Verbal intelligence quotient cesarean section interaction GWAS:3294 Verbal memory GWAS:3295 Verbal memory performance delayed recall level GWAS:3296 Verbal memory performance immediate recall change GWAS:3297 Verbal memory performance immediate recall level GWAS:3298 Verbal memory performance residualized delayed recall change GWAS:3299 Verbal memory performance residualized delayed recall level GWAS:3300 Verbal-numerical reasoning GWAS:3301 Vertical cup-disc ratio GWAS:3302 Very large VLDL particle concentration GWAS:3303 Very long-chain saturated fatty acid levels fatty acid 200 GWAS:3304 Very long-chain saturated fatty acid levels fatty acid 220 GWAS:3305 Very long-chain saturated fatty acid levels fatty acid 240 GWAS:3306 Very low density lipoprotein cholesterol levels GWAS:3307 Vestibular neuritis GWAS:3308 Vigorous physical activity GWAS:3309 Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia GWAS:3310 Viral capsid antigen IgG seropositivity GWAS:3311 Virologic severity in Herpes simplex virus type 2 infection GWAS:3312 Visceral adipose tissue GWAS:3313 Visceral adipose tissue adjusted for BMI GWAS:3314 Visceral adipose tissue attenuation Hounslow unit scale GWAS:3315 Visceral adipose tissue subcutaneous adipose tissue ratio GWAS:3316 Visceral adipose tissue subcutaneous adipose tissue ratio adjusted for BMI GWAS:3317 visceral adipose tissue total adipose tissue ratio GWAS:3318 Visceral fat GWAS:3319 Visual memory GWAS:3320 Vitamin B12 levels GWAS:3321 Vitamin B levels in ischemic stroke GWAS:3322 Vitamin D insufficiency GWAS:3323 Vitamin D levels GWAS:3324 Vitamin D levels dietary vitamin D intake interaction GWAS:3325 Vitamin E levels GWAS:3326 Vitiligo GWAS:3327 Vitiligo early onset GWAS:3328 Vitiligo late onset GWAS:3329 Vitiligo non-segmental GWAS:3330 Vogt-Koyanagi-Harada syndrome GWAS:3331 Volumetric brain MRI GWAS:3332 Voxel-wise structural brain imaging measurements GWAS:3333 vWF and FVIII levels GWAS:3334 vWF levels GWAS:3335 vWF levels in ischaemic stroke and hyperhomocysteinaemia GWAS:3336 Waist circumference GWAS:3337 Waist circumference adjusted for BMI adjusted for smoking behaviour GWAS:3338 Waist circumference adjusted for BMI in active individuals GWAS:3339 Waist circumference adjusted for BMI in inactive individuals GWAS:3340 Waist circumference adjusted for BMI in non-smokers GWAS:3341 Waist circumference adjusted for BMI in smokers GWAS:3342 Waist circumference adjusted for BMI joint analysis main effects and physical activity interaction GWAS:3343 Waist circumference adjusted for BMI joint analysis main effects and smoking interaction GWAS:3344 Waist circumference adjusted for BMI smoking interaction GWAS:3345 Waist circumference adjusted for body mass index GWAS:3346 Waist circumference and related phenotypes GWAS:3347 Waist Circumference - Triglycerides WC-TG GWAS:3348 Waist-hip ratio GWAS:3349 Waist-to-hip circumference ratio alcohol intake interaction GWAS:3350 Waist-to-hip circumference ratio dietary energy interaction GWAS:3351 Waist-to-hip circumference ratio ever vs never smoking interaction GWAS:3352 Waist-to-hip circumference ratio recreational physical activity interaction GWAS:3353 Waist-to-hip circumference ratio smoking years interaction GWAS:3354 Waist-to-hip ratio adjusted for BMI additive genetic model GWAS:3355 Waist-to-hip ratio adjusted for BMI adjusted for smoking behaviour GWAS:3356 Waist-to-hip ratio adjusted for BMI age <50 GWAS:3357 Waist-to-hip ratio adjusted for BMI age >50 GWAS:3358 Waist-to-hip ratio adjusted for BMI in active individuals GWAS:3359 Waist-to-hip ratio adjusted for BMI in inactive individuals GWAS:3360 Waist-to-hip ratio adjusted for BMI in non-smokers GWAS:3361 Waist-to-hip ratio adjusted for BMI in smokers GWAS:3362 Waist-to-hip ratio adjusted for BMI joint analysis for main effect and physical activity interaction GWAS:3363 Waist-to-hip ratio adjusted for BMI joint analysis main effects and smoking interaction GWAS:3364 Waist-to-hip ratio adjusted for BMI recessive genetic model GWAS:3365 Waist-to-hip ratio adjusted for BMI smoking interaction GWAS:3366 Waist-to-hip ratio adjusted for BMI GWAS:3367 Waist-to-hip ratio adjusted for BMI x sex interaction GWAS:3368 Waist-to-hip ratio adjusted for BMI x sex x age interaction 4df test GWAS:3369 Waist-to-hip ratio adjusted for body mass index GWAS:3370 Waldenstrom macroglobulinemia lymphoplasmacytic lymphoma GWAS:3371 Warfarin-associated bleeding GWAS:3372 Warfarin maintenance dose GWAS:3373 Wegener's granulomatosis GWAS:3374 Weight GWAS:3375 Weight loss gastric bypass surgery GWAS:3376 Well-being spectrum multivariate analysis GWAS:3377 Western dietary pattern GWAS:3378 White blood cell count GWAS:3379 White blood cell count basophil GWAS:3380 White blood cell count eosinophil GWAS:3381 White blood cell count lymphocyte GWAS:3382 White blood cell count monocyte GWAS:3383 White blood cell count neutrophil GWAS:3384 White blood cell types GWAS:3385 White matter growth GWAS:3386 White matter hyperintensities in ischemic stroke GWAS:3387 White matter hyperintensity burden GWAS:3388 White matter hyperintensity volume GWAS:3389 White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy GWAS:3390 White matter integrity GWAS:3391 White matter integrity bipolar disorder risk interaction GWAS:3392 White matter integrity fractional anisotropy GWAS:3393 White matter integrity mean diffusivity GWAS:3394 White matter lesion progression GWAS:3395 White matter lesion progression adjusted for white matter lesion burden at baseline GWAS:3396 White matter microstructure global fractional anisotropy GWAS:3397 White matter microstructure in first episode schizophrenia left anterior cingulate cortex GWAS:3398 White matter microstructure in first episode schizophrenia left inferior parietal cortex GWAS:3399 White matter microstructure in first episode schizophrenia left posterior cingulate cortex GWAS:3400 White matter microstructure in first episode schizophrenia right anterior cingulate cortex GWAS:3401 White wine liking GWAS:3402 Whole-brain volume GWAS:3403 Whole-brain volume Alzheimer's disease interaction GWAS:3404 Wilms tumor GWAS:3405 Word reading GWAS:3406 Word spelling GWAS:3407 Working memory GWAS:3408 World class endurance athleticism GWAS:3409 Worry GWAS:3410 Worry too long after an embarrassing experience GWAS:3411 Worry vulnerability special factor of neuroticism GWAS:3412 Yang-deficiency constitution GWAS:3413 Yeast infection GWAS:3414 YKL-40 levels GWAS:3415 Yu-Zhi constitution type in type 2 diabetes GWAS:3416 Adverse response to carbamazepine GWAS:3417 Albuminuria GWAS:3418 Alzheimer's disease or fasting glucose levels pleiotropy GWAS:3419 Alzheimer's disease or fasting insulin levels pleiotropy GWAS:3420 Alzheimer's disease or HDL levels pleiotropy GWAS:3421 Anti-sp100 seropositivity in primary biliary cholangitis GWAS:3422 Anti-thyroglobulin TgAb levels in Hashimoto's thyroiditis GWAS:3423 Anti-thyroid peroxidase TPOAb and anti-thyroglobulin TgAb levels in Hashimoto's thyroiditis GWAS:3424 Anti-thyroid peroxidase TPOAb levels in Hashimoto's thyroiditis GWAS:3425 Anti-Toxoplasma gondii IgG seropositivity GWAS:3426 Asthma adult onset GWAS:3427 Asthma onset childhood vs adult GWAS:3428 Carbamazepine-induced hyponatremia in epilepsy GWAS:3429 Carbamazepine metabolism carbamazepine-10,11-diol to carbamazepine ratio in epilepsy GWAS:3430 Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy GWAS:3431 Colorectal cancer or advanced adenoma GWAS:3432 Emotional lability in attention deficit hyperactivity disorder GWAS:3433 Facial attractiveness female raters GWAS:3434 Facial attractiveness male raters GWAS:3435 Fasting blood insulin adjusted for BMI GWAS:3436 Frontal fibrosing alopecia GWAS:3437 Homeostasis model assessment of insulin resistance in less-fat diet GWAS:3438 Homeostasis model assessment of insulin resistance in more-fat diet GWAS:3439 Homeostasis model assessment of insulin resistance x saturated fatty acids interaction GWAS:3440 Hyperglycemia GWAS:3441 Hyperglycemia in higher physical activity GWAS:3442 Hyperglycemia in more-fat diet GWAS:3443 Hyperinsulinemia in less-fat diet GWAS:3444 Hyperinsulinemia in lower physical activity GWAS:3445 Hyperinsulinemia in obesity GWAS:3446 Hyperinsulinemia x BMI interaction GWAS:3447 Hyperinsulinemia x physical activity interaction GWAS:3448 Hyperinsulinemia x saturated fatty acids interaction GWAS:3449 Incident chronic kidney disease GWAS:3450 KANNO antigen negativity GWAS:3451 Latent naming speed GWAS:3452 Low HDL-cholesterol levels GWAS:3453 Medication use adrenergics, inhalants GWAS:3454 Medication use agents acting on the renin-angiotensin system GWAS:3455 Medication use anilides GWAS:3456 Medication use antidepressants GWAS:3457 Medication use antiglaucoma preparations and miotics GWAS:3458 Medication use antihistamines for systemic use GWAS:3459 Medication use antihypertensives GWAS:3460 Medication use anti-inflammatory and antirheumatic products, non-steroids GWAS:3461 Medication use antimigraine preparations GWAS:3462 Medication use antithrombotic agents GWAS:3463 Medication use beta blocking agents GWAS:3464 Medication use calcium channel blockers GWAS:3465 Medication use diuretics GWAS:3466 Medication use drugs affecting bone structure and mineralization GWAS:3467 Medication use drugs for peptic ulcer and gastro-oesophageal reflux disease GWAS:3468 Medication use drugs used in diabetes GWAS:3469 Medication use glucocorticoids GWAS:3470 Medication use HMG CoA reductase inhibitors GWAS:3471 Medication use immunosuppressants GWAS:3472 Medication use opioids GWAS:3473 Medication use salicylic acid and derivatives GWAS:3474 Medication use thyroid preparations GWAS:3475 Medication use vasodilators used in cardiac diseases GWAS:3476 Monoclonal gammopathy of undetermined significance GWAS:3477 Mouth ulcers GWAS:3478 Oxcarbazepine-induced hyponatremia in epilepsy GWAS:3479 Primary central nervous system lymphoma GWAS:3480 Psychological resilience outcome-based GWAS:3481 Psychological resilience outcome-based in high deployment stress exposure GWAS:3482 Psychological resilience self-assessed GWAS:3483 Rapid alternating stimulus test for letters numbers GWAS:3484 Rapid automised naming and rapid alternating stimulus test performance GWAS:3485 Right-sided colonic diverticulosis GWAS:3486 Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy GWAS:3487 Skin reflectance Melanin index GWAS:3488 Sleep number of episodes GWAS:3489 Sodium levels in epilepsy GWAS:3490 Tinnitus in cisplatin-treated testicular cancer GWAS:3491 Trunk fat mass adjusted for trunk lean mass GWAS:3492 Type 2 diabetes and end-stage kidney disease GWAS:3493 Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals GWAS:3494 Urinary potassium to creatinine ratio GWAS:3495 Urinary sodium to creatinine ratio GWAS:3496 Urinary sodium to potassium ratio GWAS:3497 Urolithiasis GWAS:3498 Accommodative esotropia GWAS:3499 Acute post-radiotherapy pain in breast cancer GWAS:3500 Adenocarcinoma in never smokers GWAS:3501 Airway obstruction FEV1 FVC<70 in never smokers GWAS:3502 Airway obstruction FEV1 FVC18 months in genital human papillomavirus 16 infection GWAS:3633 Infliximab-induced mucosal healing in Crohn's disease GWAS:3634 Insulinogenic index GWAS:3635 Intake of sweets GWAS:3636 Intake of total sugars GWAS:3637 Intertrochanteric region size GWAS:3638 Intraocular pressure corneal compensated GWAS:3639 Intraocular pressure Goldman correlated GWAS:3640 Joint damage in rheumatoid arthritis GWAS:3641 Ketonuria GWAS:3642 Ketonuria mild GWAS:3643 Ketonuria moderate to severe GWAS:3644 Knee pain GWAS:3645 LDL cholesterol levels in current drinkers GWAS:3646 LDL cholesterol levels in current smokers GWAS:3647 LDL cholesterol levels in ever smokers GWAS:3648 LDL cholesterol levels in never smokers GWAS:3649 LDL cholesterol levels x alcohol consumption drinkers vs non-drinkers interaction 2df GWAS:3650 LDL cholesterol levels x alcohol consumption regular vs non-regular drinkers interaction 2df GWAS:3651 LDL cholesterol levels x smoking current vs non smokers interaction 1df test GWAS:3652 LDL cholesterol levels x smoking current vs non smokers interaction 2df test GWAS:3653 LDL cholesterol levels x smoking ever vs never smokers interaction 1df test GWAS:3654 LDL cholesterol levels x smoking ever vs never smokers interaction 2df test GWAS:3655 Leukocyte telomere length GWAS:3656 Lipoprotein a levels in coronary artery disease percutaneous coronary intervention GWAS:3657 Liver fibrosis in non-alcoholic fatty acid liver disease GWAS:3658 Longevity age >90th survival percentile GWAS:3659 Longevity age >99th survival percentile GWAS:3660 Low susceptibility to hepatitis C infection GWAS:3661 Low urine pH GWAS:3662 Lung function in heavy smokers high FEV1 vs average FEV1 GWAS:3663 Lung function in heavy smokers low FEV1 vs high FEV1 GWAS:3664 Lung function in never smokers high FEV1 vs average FEV1 GWAS:3665 Lung function in never smokers low FEV1 vs average FEV1 GWAS:3666 Lung function in never smokers low FEV1 vs high FEV1 GWAS:3667 Lung function low FEV1 vs high FEV1 GWAS:3668 Lung function low FEV1 vs high FEV1 x smoking interaction GWAS:3669 Lymphangioleiomyomatosis sporadic GWAS:3670 Marginal zone lymphoma or multiple sclerosis GWAS:3671 Marginal zone lymphoma or rheumatoid arthritis GWAS:3672 Marginal zone lymphoma or systemic lupus erythematosus GWAS:3673 Maximum habitual alcohol consumption GWAS:3674 Meningococcal C functional antibody titers post childhood immunization GWAS:3675 Meningococcal C IgG concentrations post childhood immunization GWAS:3676 Mental health study participation completed survey GWAS:3677 Mental health study participation provided email address GWAS:3678 Mild to moderate chronic kidney disease GWAS:3679 Minimum ankle-brachial index GWAS:3680 Moderate-to-late spontaneous preterm birth GWAS:3681 Morningness GWAS:3682 Multisite chronic pain GWAS:3683 Neurological blood protein biomarker levels GWAS:3684 Neuropathy in Charcot-Marie-Tooth disease type 1A GWAS:3685 Non-accommodative esotropia GWAS:3687 Non-muscle-invasive bladder cancer tumour size GWAS:3688 Nonobstructive coronary artery disease GWAS:3689 Number of alcoholic drinks required to feel an effect first five times drinking GWAS:3690 Number of alcoholic drinks required to feel an effect long-term average GWAS:3691 Number of decayed, missing and filled tooth surfaces GWAS:3692 Number of decayed, missing and filled tooth surfaces or use of dentures GWAS:3693 Occipital lobe volume GWAS:3694 Opioid overdose severity score GWAS:3695 Parietal lobe volume GWAS:3696 Peginterferon alfa-2a treatment response in chronic hepatitis B infection GWAS:3697 Pemphigus GWAS:3698 Pepsinogen I II ratio GWAS:3699 Perceived intensity of aspartame GWAS:3700 Perceived intensity of fructose GWAS:3701 Perceived intensity of glucose GWAS:3702 Perceived intensity of neohesperidin dihydrochalcone GWAS:3703 Perceived intensity of sucrose GWAS:3704 Perceived intensity of sweet substances GWAS:3705 Perceived sweetness of sucrose GWAS:3706 Periodontal disease related phenotype PCT3 GWAS:3707 Periodontal disease related phenotype PCT4 GWAS:3708 Periodontal disease related phenotype PCT5 GWAS:3709 Periodontal disease-related phenotype Socransky GWAS:3710 Phenylephrine infusion rate during anesthesia GWAS:3711 Plasma anti-thyroglobulin and anti-thyroid peroxidase levels bivariate analysis GWAS:3712 Plasma anti-thyroglobulin levels GWAS:3713 Plasma anti-thyroid peroxidase levels GWAS:3714 Plasma factor V levels in venous thrombosis GWAS:3715 Plasma factor V levels in venous thrombosis conditioned on rs6027 GWAS:3716 Platelet reactivity measurement collagen-ADP GWAS:3717 Platelet reactivity measurement collagen-epinephrine GWAS:3718 Post-bronchodilator FEV1 x air pollution CO interaction in childhood asthma GWAS:3719 Post-bronchodilator FEV1 x air pollution NO2 interaction in childhood asthma GWAS:3720 Postoperative acute renal failure after cardiac surgery GWAS:3721 Postoperative atrial fibrillation after cardiac surgery GWAS:3722 Postoperative complication after cardiac surgery GWAS:3723 Postoperative delirium after cardiac surgery GWAS:3724 Postoperative myocardial infarction after cardiac surgery GWAS:3725 Postoperative stroke after cardiac surgery GWAS:3726 Post-term birth GWAS:3727 Post-traumatic stress disorder re-experiencing symptoms GWAS:3728 Post-traumatic stress disorder symptoms in trauma-exposed soldiers GWAS:3729 Predicted visceral adipose tissue GWAS:3730 Pre-treatment viral load in hepatitis C virus genotype 3 GWAS:3731 Pre-treatment viral load in HIV-1 infection GWAS:3732 Proinsulin levels early-phase conversion GWAS:3733 Proinsulin levels late-phase conversion GWAS:3734 Proliferative diabetic retinopathy GWAS:3735 Proteinuria GWAS:3736 Proteinuria mild GWAS:3737 Proteinuria moderate to severe GWAS:3738 Psychological wellbeing index 12 lack of enjoying daily life GWAS:3739 Psychological wellbeing index 1 lack of subjective wellbeing and health GWAS:3740 Pulmonary function FVC x omega-3 PUFA docosahexaenoic acid interaction 2df GWAS:3741 Pure non-grapefruit juice consumption GWAS:3742 Renal cell carcinoma x sex interaction GWAS:3743 Response to allopurinol in gout change in serum uric acid levels GWAS:3744 Response to beta blocker use in hypertension systolic blood pressure GWAS:3745 Response to cognitive-behavioural therapy in anxiety and major depressive disorders GWAS:3746 Response to cognitive-behavioural therapy in major depressive disorder GWAS:3747 Response to direct-acting antiviral treatment in hepatitis C virus genotype 3 GWAS:3748 Response to fluticasone propionate salmeterol in chronic obstructive pulmonary disease GWAS:3749 Response to interferon treatment in hepatitis C virus genotype 3 GWAS:3750 Response to intravenous immunoglobulin treatment in Kawasaki disease GWAS:3751 Salty taste perception in obesity with metabolic syndrome GWAS:3752 same-sex sexual behaviour GWAS:3753 Schizoaffective disorder-bipolar type GWAS:3754 Scoliosis in Charcot-Marie-Tooth disease 1A GWAS:3755 Serum platinum levels after completion of cisplatin chemotherapy GWAS:3756 Severe gastric atrophy GWAS:3757 Simvastatin-induced myopathy GWAS:3758 Skin pigmentation conditioned on rs1426654 and rs35397 GWAS:3759 Smoking status heavy vs never GWAS:3760 Soluble VCAM-1 levels GWAS:3761 Sour taste perception in obesity with metabolic syndrome GWAS:3762 Spontaneous preterm birth without premature rupture of membranes GWAS:3763 Spontaneous preterm birth with premature rupture of membranes GWAS:3764 Statin-induced myopathy GWAS:3765 Statin-induced myopathy severe GWAS:3766 Stress-related disorders GWAS:3767 Stress sensitivity neuroticism score x major depressive disorder status interaction GWAS:3768 Sucrose liking GWAS:3769 Sugar-sweetened beverage consumption GWAS:3770 Suicide attempts in bipolar disorder or schizophrenia GWAS:3771 Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia GWAS:3772 Suicide attempts in schizophrenia GWAS:3773 Sural nerve amplitude potential GWAS:3774 Sweet beverage consumption GWAS:3775 Sweet taste perception in obesity with metabolic syndrome GWAS:3776 Taste perception total score including 6-n-propylthiouracil in obesity with metabolic syndrome GWAS:3777 Taste perception total score including phenylthiocarbamide in obesity with metabolic syndrome GWAS:3778 Tea consumption GWAS:3779 Tetanus toxoid IgG concentrations post childhood immunization GWAS:3780 Thyroglobulin plasma levels GWAS:3781 Thyrotoxic hypokalemic periodic paralysis and Graves disease GWAS:3782 Thyrotoxic hypokalemic periodic paralysis in Graves disease GWAS:3783 Time to smoke first cigarette in the morning GWAS:3784 Total body bone mineral density MTAG GWAS:3785 Toxicity response to radiotherapy in prostate cancer decreased urine stream time to event GWAS:3786 Toxicity response to radiotherapy in prostate cancer hematuria time to event GWAS:3787 Toxicity response to radiotherapy in prostate cancer increased urinary frequency time to event GWAS:3788 Toxicity response to radiotherapy in prostate cancer rectal bleeding time to event GWAS:3789 Triglyceride levels in current drinkers GWAS:3790 Triglyceride levels in ever smokers GWAS:3791 Triglyceride levels in non smokers GWAS:3792 Triglyceride levels x alcohol consumption drinkers vs non-drinkers interaction 2df GWAS:3793 Triglyceride levels x alcohol consumption regular vs non-regular drinkers interaction 2df GWAS:3794 Triglyceride levels x smoking current vs non smokers interaction 1df test GWAS:3795 Triglyceride levels x smoking current vs non smokers interaction 2df test GWAS:3796 Triglyceride levels x smoking ever vs never smokers interaction 1df test GWAS:3797 Triglyceride levels x smoking ever vs never smokers interaction 2df test GWAS:3798 Trochanter size GWAS:3799 Trunk fat mass GWAS:3800 Umami taste perception in obesity with metabolic syndrome GWAS:3801 Urinary potassium excretion GWAS:3802 Urinary sodium excretion GWAS:3803 Urine pH measurement GWAS:3804 Walking difficulty in Charcot-Marie-Tooth disease 1A GWAS:3805 Warfarin maintenance dose adjusted for clinical factors GWAS:3806 17-hydroxyprogesterone 17-OHP levels GWAS:3807 Abdominal aortic calcification levels GWAS:3808 Abstraction and mental flexibility GWAS:3809 Adult hearing aid use GWAS:3810 Adult hearing difficulty GWAS:3811 Adverse response to chemotherapy amenorrhea in breast cancer GWAS:3812 Adverse response to drug GWAS:3813 Age at adiposity rebound GWAS:3814 Age at suicide GWAS:3815 Age-related cognitive decline attention processing speed slope of z-scores GWAS:3816 Age-related cognitive decline executive function slope of z-scores GWAS:3817 Age-related cognitive decline global cognition slope of z-scores GWAS:3818 Age-related cognitive decline language slope of z-scores GWAS:3819 Age-related cognitive decline memory slope of z-scores GWAS:3820 Age-related cognitive decline visuospatial skill slope of z-scores GWAS:3821 Age-related hearing impairment high frequency GWAS:3822 Age-related hearing impairment high minus low frequency GWAS:3823 Age-related hearing impairment low mid frequency GWAS:3824 Airflow obstruction in ever smokers GWAS:3825 Alzheimer's disease and or vascular dementia clinical subgroup VaD GWAS:3826 Alzheimer's disease clinical subgroup AD GWAS:3827 Alzheimer's disease onset at age over 80 GWAS:3828 Alzheimer's disease onset between ages 58 and 79 GWAS:3829 Amygdala volume GWAS:3830 Androstenedione levels GWAS:3831 anorexia nervosa, attention-deficit hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome pleiotropy GWAS:3832 Anti-anoctamin 2 antibody levels GWAS:3833 Antipsychotic drug-induced weight gain in schizophrenia GWAS:3834 Antipsychotic drug-induced weight gain in schizophrenia or autism GWAS:3835 Antisaccade task score GWAS:3836 Anxiety symptoms GWAS:3837 Asthma and anxiety disorder GWAS:3838 Asthma and attention deficit hyperactivity disorder GWAS:3839 Asthma and major depressive disorder GWAS:3840 Asthma time to childhood onset in early life tobacco smoke exposure GWAS:3841 Asthma time to childhood onset x early life tobacco smoke interaction GWAS:3842 Asthma time to onset GWAS:3843 Asthma x air pollution interaction 2df GWAS:3844 Asthma x Hispanic interaction 2df GWAS:3845 Basal metabolic rate variance GWAS:3846 B-cell acute lymphoblastic leukaemia GWAS:3847 B-cell acute lymphoblastic leukaemia ETV6-RUNX1 positive GWAS:3848 B-cell acute lymphoblastic leukaemia high-hyperdiploidy GWAS:3849 Bicuspid aortic valve GWAS:3850 Bicuspid aortic valve without aortic dilation GWAS:3851 Bipolar disorder or body mass index GWAS:3852 Bipolar disorder or type 2 diabetes GWAS:3853 Birth length MTAG GWAS:3854 Birth weight MTAG GWAS:3855 Birth weight variance GWAS:3856 Blood protein levels in cardiovascular risk GWAS:3857 BMI at 15 years old GWAS:3858 BMI at 1 year old GWAS:3859 BMI at 2 years old GWAS:3860 BMI at 3 months old GWAS:3861 BMI at 3 years old GWAS:3862 BMI at 5 years old GWAS:3863 BMI at 6 months old GWAS:3864 BMI at 7 years old GWAS:3865 BMI at 8 months old GWAS:3866 BMI at 8 years old GWAS:3867 BMI at adiposity peak GWAS:3868 BMI at adiposity rebound GWAS:3869 BMI at birth GWAS:3870 Body fat percentage variance GWAS:3871 Bone mineral content GWAS:3872 Brain region volumes GWAS:3873 Brainstem volume GWAS:3874 California verbal learning test score GWAS:3875 Carotenoid levels GWAS:3876 Carotid artery external diameter GWAS:3877 Carotid artery internal diameter GWAS:3878 Carotid intima media thickness maximum GWAS:3879 Carotid intima media thickness mean GWAS:3880 Carotid intima media thickness mean-maximum GWAS:3881 Caudal anterior-cingulate cortex volume GWAS:3882 Caudal middle frontal gyrus volume GWAS:3883 CCL19 levels GWAS:3884 CCL24 levels GWAS:3885 CD40 ligand levels GWAS:3886 Central retinal arteriolar equivalent GWAS:3887 Central retinal vein equivalent GWAS:3888 Central serous retinopathy GWAS:3889 Ceramide levels GWAS:3890 Cerebellum cortex volume GWAS:3891 Cerebellum white matter volume GWAS:3892 Cerebral cortex AV-45 amyloid PET measurement GWAS:3893 Cerebral white matter volume GWAS:3894 Cerebrospinal fluid neurofilament light levels GWAS:3895 Change in serum metabolite levels GWAS:3896 Change in serum metabolite levels CMS GWAS:3897 Childhood obesity GWAS:3898 Cholesteryl ester levels GWAS:3899 Choroidal melanoma GWAS:3900 Choroid plexus volume GWAS:3901 Chromosomal aberration frequency chromatid type GWAS:3902 Chromosomal aberration frequency chromatid type in genotoxic compound exposure GWAS:3903 Chromosomal aberration frequency chromosome type GWAS:3904 Chromosomal aberration frequency chromosome type in genotoxic compound exposure GWAS:3905 Chromosomal aberration frequency total GWAS:3906 Chromosomal aberration frequency total in genotoxic compound exposure GWAS:3907 Chronic kidney disease end stage renal disease vs normal eGFR in type 1 diabetes GWAS:3908 Chronic kidney disease reduced eGFR or end stage renal disease in type 1 diabetes GWAS:3909 Circulating leptin levels in high cardiovascular risk GWAS:3910 Circulating leptin levels x sex interaction in high cardiovascular risk GWAS:3911 Cirrhosis GWAS:3912 Cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction parent of origin effect GWAS:3913 Cleft lip with or without cleft palate x maternal periconceptional smoking interaction parent of origin effect GWAS:3914 Cleft lip with or without cleft palate x maternal periconceptional vitamin use interaction parent of origin effect GWAS:3915 Cocaine use disorder GWAS:3916 Cocaine use disorder x change in residence interaction GWAS:3917 Cocaine use disorder x household tobacco use interaction GWAS:3918 Cognitive performance in schizophrenia or bipolar disorder GWAS:3919 Cognitive performance processing speed GWAS:3920 Corpus callosum anterior volume GWAS:3921 Corpus callosum central volume GWAS:3922 Corpus callosum mid-anterior volume GWAS:3923 Corpus callosum Mid-posterior volume GWAS:3924 Corpus callosum posterior volume GWAS:3925 Cortex volume GWAS:3926 Cortisol levels plasma GWAS:3927 Cuneus cortex volume GWAS:3928 CXCL5 levels GWAS:3929 C-X-C motif chemokine 10 levels GWAS:3930 Cytokine levels GWAS:3931 Cytokine network levels multivariate analysis GWAS:3932 Decreased low contrast letter acuity in multiple sclerosis GWAS:3933 Degraded stimulus continuous performance test score GWAS:3934 Dental caries decayed and filled deciduous teeth GWAS:3935 Dental caries decayed and filled deciduous tooth surfaces GWAS:3936 Dental caries decayed, missing and filled teeth GWAS:3937 Dental caries decayed, missing and filled tooth surfaces GWAS:3938 Depressive symptom anhedonia binary trait GWAS:3939 Depressive symptom anhedonia ordinal trait GWAS:3940 Depressive symptom appetite changes binary trait GWAS:3941 Depressive symptom depressed mood binary trait GWAS:3942 Depressive symptom depressed mood ordinal trait GWAS:3943 Depressive symptom fatigue ordinal trait GWAS:3944 Depressive symptom low self-esteem ordinal trait GWAS:3945 Depressive symptoms binary sum-score GWAS:3946 Depressive symptom sleep problems binary trait GWAS:3947 Depressive symptoms sum-score GWAS:3948 DHEAS levels GWAS:3949 Diacylglyceride levels GWAS:3950 Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension GWAS:3951 Differential aging frontal cortex GWAS:3952 Differential aging in older adults frontal cortex GWAS:3953 Disability impaired activities of daily living GWAS:3954 Disease progression in age-related macular degeneration adjusted for baseline GWAS:3955 Disease severity in uveal melanoma TNM stage 3 or 4 vs TNM stage 1 or 2 GWAS:3956 Early cardiac repolarization GWAS:3957 Early onset periodontitis x smoking status interaction GWAS:3958 Emotional recognition GWAS:3959 Eosinophilic granulomatosis with polyangiitis GWAS:3960 Eosinophilic granulomatosis with polyangiitis ANCA negative GWAS:3961 Eosinophilic granulomatosis with polyangiitis MPO-ANCA positive GWAS:3962 epithelial cell adhesion molecule levels GWAS:3963 Estimated glomerular filtration rate reduction 30 GWAS:3964 Face memory GWAS:3965 Fibrosis improvement in nonalcoholic steatohepatitis GWAS:3966 Figural spatial cognitive ability GWAS:3967 Fourth ventricle volume GWAS:3968 Frontal pole volume GWAS:3969 Fusiform gyrus volume GWAS:3970 Glaucoma multi-trait analysis GWAS:3971 Gut microbiota alpha diversity GWAS:3972 Gut microbiota relative abundance bacterial taxa GWAS:3973 Hallucinations in long-term cannabis use GWAS:3974 Handedness left-handed vs right-handed GWAS:3975 Handedness non-right-handed vs right-handed GWAS:3976 Hay fever and or eczema GWAS:3977 HDL cholesterol levels x long total sleep time interaction 1df test GWAS:3978 HDL cholesterol levels x long total sleep time interaction 2df test GWAS:3979 HDL cholesterol levels x loop diuretics use interaction GWAS:3980 HDL cholesterol levels x short total sleep time interaction 1df test GWAS:3981 HDL cholesterol levels x short total sleep time interaction 2df test GWAS:3982 HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction GWAS:3983 Heavy menstrual bleeding GWAS:3984 Heel bone mineral density variance GWAS:3985 High chromosomal aberration frequency chromatid type GWAS:3986 High chromosomal aberration frequency chromatid type in genotoxic compound exposure GWAS:3987 High chromosomal aberration frequency chromosome type GWAS:3988 High chromosomal aberration frequency chromosome type in genotoxic compound exposure GWAS:3989 High chromosomal aberration frequency total GWAS:3990 High fasting blood glucose GWAS:3991 Hip circumference variance GWAS:3992 Hippocampal atrophy rate GWAS:3993 HIV progression CD4 and viral load GWAS:3994 Hospital contact for infections GWAS:3995 Household income MTAG GWAS:3996 Hydrolysed wheat protein allergy GWAS:3997 Hypospadias moderate to severe GWAS:3998 Impaired insulin sensitivity in response to n-3 PUFA supplementation GWAS:3999 Infant head circumference MTAG GWAS:4000 Inferior parietal cortex volume GWAS:4001 Inferior temporal gyrus volume GWAS:4002 Insular cortex volume GWAS:4003 interleukin 12 receptor subunit beta-1 levels GWAS:4004 interleukin 17 receptor B levels GWAS:4005 Interleukin-6 receptor subunit alpha levels GWAS:4006 Interstitial lung abnormalities GWAS:4007 Intraocular pressure and central corneal thickness multi-trait analysis GWAS:4008 Isthmus-cingulate cortex volume GWAS:4009 kallikrein-11 levels GWAS:4010 Keratinocyte cancer MTAG GWAS:4011 Keratoconus GWAS:4012 Kidney disease end stage renal disease or albuminuria in type 1 diabetes GWAS:4013 Kidney disease end stage renal disease vs macroalbuminuria in type 1 diabetes GWAS:4014 Kidney disease reduced eGFR and albuminuria or end stage renal disease in type 1 diabetes GWAS:4015 Lactose tolerance test GWAS:4016 Lateral occipital cortex volume GWAS:4017 Lateral orbital frontal cortex volume GWAS:4018 Lateral ventricle temporal horn volume GWAS:4019 Lateral ventricle volume GWAS:4020 LDL cholesterol levels x long total sleep time interaction 1df test GWAS:4021 LDL cholesterol levels x long total sleep time interaction 2df test GWAS:4022 LDL cholesterol levels x loop diuretics use interaction GWAS:4023 LDL cholesterol levels x short total sleep time interaction 1df test GWAS:4024 LDL cholesterol levels x short total sleep time interaction 2df test GWAS:4025 LDL cholesterol levels x thiazide or thiazide-like diuretics use interaction GWAS:4026 Left planum temporale grey matter volume GWAS:4027 Left ventricular ejection fraction GWAS:4028 Letter-number span reordering GWAS:4029 Leukocyte count in ischemic stroke GWAS:4030 Lifetime anxiety disorder GWAS:4031 Lifetime smoking index GWAS:4032 Lingual gyrus volume GWAS:4033 Lipid or lipoprotein levels GWAS:4034 Liver disease biomarker GWAS:4035 Lobar intracerebral hemorrhage GWAS:4036 Longitudinal brain connectivity change characteristic path length GWAS:4037 Longitudinal brain connectivity change global efficiency GWAS:4038 Longitudinal brain connectivity change Louvain modularity GWAS:4039 Longitudinal brain connectivity change transitivity GWAS:4040 Longitudinal cocaine use GWAS:4041 Lung function FEV1 FVC variance GWAS:4042 Lysophosphatidylcholine levels GWAS:4043 Lysophosphatidylethanolamine levels GWAS:4044 Macroalbuminuria in type 1 diabetes GWAS:4045 Malate levels GWAS:4046 Maternal nondisjunction of chromosome 21 MI error vs fathers GWAS:4047 Maternal nondisjunction of chromosome 21 MI error vs MII error GWAS:4048 Maternal nondisjunction of chromosome 21 MII error vs fathers GWAS:4049 Maternal nondisjunction of chromosome 21 mothers vs fathers GWAS:4050 Maximum retinal arteriolar tortuosity GWAS:4051 Maximum retinal venular tortuosity GWAS:4052 Medial orbital frontal cortex volume GWAS:4053 melanoma-derived growth regulatory protein levels GWAS:4054 Metabolite risk score for predicting weight gain GWAS:4055 MHC class I polypeptide-related sequence A levels GWAS:4056 Microalbuminuria in type 1 diabetes GWAS:4057 Middle temporal gyrus volume GWAS:4058 Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis GWAS:4059 Mosaic loss of chromosome Y Y chromosome dosage GWAS:4060 NASH resolution in nonalcoholic steatohepatitis GWAS:4061 Niacinamide levels GWAS:4062 Non-del5q myelodysplastic syndromes GWAS:4063 Non-lobar intracerebral hemorrhage GWAS:4064 Non-lobar intracerebral hemorrhage MTAG GWAS:4065 Nonsyndromic cleft lip GWAS:4066 Nonsyndromic cleft palate GWAS:4067 Nucleus accumbens volume GWAS:4068 Numerical cognitive ability GWAS:4069 Obstructive sleep apnea trait apnea hypopnea index, change over time GWAS:4070 Opioid dependence x sex interaction GWAS:4071 Optic disc radius GWAS:4072 Optic disc size GWAS:4073 Optic nerve head parameters multi-trait analysis GWAS:4074 Osteoarthritis of the hand GWAS:4075 Pallidum volume GWAS:4076 Paracentral lobule volume GWAS:4077 Parahippocampal gyrus volume GWAS:4078 Parental longevity father's age at death or father's attained age GWAS:4079 Parental longevity mother's age at death or mother's attained age GWAS:4080 Parkinson's disease in GBA mutation carriers GWAS:4081 Parkinson's disease or first degree relation to individual with Parkinson's disease GWAS:4082 Pars opercularis volume GWAS:4083 Pars orbitalis volume GWAS:4084 Pars triangularis volume GWAS:4085 Pericalcarine cortex volume GWAS:4086 Peripheral artery disease borderline GWAS:4087 Phosphatidylcholine-ether levels GWAS:4088 Phosphatidylcholine levels GWAS:4089 Phosphatidylethanolamine-ether levels GWAS:4090 Phosphatidylethanolamine levels GWAS:4091 Phosphatidylinositol levels GWAS:4092 Planum temporale asymmetry index GWAS:4093 Pneumococcal meningitis GWAS:4094 Pneumococcal meningitis x streptococcus pneumoniae genotype cluster interaction GWAS:4095 Postcentral gyrus volume GWAS:4096 Posterior-cingulate cortex volume GWAS:4097 Precentral gyrus volume GWAS:4098 Precuneus cortex volume GWAS:4099 Prepulse inhibition of the startle response GWAS:4100 Presence of epithelioid cells in uveal melanoma GWAS:4101 Priapism in sickle cell disease GWAS:4102 Progesterone levels GWAS:4103 Pruritus in nonalcoholic steatohepatitis GWAS:4104 Psychotic experience GWAS:4105 Psychotic experience distressing GWAS:4106 Pyridoxal levels GWAS:4107 Rate of ventricular enlargement GWAS:4108 Recurrence of malaria infection mild or asymptomatic GWAS:4109 Recurrence of mild malaria attacks GWAS:4110 Response to adalimumab in hidradenitis suppurativa abscess and inflammatory nodule count increase GWAS:4111 Response to pegylated interferon in chronic hepatitis B GWAS:4112 Response to pegylated interferon in HBeAg-negative hepatitis B GWAS:4113 Response to pegylated interferon in HBeAG-positive hepatitis B GWAS:4114 Response to placebo treatment in childhood asthma FVC change GWAS:4115 Retinal arteriolar tortuosity GWAS:4116 Retinal arteriole-to-venule ratio GWAS:4117 Retinal venular tortuosity GWAS:4118 Right planum temporale grey matter volume GWAS:4119 Rostral anterior cingulate cortex volume GWAS:4120 Rostral middle frontal gyrus volume GWAS:4121 Schizophrenia or schizoaffective disorder GWAS:4122 Sensorimotor dexterity GWAS:4123 Serum alpha-fetoprotein levels GWAS:4124 Serum cancer antigen 125 levels GWAS:4125 Serum cancer antigen 153 levels GWAS:4126 Serum cancer antigen 199 levels GWAS:4127 Serum carcinoembryonic antigen levels GWAS:4128 Serum metabolite levels CMS GWAS:4129 Serum oxytocin levels GWAS:4130 Serum sclerostin levels GWAS:4131 Severe aplastic anemia GWAS:4132 Severe bacterial meningitis GWAS:4133 Skin aging measurement GWAS:4134 Smoking behaviour age at first cigarette GWAS:4135 Smoking behaviour cigarette pack-years GWAS:4136 Spatial memory GWAS:4137 Spatial processing GWAS:4138 Sphingomyelin 240 levels GWAS:4139 Sphingomyelin levels GWAS:4140 Strabismus GWAS:4141 Stress-related phenotypes multivariate analysis GWAS:4142 Sub-cortical grey matter volume GWAS:4143 Subjective response to placebo treatment in childhood asthma change in cough wheeze GWAS:4144 Subpleural-predominant interstitial lung abnormalities GWAS:4145 Subscapular skin fold thickness GWAS:4146 Superior frontal gyrus volume GWAS:4147 Superior parietal cortex volume GWAS:4148 Superior temporal gyrus volume GWAS:4149 Superior temporal sulcus banks volume GWAS:4150 Supramarginal gyrus volume GWAS:4151 Systemising GWAS:4152 Systolic blood pressure response to thiazide and thiazide-like diuretics in hypertension GWAS:4153 Temporal pole volume GWAS:4154 Tendinopathy GWAS:4155 Thalamus volume GWAS:4156 Thiopurine-induced myelosuppression in inflammatory bowel disease GWAS:4157 Third ventricle volume GWAS:4158 Thoracic aortic calcification levels GWAS:4159 Total grey matter volume GWAS:4160 Total intracranial volume GWAS:4161 Transverse temporal cortex volume GWAS:4162 Trastuzumab-induced cardiotoxicity in cancer GWAS:4163 Triacylglyceride levels GWAS:4164 Triacylglycerol 562 levels GWAS:4165 Triacylglycerol 566 levels GWAS:4166 Triglyceride levels x long total sleep time interaction 1df test GWAS:4167 Triglyceride levels x long total sleep time interaction 2df test GWAS:4168 Triglyceride levels x loop diuretics use interaction GWAS:4169 Triglyceride levels x short total sleep time interaction 1df test GWAS:4170 Triglyceride levels x short total sleep time interaction 2df test GWAS:4171 Triglyceride levels x thiazide or thiazide-like diuretics use interaction GWAS:4172 T wave morphology restitution during exercise GWAS:4173 T wave morphology restitution during exercise MTAG GWAS:4174 T wave morphology restitution during recovery from exercise GWAS:4175 T wave morphology restitution during recovery from exercise MTAG GWAS:4176 Tyrosine levels GWAS:4177 Uric acid elevation in response to thiazide-like diuretic in hypertension GWAS:4178 Uridine levels GWAS:4179 Urinary calcium excretion GWAS:4180 Urinary magnesium excretion GWAS:4181 Urinary metabolite levels in chronic kidney disease GWAS:4182 Urinary metabolite modules eigenmetabolites in chronic kidney disease GWAS:4183 Urinary uric acid excretion GWAS:4184 Uterine fibroids and heavy menstrual bleeding GWAS:4185 Uveal melanoma TNM stage 1 or 2 GWAS:4186 Uveal melanoma TNM stage 3 or 4 GWAS:4187 Uveal melanoma with any chromosomal aberration GWAS:4188 Uveal melanoma with chromosome 3 loss GWAS:4189 Uveal melanoma with epithelioid cells GWAS:4190 vascular endothelial growth factor D levels GWAS:4191 Ventral diencephalon volume GWAS:4192 Verbal cognitive ability GWAS:4193 Vertical cup-disc ratio adjusted for vertical disc diameter GWAS:4194 Vertical cup-disc ratio multi-trait analysis GWAS:4195 Vitamin levels GWAS:4196 Voxel-wise structural brain imaging measurements in Alzheimer's disease GWAS:4197 Waist circumference variance GWAS:4198 Waist-hip ratio variance GWAS:4199 White coat effect clinic diastolic blood pressure minus ambulatory diastolic blood pressure GWAS:4200 White coat effect clinic systolic blood pressure minus ambulatory systolic blood pressure GWAS:4201 White matter microstructure axial diusivities GWAS:4202 White matter microstructure fractional anisotropy GWAS:4203 White matter microstructure mean diusivities GWAS:4204 White matter microstructure mode of anisotropy GWAS:4205 White matter microstructure radial diusivities GWAS:4206 Whole brain grey matter density GWAS:4207 Xanthine levels GWAS:4208 Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis GWAS:4209 Adult onset asthma and or BMI GWAS:4210 Adult onset asthma and or waist-to-hip ratio adjusted for BMI GWAS:4211 Adult onset asthma or fasting glucose levels GWAS:4212 Adult onset asthma or type 2 diabetes GWAS:4213 Adverse response to inhaled corticosteroid treatment x age interaction in asthma GWAS:4214 Anxiety GWAS:4215 Atopic asthma GWAS:4216 Autoimmune traits pleiotropy GWAS:4217 Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis GWAS:4218 Cataracts operation GWAS:4220 Childhood maltreatment GWAS:4221 Chronic postoperative pain GWAS:4222 Clozapine-induced myocarditis in schizophrenia GWAS:4223 Compulsion score in obsessive compulsive disorder GWAS:4224 Cotinine and 3'-hydroxycotinine levels in current smokers GWAS:4225 Cotinine levels in current smokers GWAS:4226 Creatine kinase levels in off-statin users GWAS:4227 Creatine kinase levels in statin users GWAS:4228 Creativity GWAS:4229 Cryptosporidiosis GWAS:4232 Extranodal natural killer T-cell lymphoma nasal type GWAS:4233 Fecal incontinence GWAS:4234 Follicle stimulating hormone levels GWAS:4235 Follicle stimulating hormone levels in polycystic ovary syndrome GWAS:4236 Frequency of relapse in mepolizumab-treated eosinophilic granulomatosis with polyangiitis GWAS:4237 Gastrointestinal infection GWAS:4238 Green tea consumption GWAS:4239 Gynecologic disease GWAS:4240 Gynecologic disease multivariate analysis GWAS:4241 Hallux valgus GWAS:4242 HDL cholesterol change in response to niacin in statin-treated individuals GWAS:4243 Head and neck squamous cell carcinoma GWAS:4244 Help-seeking from a GP GWAS:4245 Help-seeking from a GP without major depressive disorder symptoms GWAS:4246 Help-seeking from a psychiatrist GWAS:4247 High myopia GWAS:4248 Insulin-related traits multivariate analysis GWAS:4249 Lactate dehydrogenase levels in off-statin users GWAS:4250 Lactate dehydrogenase levels in statin users GWAS:4251 Lean mass index GWAS:4252 Left ventricular mass x antihypertensive treatment interaction GWAS:4253 Lung function GWAS:4254 Major depressive disorder in trauma exposed individuals GWAS:4255 Major depressive disorder in trauma-unexposed individuals GWAS:4256 Major depressive disorder lifetime GWAS:4257 Milk consumption GWAS:4258 Natto consumption GWAS:4259 Nicotine metabolite ratio in current smokers GWAS:4260 Nonatopic asthma GWAS:4261 Nonatopic asthma and or BMI GWAS:4262 Nonatopic asthma and or waist-to-hip ratio adjusted for BMI GWAS:4263 Nonatopic asthma or fasting glucose levels GWAS:4264 Nonatopic asthma or type 2 diabetes GWAS:4265 Obsession score in obsessive compulsive disorder GWAS:4266 Obsessive compulsive disorder severity GWAS:4267 Ocular sarcoidosis GWAS:4268 Ocular sarcoidosis in sarcoidosis GWAS:4269 Opioid exposure GWAS:4270 Opioid use cessation GWAS:4271 Opioid use disorder GWAS:4272 Osteoporosis-related phenotypes MTAG GWAS:4274 Physiological traits GWAS:4275 Reading disability GWAS:4276 Relative wall thickness x antihypertensive treatment interaction GWAS:4277 Response to statins LDL cholesterol percent change GWAS:4278 Retinal detachment GWAS:4279 Retinal detachment or retinal break GWAS:4280 Retinal detachment with retinal break GWAS:4281 Salivary metabolite levels GWAS:4282 Schizophrenia MTAG GWAS:4283 Small whole fish consumption GWAS:4284 Smoking intensity cotinine levels cigarettes per day GWAS:4285 Soluble gp130 levels GWAS:4286 Sphingolipid d181 d182 ratio GWAS:4287 Stress urinary incontinence GWAS:4288 Suicidal or self-harm ideation GWAS:4289 Thyroid autoantibody positivity anti-thyroglobulin TgAb and or anti-thyroid peroxidase TPOAb levels GWAS:4290 Thyroid volume in Hashimoto's thyroiditis GWAS:4291 Tofu consumption GWAS:4292 Trauma exposure GWAS:4293 Trauma exposure in major depressive disorder GWAS:4294 Trauma exposure in major depressive disorder-negative individuals GWAS:4296 Visceral fat, circulating phospholipid PC160 20 and white matter microstructure shared variance GWAS:4297 Weight gain in amisulpride-treated first-episode psychosis GWAS:4299 Acute cholecystitis GWAS:4300 Adult onset Still's disease GWAS:4301 Aseptic loosening in total joint arthroplasty GWAS:4302 Beef consumption GWAS:4303 Brain imaging measurements variance GWAS:4304 Buruli ulcer GWAS:4305 Buruli ulcer age at onset GWAS:4306 Cardioembolic stroke CCS and TOAST classification GWAS:4307 Cardioembolic stroke CCSc classification GWAS:4308 Cardioembolic stroke CCS or TOAST classification GWAS:4309 Cardioembolic stroke CCSp classification GWAS:4310 Cardioembolic stroke TOAST classification GWAS:4311 Carotid intima media thickness x smoking interaction GWAS:4312 Ceramide levels C220 GWAS:4313 Ceramide levels C240 GWAS:4314 Cerebrospinal fluid immune biomarker levels GWAS:4315 Cervical cancer MTAG GWAS:4316 Conjunctival UV autofluorescence CUVAF GWAS:4317 Cooked vegetable consumption GWAS:4318 Crohn's disease or systemic sclerosis GWAS:4319 Driving hours per day GWAS:4320 Endometrial cancer MTAG GWAS:4321 Endometriosis MTAG GWAS:4322 Endometriosis or migraine GWAS:4323 Fish- and plant-related diet GWAS:4324 Fruit consumption GWAS:4325 Idiopathic downbeat nystagmus GWAS:4326 Invasive breast cancer GWAS:4327 Lamb consumption GWAS:4328 Large artery stroke CCS and TOAST classification GWAS:4329 Large artery stroke CCS or TOAST classification GWAS:4330 Large artery stroke CCSp classificationj GWAS:4331 Large artery stroke TOAST classification GWAS:4332 Left ventricular end-diastolic volume GWAS:4333 Left ventricular end-systolic volume GWAS:4334 Leisure sedentary behaviour computer use GWAS:4335 Leisure sedentary behaviour television watching GWAS:4336 Meat-related diet GWAS:4337 Midgestational total 25-hydroxyvitamin D levels fetal genetic effect GWAS:4338 Midgestational total 25-hydroxyvitamin D levels maternal genetic effect GWAS:4339 Neck pain or shoulder pain GWAS:4340 Neonatal total 25-hydroxyvitamin D levels fetal genetic effect GWAS:4341 Neonatal total 25-hydroxyvitamin D levels maternal genetic effect GWAS:4342 Neuroblastoma or malignant cutaneous melanoma GWAS:4343 Non-oily fish consumption GWAS:4344 Oily fish consumption GWAS:4345 Ovarian cancer MTAG GWAS:4346 Pork consumption GWAS:4347 Poultry consumption GWAS:4348 Processed meat consumption GWAS:4349 Protein level change in low calorie diet obesity intervention GWAS:4350 Protein levels in obesity GWAS:4351 Raw vegetable consumption GWAS:4352 Sensitivity to environmental stress and adversity GWAS:4353 Serum immune biomarker levels GWAS:4354 Severe COVID-19 infection with respiratory failure analysis I GWAS:4355 Severe COVID-19 infection with respiratory failure analysis II GWAS:4356 Small vessel stroke CCS and TOAST classification GWAS:4357 Small vessel stroke CCS or TOAST classification GWAS:4358 Small vessel stroke CCSp classification GWAS:4359 Spontaneous adipocyte lipolysis GWAS:4360 Stimulated adipocyte lipolysis GWAS:4361 Sudden cardiac arrest in coronary artery disease GWAS:4362 Time to aseptic loosening in total joint arthroplasty GWAS:4363 Urinary volume GWAS:4364 Uterine fibroids MTAG GWAS:4365 White matter hyperintensities GWAS:4366 Acute ischemic stroke x type 2 diabetes interaction GWAS:4367 Acute respiratory distress syndrome in sepsis GWAS:4368 Adenosine Deaminase levels GWAS:4369 Adherence to a Japanese dietary pattern GWAS:4370 Adipose morphology GWAS:4371 Adrenomedullin levels GWAS:4372 Adult body size GWAS:4373 Adult diffuse glioma IDH mutation, 1p 19q codeletion GWAS:4374 Adult diffuse glioma IDH mutation, 1p 19q non-codeleted GWAS:4375 Adult diffuse glioma IDH mutation GWAS:4376 Adult diffuse glioma IDH mutation only GWAS:4377 Adult diffuse glioma IDH wildtype GWAS:4378 Adult diffuse glioma TERT mutation only GWAS:4379 Adult diffuse triple positive glioma IDH and TERT mutations, 1p19q codeletion GWAS:4380 Age-related hearing impairment MTAG GWAS:4381 Age-related macular degeneration MTAG GWAS:4382 Aging traits healthspan, parental lifespan or longevity multivariate analysis GWAS:4383 Agouti-related protein levels GWAS:4384 Alanine transaminase levels in high alcohol intake GWAS:4385 Allergic disease asthma, hay fever and or eczema age of onset GWAS:4386 Allergic disease asthma, hay fever and or eczema multivariate analysis GWAS:4387 Allergic march atopic dermatitis to allergic rhinitis GWAS:4388 Allergic march atopic dermatitis to asthma GWAS:4389 Alpha electroencephalogram power GWAS:4390 Ambidextrousness GWAS:4391 Angioedema in response to angiotensin-converting enzyme inhibitor and or angiotensin receptor blocker GWAS:4392 Angiopoietin-1 receptor levels GWAS:4393 Anorectal malformation GWAS:4394 Anthracycline-induced cardiotoxicity in early breast cancer GWAS:4395 Anti-chlamydia trachomatis IgG seropositivity GWAS:4396 Anti-drug antibodies in autoimmune disease time to event GWAS:4397 Anti-Epstein-Barr virus IgG seropositivity GWAS:4398 Anti-herpes simplex virus 2 IgG seropositivity GWAS:4399 Anti-herpes simplex virus 6 IE1A IgG seropositivity GWAS:4400 Anti-Merkel cell polyomavirus IgG seropositivity GWAS:4401 Anti-polyomavirus 2 IgG seropositivity GWAS:4402 Anti-varicella zoster virus IgG seropositivity GWAS:4403 Apolipoprotein B levels GWAS:4404 Arterial stiffness brachial-ankle pulse wave velocity GWAS:4405 Arterial stiffness brachial-femoral pulse wave velocity GWAS:4406 Arterial stiffness carotid-femoral pulse wave velocity GWAS:4407 Aspartate aminotransferase platelet ratio index in high alcohol intake GWAS:4408 Aspartate transaminase levels in high alcohol intake GWAS:4409 Asthma time to event GWAS:4410 Attention deficit hyperactivity disorder childhood GWAS:4411 Attention deficit hyperactivity disorder MTAG GWAS:4412 Attention deficit hyperactivity disorder persistent GWAS:4413 Autism spectrum disorder MTAG GWAS:4414 Autism spectrum disorders peer interaction GWAS:4415 Autism spectrum disorders repetitive sensory-motor behaviour GWAS:4416 Autism spectrum disorders social interaction GWAS:4417 Autoimmune disease and mental disorder GWAS:4418 Autoimmune thyroid disease GWAS:4419 Basophil count GWAS:4420 Benign childhood epilepsy with centro-temporal spikes GWAS:4421 Beta 1 electroencephalogram power GWAS:4422 Beta 2 electroencephalogram power GWAS:4423 Beta blocker survival benefit in heart failure with reduced ejection fraction time to all cause mortality x beta blocker interaction GWAS:4424 Bioavailable testosterone levels GWAS:4425 Bipolar disorder MTAG GWAS:4426 BK polyomavirus VP1 antibody levels GWAS:4427 Body size at age 10 GWAS:4428 Bone mineral density hip and hip bone size GWAS:4429 Brain amyloid deposition PET imaging GWAS:4430 Brain morphology min-P GWAS:4431 Brain morphology MOSTest GWAS:4432 Breast cancer, ovarian cancer or prostate cancer pleiotropy GWAS:4433 Breast cancer somatic mutation signature APOBEC C>G GWAS:4434 Breast cancer somatic mutation signature APOBEC C>T GWAS:4435 Breslow thickness in cutaneous melanoma GWAS:4436 Caffeine consumption from coffee GWAS:4437 Caffeine consumption from coffee or tea GWAS:4438 Caffeine consumption from tea GWAS:4439 Cancer pleiotropybidirectional GWAS:4440 Cardiac dysrhythmias time to event GWAS:4441 Cardiorespiratory fitness 800m run time GWAS:4442 Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment GWAS:4443 Cardiovascular death or myocardial infarction in response to clopidogrel treatment GWAS:4444 Carotid plaque maximum area GWAS:4445 Caspase 8 levels GWAS:4446 Cataract time to event GWAS:4447 Cathepsin D levels GWAS:4448 Cathepsin L1 levels GWAS:4449 CCL23 levels GWAS:4450 CCL25 levels GWAS:4451 C-C motif chemokine 20 levels GWAS:4452 C-C motif chemokine 3 levels GWAS:4453 C-C motif chemokine 4 levels GWAS:4454 CD40 levels GWAS:4455 CD6 levels GWAS:4456 CDH6 protein levels in plasma GWAS:4457 Childhood ALL LBL acute lymphoblastic leukemia lymphoblastic lymphoma treatment-related venous thromboembolism GWAS:4458 Chitinase-3-like protein 1 levels GWAS:4459 Chlamydia trachomatis PorB antibody levels GWAS:4460 Chronic kidney disease x type 2 diabetes interaction GWAS:4461 Chronotype sMEQ score GWAS:4462 Circulating fibroblast growth factor 21 levels GWAS:4463 Circulating leptin levels or fasting insulin levels GWAS:4464 Circulating leptin levels or HOMA-B GWAS:4465 Circulating leptin levels or HOMA-IR GWAS:4466 Circulating leptin levels or type 2 diabetes GWAS:4467 Clozapine concentration in schizophrenia GWAS:4468 Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia GWAS:4469 Cognitive aspects of educational attainment GWAS:4470 Cognitive decline in depression GWAS:4471 Cognitive function in depression GWAS:4472 Cognitive impairment in depression GWAS:4473 Colorectal cancer x BMI interaction 2df GWAS:4474 Colorectal cancer x fine particulate matter exposure levels interaction GWAS:4475 Complement factor H binding to malondialdehyde GWAS:4476 Coronary atherosclerosis time to event GWAS:4477 Coronary heart disease x type 2 diabetes interaction GWAS:4478 Cortical surface area GWAS:4479 Cortical surface area global PC1 GWAS:4480 Cortical surface area min-P GWAS:4481 Cortical surface area MOSTest GWAS:4482 Cortical surface area visual PC2 GWAS:4483 Cortical thickness min-P GWAS:4484 Cortical thickness MOSTest GWAS:4485 COVID-19 critical illness vs population GWAS:4486 Cutaneous melanoma or hair colour GWAS:4487 CV-A6-associated hand, foot, and mouth disease severe vs mild GWAS:4488 CX3CL1 levels GWAS:4489 CXCL6 levels GWAS:4490 C-X-C motif chemokine 16 levels GWAS:4491 C-X-C motif chemokine 1 levels GWAS:4492 C-X-C motif chemokine 6 levels GWAS:4493 Cystatin-B levels GWAS:4494 Cytomegalovirus pp28 antibody levels GWAS:4495 Deep white matter hyperintensities GWAS:4496 Delta electroencephalogram power GWAS:4497 Depression x herpes simplex 1 infection interaction GWAS:4498 Depressive symptoms x herpes simplex 1 infection interaction GWAS:4499 Diastolic blood pressure x dichotomous lifestyle risk score interaction 1df test GWAS:4500 Diastolic blood pressure x dichotomous lifestyle risk score interaction 2df test GWAS:4501 Diastolic blood pressure x educational attainment graduated college interaction 2df GWAS:4502 Diastolic blood pressure x educational attainment some college interaction 2df GWAS:4503 Diastolic blood pressure x quantitative lifestyle risk score interaction 1df test GWAS:4504 Diastolic blood pressure x quantitative lifestyle risk score interaction 2df test GWAS:4505 Dickkopf-related protein 1 levels GWAS:4506 Diffuse plaques GWAS:4507 Disease free survival in colon cancer GWAS:4508 Early age-related macular degeneration GWAS:4509 Early-onset ischemic stroke GWAS:4510 Electrocardiogram morphology amplitude at temporal datapoints GWAS:4511 Endometriosis or depression pleiotropy GWAS:4512 Endothelial cell-specific molecule 1 levels GWAS:4513 Eosinophil cationic protein levels GWAS:4514 Epidermal growth factor levels GWAS:4515 Epstein-Barr virus EA-D antibody levels GWAS:4516 Epstein-Barr virus EBNA-1 antibody levels GWAS:4517 Epstein-Barr virus VCA p18 antibody levels GWAS:4518 Epstein-Barr virus ZEBRA antibody levels GWAS:4519 Esophageal or stomach cancer GWAS:4520 Essential hypertension time to event GWAS:4521 Evening vs morning chronotype self-assessed GWAS:4522 Evening vs morning chronotype sMEQ score GWAS:4523 Executive function trail making test B GWAS:4524 Externalizing behaviour score GWAS:4525 Facial pigmentation measurement polar light GWAS:4526 Facial pigmentation measurement UV light GWAS:4527 Falling risk GWAS:4528 Fasting triglyceride levels GWAS:4529 Fatty acid-binding protein, adipocyte levels GWAS:4530 Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass GWAS:4531 Fibroblast growth factor 23 levels GWAS:4532 Fibroblast growth factor 5 levels GWAS:4533 Fibrosis-4 index in high alcohol intake GWAS:4534 First fracture in long-term childhood cancer survivors time to event GWAS:4535 First year height change in growth hormone-treated short stature GWAS:4536 Follicle stimulating hormone in healthy women GWAS:4537 Follistatin levels GWAS:4538 Forns index in high alcohol intake GWAS:4539 Fractures paediatric GWAS:4540 Galanin peptide levels GWAS:4541 Galectin-3 levels GWAS:4542 Gestational insulin sensitivity GWAS:4543 Glucagon levels in response to oral glucose tolerance test 30 minutes GWAS:4544 Glucagon levels in response to oral glucose tolerance test decremental area under the curve for 0-120 minutes GWAS:4545 Glucagon levels in response to oral glucose tolerance test decremental area under the curve for 0-30 minutes GWAS:4546 Glycosuria in pregnancy maternal and offspring genotype effect GWAS:4547 Glycosuria in pregnancy maternal genotype effect GWAS:4548 Glycosuria in pregnancy offspring genotype effect GWAS:4549 Gout combined type GWAS:4550 Gout normal type GWAS:4551 Graft survival time in renal transplantation donor effect GWAS:4552 Graft survival time in renal transplantation donor effect x APOL1 genotype interaction GWAS:4553 Gut microbiota alpha diversity Chao1 index GWAS:4554 Gut microbiota alpha diversity PD whole tree index GWAS:4555 Gut microbiota alpha diversity Shannon index GWAS:4556 Gut microbiota bacterial taxa, hurdle binary method GWAS:4557 Gut microbiota bacterial taxa, rank normal transformation method GWAS:4558 Gut microbiota beta diversity weighted UniFrac distance GWAS:4559 Gut microbiota relative abundance Bacteroides GWAS:4560 Gut microbiota relative abundance Bifidobacterium GWAS:4561 Gut microbiota relative abundance Blautia GWAS:4562 Gut microbiota relative abundance Coprococcus GWAS:4563 Gut microbiota relative abundance Dorea GWAS:4564 Gut microbiota relative abundance Eubacterium belonging to family Erysipelotrichaceae GWAS:4565 Gut microbiota relative abundance Faecalibacterium GWAS:4566 Gut microbiota relative abundance Oscillospira GWAS:4567 Gut microbiota relative abundance Parabacteroides GWAS:4568 Gut microbiota relative abundance Prevotella GWAS:4569 Gut microbiota relative abundance Ruminococcus belonging to family Erysipelotrichaceae GWAS:4570 Gut microbiota relative abundance Ruminococcus belonging to family Lachnospiraceae GWAS:4571 Gut microbiota relative abundance Streptococcus GWAS:4572 Gut microbiota relative abundance Sutterella GWAS:4573 Gut microbiota relative abundance unassigned genus belonging to family Clostridiales GWAS:4574 Gut microbiota relative abundance unassigned genus belonging to family Lachnospiraceae GWAS:4575 Gut microbiota relative abundance unclassified genus belonging to family Clostridiaceae GWAS:4576 Gut microbiota relative abundance unclassified genus belonging to family Erysipelotrichaceae GWAS:4577 Gut microbiota relative abundance unclassified genus belonging to family Lachnospiraceae GWAS:4578 Gut microbiota relative abundance unclassified genus belonging to family Ruminococcaceae GWAS:4579 Gut microbiota relative abundance unclassified genus belonging to the order Clostridiales GWAS:4580 Hand grip strength Mahalanobis distance GWAS:4581 Heat shock 27 kDa protein levels GWAS:4582 Helicobacter pylori OMP antibody levels GWAS:4583 Helicobacter pylori UREA antibody levels GWAS:4584 Herpes simplex virus 2 mgG-1 antibody levels GWAS:4585 Herpes simplex virus 6 IE1B antibody levels GWAS:4586 Herpes simplex virus 7 U14 antibody levels GWAS:4587 Hip bone mineral content accrual during adolescent growth spurt GWAS:4588 Hip bone mineral density and total body fat mass bivariate analysis GWAS:4589 HOMA-B corrected for HOMA-IR GWAS:4590 Hyperlipidemia time to event GWAS:4591 Hypo-HDL-cholesterolemia GWAS:4592 Hypopharyngeal or laryngeal cancer GWAS:4593 Hypotension and cognitive impairment GWAS:4594 Inflammatory biomarkers multivariate analysis GWAS:4595 Inhibin B levels GWAS:4596 Interleukin-10 receptor B levels GWAS:4597 Interleukin-12 subunit B levels GWAS:4598 interleukin 15 receptor subunit alpha levels GWAS:4599 interleukin-18 receptor 1 levels GWAS:4600 Interleukin-27 levels GWAS:4601 Kallikrein-6 levels GWAS:4602 Kidney cancer GWAS:4603 Kidney injury molecule 1 levels GWAS:4604 Lean nonalcoholic fatty liver disease GWAS:4605 Lectin-like oxidized LDL receptor 1 levels GWAS:4606 Left-handedness GWAS:4607 Leukoderma in response to rhododendrol GWAS:4608 Levodopa-induced dyskinesia in levodopa treated Parkinson's disease GWAS:4609 Levodopa wearing off effect motor symptom score change in Parkinson's disease response to zonisamide GWAS:4610 Levodopa wearing off effect time symptoms uncontrolled in Parkinson's disease response to zonisamide GWAS:4611 Liver fat content MRI proton density fat fraction measure GWAS:4612 Liver fibrogenesis alpha smooth muscle actin levels GWAS:4613 Liver fibrosis and steatohepatitis severity MRI cT1 measure GWAS:4614 Liver fibrosis total hepatic collagen content GWAS:4615 Long QT syndrome GWAS:4616 Low density lipoprotein cholesterol levels on statin treatment GWAS:4617 Low hand grip strength 60 years and older EWGSOP GWAS:4618 Low hand grip strength 60 years and older FNIH GWAS:4619 Luteinizing hormone levels in healthy women GWAS:4620 Lymphocytic leukemia GWAS:4621 Machado-Joseph disease age at onset GWAS:4622 Macrophage colony-stimulating factor 1 levels GWAS:4623 Macroscopic brain infarct GWAS:4624 Male puberty timing age at voice breaking MTAG GWAS:4625 Male puberty timing early vs average onset facial hair GWAS:4626 Male puberty timing early vs average onset voice breaking GWAS:4627 Male puberty timing late vs average onset facial hair GWAS:4628 Male puberty timing late vs average onset voice breaking GWAS:4629 Matrix metalloproteinase-10 levels GWAS:4630 Matrix metalloproteinase-12 levels GWAS:4631 Matrix metalloproteinase-1 levels GWAS:4632 Matrix metalloproteinase-3 levels GWAS:4633 Matrix metalloproteinase-7 levels GWAS:4634 Maximum stenosis GWAS:4635 Mean area of carotid plaque GWAS:4636 Mean arterial pressure x educational attainment graduated college interaction 2df GWAS:4637 Mean arterial pressure x educational attainment some college interaction 2df GWAS:4638 Mean degree of stenosis GWAS:4639 Mean reticulocyte volume GWAS:4640 Mean spheric corpuscular volume GWAS:4641 Medial temporal lobe substructure volumes GWAS:4642 Melusin levels GWAS:4643 Membrane-bound aminopeptidase P levels GWAS:4644 Memory decline GWAS:4645 Mental disorder without autoimmune disease GWAS:4646 Merkel cell polyomavirus VP1 antibody levels GWAS:4647 Metamizole-induced agranulocytosis GWAS:4648 Metamizole-induced agranulocytosis or neutropenia GWAS:4649 Metopic nonsyndromic craniosynostosis GWAS:4650 Microscopic brain infarct GWAS:4651 Midline nonsyndromic craniosynostosis GWAS:4652 Migraine and or diastolic blood pressure GWAS:4653 Migraine and or pulse pressure GWAS:4654 Migraine and or systolic blood pressure GWAS:4655 Migraine with aura and or diastolic blood pressure GWAS:4656 Migraine with aura and or pulse pressure GWAS:4657 Migraine with aura and or systolic blood pressure GWAS:4658 Migraine without aura and or diastolic blood pressure GWAS:4659 Migraine without aura and or pulse pressure GWAS:4660 Migraine without aura and or systolic blood pressure GWAS:4661 Monocyte chemoattractant protein-4 levels GWAS:4662 Motor fluctuations in levodopa treated Parkinson's disease GWAS:4663 Myeloid clonal hematopoiesis GWAS:4664 Myeloperoxidase levels GWAS:4665 Myocardial fractal dimension slice 2 GWAS:4666 Myocardial fractal dimension slice 3 GWAS:4667 Myocardial fractal dimension slice 4 GWAS:4668 Myocardial fractal dimension slice 5 GWAS:4669 Myocardial fractal dimension slice 6 GWAS:4670 Myocardial fractal dimension slice 7 GWAS:4671 Myocardial fractal dimension slice 8 GWAS:4672 Myocardial fractal dimension slice 9 GWAS:4673 Myoglobin levels GWAS:4674 N-desmethylclozapine concentration in schizophrenia GWAS:4675 Neuroblastoma pediatric GWAS:4676 Neuropathologic traits pleiotropy GWAS:4677 Neuropathy x type 2 diabetes interaction GWAS:4678 Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease GWAS:4679 Nonalcoholic steatohepatitis GWAS:4680 Noncognitive aspects of educational attainment GWAS:4681 Non-Hodgkin's lymphoma GWAS:4682 Non-tuberculous mycobacterial pulmonary disease GWAS:4683 N-terminal prohormone brain natriuretic peptide levels GWAS:4684 Osteoarthrosis time to event GWAS:4685 Ovarian cancer-related tumor marker CA 125 levels GWAS:4686 Pappalysin-1 levels GWAS:4687 Parent of origin effect on receptive language ability maternal GWAS:4688 Parent of origin effect on receptive language ability paternal GWAS:4689 Parkinson's disease progression cognitive GWAS:4690 Parkinson's disease progression composite GWAS:4691 Parkinson's disease progression motor GWAS:4692 Peak hip bone mineral content GWAS:4693 Pentraxin-related protein PTX3 levels GWAS:4694 Percent liver fat GWAS:4695 Peripheral arterial disease x type 2 diabetes interaction GWAS:4696 Periventricular white matter hyperintensities GWAS:4697 Physical aggression in schizophrenia GWAS:4698 Physiological dysregulation Mahalanobis distance GWAS:4699 Placenta growth factor levels GWAS:4700 Platelet-derived growth factor subunit B levels GWAS:4701 Platelet endothelial cell adhesion molecule levels GWAS:4702 Platelet reactivity in response to clopidogrel treatment GWAS:4703 Polycystic ovary syndrome indeterminate subtype GWAS:4704 Polycystic ovary syndrome metabolic subtype GWAS:4705 Polycystic ovary syndrome reproductive subtype GWAS:4706 Polyomavirus 2 JC VP1 antibody levels GWAS:4707 Postprandial triglyceride levels GWAS:4708 Postprandial triglyceride response GWAS:4709 Preeclampsia fetal genotype effect GWAS:4710 Preeclampsia maternal genotype effect GWAS:4711 Problematic alcohol use GWAS:4712 Problematic alcohol use MTAG GWAS:4713 Proheparin-binding EGF-like growth factor levels GWAS:4714 Pro-interleukin-16 levels GWAS:4715 Proportion of activated microglia inferior temporal cortex GWAS:4716 Proportion of activated microglia midfrontal cortex GWAS:4717 Proteinase-activated receptor 1 levels GWAS:4718 P-selectin glycoprotein ligand 1 levels GWAS:4719 Pulse pressure x educational attainment some college interaction 2df GWAS:4720 QT dynamics during exercise GWAS:4721 QT dynamics during recovery from exercise GWAS:4722 Rate of cognitive decline in Alzheimer's disease GWAS:4723 Receptive language ability GWAS:4724 Receptor for advanced glycosylation end products levels GWAS:4725 Rectal cancer GWAS:4726 Recurrence of Clostridium difficile infection x bezlotuxumab treatment interaction 2df test GWAS:4727 Relative carbohydrate intake GWAS:4728 Relative fat intake GWAS:4729 Relative protein intake GWAS:4730 Relative sugar intake GWAS:4731 Renin levels GWAS:4732 Response to antiepileptic drugs in genetic generalized epilepsy GWAS:4733 Response to antiepileptic mood-stabilizing treatment in bipolar disorder GWAS:4734 Response to lamotrigine and valproic acid in genetic generalized epilepsy GWAS:4735 Response to lamotrigine in genetic generalized epilepsy GWAS:4736 Response to levetiracetam in genetic generalized epilepsy GWAS:4737 Response to radiotherapy in nasopharyngeal carcinoma acute oral mucositis GWAS:4738 Response to valproic acid in genetic generalized epilepsy GWAS:4739 Retinopathy x type 2 diabetes interaction GWAS:4740 Self-harm ideation GWAS:4741 Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer GWAS:4742 Serum 25-Hydroxyvitamin D levels x season interaction GWAS:4743 Serum 25-Hydroxyvitamin D level variance GWAS:4744 Serum docosahexaenoic fatty acid concentration in metabolic syndrome GWAS:4745 Serum linoleic acid concentration in metabolic syndrome GWAS:4746 Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome GWAS:4747 Serum omega-6 polyunsaturated fatty acid concentration in metabolic syndrome GWAS:4748 Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome GWAS:4749 Serum polyunsaturated fatty acid concentration x Mediterranean diet adherence interaction in metabolic syndrome GWAS:4750 Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome GWAS:4751 Serum total polyunsaturated fatty acid concentration in metabolic syndrome GWAS:4752 Sex hormone-binding globulin levels adjusted for BMI GWAS:4753 Shoulder impingement syndrome GWAS:4754 SIR2-like protein 2 levels GWAS:4755 Spondin-1 levels GWAS:4756 Spontaneous coronary artery dissection GWAS:4757 ST2 protein levels GWAS:4758 Stent thrombosis in response to clopidogrel treatment GWAS:4759 Subcortical volume min-P GWAS:4760 Subcortical volume MOSTest GWAS:4761 Sum of carotid plaque area GWAS:4762 Sum of stenosis GWAS:4763 Sweet taste preference GWAS:4764 Systolic blood pressure x dichotomous lifestyle risk score interaction 1df test GWAS:4765 Systolic blood pressure x dichotomous lifestyle risk score interaction 2df test GWAS:4766 Systolic blood pressure x educational attainment graduated college interaction 2df GWAS:4767 Systolic blood pressure x educational attainment some college interaction 2df GWAS:4768 Systolic blood pressure x quantitative lifestyle risk score interaction 1df test GWAS:4769 Systolic blood pressure x quantitative lifestyle risk score interaction 2df test GWAS:4770 Tafenoquine efficacy in P vivax malaria recurrence by 4 months GWAS:4771 Tafenoquine efficacy in P vivax malaria recurrence by 6 months GWAS:4772 T-Cell Immunoglobulin and Mucin domain 1 levels GWAS:4773 Theta EEG coherence GWAS:4774 Theta electroencephalogram power GWAS:4775 Thrombin-induced platelet aggregation GWAS:4776 Thrombomodulin levels GWAS:4777 Tissue factor levels GWAS:4778 Tissue-type plasminogen activator levels GWAS:4779 TNF-related activation-induced cytokine levels GWAS:4780 TNF-related apoptosis-inducing ligand levels GWAS:4781 TNF-related apoptosis-inducing ligand receptor 2 levels GWAS:4782 Total testosterone levels GWAS:4783 Toxoplasma gondii sag1 antibody levels GWAS:4784 TPE interval recovery after exercise GWAS:4785 TPE interval response to exercise GWAS:4786 TPE interval resting GWAS:4787 Tumor necrosis factor levels GWAS:4788 Tumor necrosis factor ligand superfamily member 12 levels GWAS:4789 Tumor necrosis factor ligand superfamily member 14 levels GWAS:4790 Tumor necrosis factor receptor 1 levels GWAS:4791 Tumor necrosis factor receptor 2 levels GWAS:4792 Tumor necrosis factor receptor superfamily member 5 levels GWAS:4793 Tumor necrosis factor receptor superfamily member 6 levels GWAS:4794 Type 2 diabetes time to event GWAS:4795 Ultradistal forearm bone mineral density GWAS:4796 Urine 6-bromotryptophan levels in chronic kidney disease GWAS:4797 Urokinase plasminogen activator surface receptor levels GWAS:4798 Varicella zoster virus glycoproteins E and I antibody levels GWAS:4799 Verbal aggression in schizophrenia GWAS:4800 Walking pace GWAS:4801 Yoghurt consumption GWAS:4802 Youthful appearance self-reported